.png)
COVID-19 Evidence Reviews
as of 10/4/22
Today's Feature
|
9/14/2022 |
The COVID-19 Evidence Reviews website will be discontinuing updates at the end of September 2022. The website will remain available through April 2023. Additional COVID-19 evidence resources can be found on the Resources page. | |
= living reviewA review with this mark was peer-reviewed, described systematic search and study selection, and included critical appraisal of primary studies.
 latest update date
 |
select |
|
|---|---|---|
|
9/30/22
|
Thapa Magar S, Lokhandwala HI, Batool S, et al. | Cureus
Aim: To investigate COVID-19's neurological manifestations and potential risk variables linked to the emergence of neurological symptoms and signs.
CLINICAL CHARACTERISTICS
|
|
|
9/30/22
|
Aziz AA, Aziz MA, Saleem M, et al. | Cureus
Aim: To determine the clinical, imaging, and laboratory features in adult patients with COVID-19 infection and AP and to determine if there is any relationship between AP and COVID-19 infection.
CLINICAL CHARACTERISTICS
|
|
|
9/30/22
|
Azami M, Nasirkandy MP, Esmaeili Gouvarchin Ghaleh H, et al. | PLoS One
Aim: To evaluate the acceptance of COVID-19 vaccine in pregnant women.
INFECTION CONTROL
|
|
|
9/30/22
|
Yang L, Li J, Wei W, et al. | Front Public Health
Aim: To consolidate evidence from systematic reviews and meta-analyses investigating the impact of the coronavirus disease?2019 (COVID-19) on kidney health, and the associations between kidney diseases and clinical outcomes in COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
9/30/22
|
Bepouka B, Odio O, Mayasi N, et al. | Infect Drug Resist
Aim: To summarize information on the prevalence, risk factors, and outcomes of patients with happy hypoxia to improve their management.
CLINICAL CHARACTERISTICS
|
|
|
9/30/22
|
Mahmud S, Mohsin M, Hossain S, et al. | Heliyon
Aim: To inspect the COVID-19 vaccine acceptance rate worldwide and the regional variation of the acceptance rates among the general population and healthcare workers across different territories of the world.
INFECTION CONTROL
|
|
|
9/30/22
|
Asvapoositkul V, Samuthpongtorn J, Aeumjaturapat S, et al. | Rhinology
Aim: To consolidate existing evidence for current therapies in patients with persistent olfactory dysfunction related to COVID-19 infection and evaluate the possible role of corticosteroid add-on therapy in olfactory training.
LONG COVID
|
|
|
9/28/22
|
Zong X, Wang X, Liu Y, et al. | Front Med
Aim: To provide an overview of existing evidence on antiplatelet therapy in patients with COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
9/28/22
|
Huang HB, Yao Y, Zhu YB, et al. | Front Med
Aim: To conduct an updated meta-analysis enrolling only COVID-19 patients in the ICU who received APP.
|
|
|
9/28/22
|
Zuin M, Rigatelli G, Bilato C, et al. | J Cardiovasc Med
Aim: To evaluate the mortality risk in COVID-19 Italian patients complicated by acute pulmonary embolism in the short-term period.
CLINICAL CHARACTERISTICS
|
|
|
9/28/22
|
Kafadar AH, Tekeli GG, Jones KA, et al. | Z Gesundh Wiss
Aim: To identify those factors that influence COVID-19 vaccination hesitancy in the general population.
INFECTION CONTROL
|
|
|
9/28/22
|
Zhu H, Li M, Tian C, et al. | Front Pharmacol
Aim: To summarize the effectiveness and safety of CHM in the treatment of mild/moderate COVID-19 patients.
CANDIDATE THERAPEUTICS
|
|
|
9/28/22
|
Mardi P, Djalalinia S, Kargar R, et al. | Front Med
Aim: To investigate the existing research evidence and evaluate the effectiveness and consequences of all incentives provided for increasing the uptake of COVID-19 vaccination.
INFECTION CONTROL
|
|
|
9/28/22
|
Mirmosayyeb O, Moases Ghaffary E, et al. | Can J Infect Dis Med Microbiol
Aim: To assess MG patients after the COVID-19 vaccination.
|
|
|
9/28/22
|
Foka FET, Manamela N, Mufamadi SM, et al. | Biomed Res Int
Aim: To highlight the specific attributes that make Azadirachta indica (neem plant) a suitable candidate for the biosynthesis of anti-SARS-CoV-2 nanoparticles.
|
|
|
9/28/22
|
Manolache NG, Mjaess G, Diamand R, et al. | Prog Urol
Aim: To evaluate the effect of androgen deprivation therapy (ADT) on the incidence of infection and severity of SARS-CoV-2 in prostate cancer patients.
CLINICAL CHARACTERISTICS
|
|
|
9/28/22
|
Sharma A, Vats S, Gupta R, et al. | J Lifestyle Med
Aim: To analyse the overall certainty of evidence regarding the effectiveness of exercise treatment, as well as novel emerging chest rehabilitation approaches during COVID-19 outbreak. UPDATED
|
|
|
9/28/22
|
Yin J, Chen Y, Li Y, et al. | Hum Vaccin Immunother
Aim: To investigate the currently available evidence about the efficacy of COVID-19 vaccines in patients with solid cancer.
INFECTION CONTROL
|
|
|
9/26/22
|
Saluja P, Amisha F, Gautam N, et al. | Vaccines
Aim: To analyze the clinical characteristics, therapeutic strategies, and outcomes of patients presenting with ITP after receiving COVID-19 vaccination.
|
|
|
9/26/22
|
Garcia-Lara RA, Gomez-Urquiza JL, Membrive-Jimenez MJ, et al. | J Pers Med
Aim: To analyse the levels and prevalence of anxiety, distress, and stress during the COVID-19 pandemic in diabetic patients. UPDATED
MENTAL HEALTH
|
|
|
9/26/22
|
Albanese A, Sormani MP, Gattorno G, et al. | Mult Scler Relat Disord
Aim: To review the evidence for estimating the severity of COVID-19 events, evaluated as mortality and hospitalization rate, among patients treated with cladribine. UPDATED
|
|
|
9/26/22
|
Bellinato F, Fratton Z, Girolomoni G, et al. | Vaccines
Aim: To estimate the pooled incidence of CARs associated with SARS-CoV-2 vaccination in the general adult population. UPDATED
INFECTION CONTROL
|
|
|
9/26/22
|
Patrizio A, Ferrari SM, Elia G, et al. | Vaccines
Aim: To report all the postvaccine cases of GD documented in the literature up to 31 July 2022, more than a year after the beginning of the immunization campaign, focusing on their main epidemiological and clinics features.
|
|
|
9/26/22
|
Kovacs EH, Tanczos K, Szabo L, et al. | Biomedicines
Aim: To assess whether higher dose (HD) compared with standard dose (SD) versions of thromboprophylaxis have different effects on clinical outcomes without jeopardizing the safety of COVID-19 patients. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
9/26/22
|
Kiaei A, Salari N, Boush M, et al. | Life
Aim: To assess the impact and application of artificial intelligence on the identification of suitable drug combinations for treating COVID-19. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
9/26/22
|
Kang L, Shang W, Gao P, et al. | Vaccines
Aim: To systematically evaluate the immunogenicity and safety of COVID-19 among PLWH. UPDATED
|
|
|
9/26/22
|
Ahmed A, Tanveer M, Shrestha S, et al. | Healthcare
Aim: To review the evidence on the interventions and impact of pharmacist-delivered services in managing COVID-19 patients. UPDATED
|
|
|
9/26/22
|
Veronese N, Bonica R, Cotugno S, et al. | Viruses
Aim: To understand which therapies have proved effective against the symptoms of long COVID-19.
LONG COVID
|
|
|
9/26/22
|
Renzi E, Baccolini V, Migliara G, et al. | Vaccines
Aim: To quantify the prevalence estimates of COVID-19 vaccine acceptance with a specific focus on worldwide geographical differences. UPDATED
INFECTION CONTROL
|
|
|
9/26/22
|
Wang Z, Chen S, Fang Y | Vaccines
Aim: To systematically search and summarize the evidence from literature reporting parental willingness/hesitancy about the vaccination uptake in their children in the time of COVID-19 (in terms of childhood/routine vaccination, seasonal influenza vaccination, human papillomavirus (HPV) vaccination, and pneumococcal conjugate vaccination (PCV)). UPDATED
INFECTION CONTROL
|
|
|
9/26/22
|
Ricco M, Zaniboni A, Satta E, et al. | Diagnostics
Aim: To explore the reliability of EBC as a way to collect respiratory specimens for RT-qPCR for diagnosis of COVID-19.
DIAGNOSTICS
|
|
|
9/26/22
|
Dhungel B, Rahman MS, Rahman MM, et al. | Int J Environ Res Public Health
Aim: To estimate the pooled R0 for early COVID-19 outbreaks and identified the impact of study-related factors such as methods, study location and study period on the estimated R0. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
9/26/22
|
Lao US, Law CF, Baptista-Hon DT, et al. | J Clin Med
Aim: To evaluate the association between statin use and mortality, intensive care unit (ICU) admission and mechanical ventilation in COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
9/26/22
|
Zace D, La Gatta E, Petrella L, et al. | Vaccine
Aim: To summarize and assess available data on the possible impact of COVID-19 vaccines on male and female fertility. UPDATED
|
|
|
9/26/22
|
McLean CP, Utpala R, Sharp G | Front Psychol
Aim: To examine the impact of the COVID-19 pandemic on eating disorders and disordered eating behaviors. UPDATED
MENTAL HEALTH
|
|
|
9/23/22
|
Tsang NNY, So HC, Cowling BJ, et al. | Eur Respir Rev
Aim: To assess the performance of saline and water gargling for SARS-CoV-2 RT-PCR testing in the settings of diagnosing and monitoring viral shedding.
DIAGNOSTICS
|
|
|
9/23/22
|
Moore E, Fadel A, Lane KE, et al. | Nutr Health
Aim: To investigate the effects of consuming a Mediterranean diet on BMI and inflammatory markers of obese/overweight adults (?18 years) at risk of developing severe COVID-19 outcomes. UPDATED
|
|
|
9/22/22
|
Almeda N, Diaz-Milanes D, Guiterrez-Colosia MR, et al. | BMC Psychiatry
Aim: To evaluate the evolution of online MH strategies and recommendations of selected countries to cope with the MH impact of COVID-19 and to review and analyse the current structures of these online MH strategies and recommendations
MENTAL HEALTH
|
|
|
9/22/22
|
Shahsavarinia K, Mahmoodpoor A, Sadeghi-Ghyassi F, et al. | Med J Islam Repub Iran
Aim: To systematically review the reported cases of Bell’s palsy following vaccination against COVID-19.
|
|
|
9/22/22
|
Witarto BS, Visuddho V, Witarto AP, et al. | PLoS One
Aim: To investigate the effect of online MBIs in improving mental health, mainly depression, anxiety, and stress during the COVID-19 pandemic. UPDATED
MENTAL HEALTH
|
|
|
9/22/22
|
Reis S, Metzendorf M, Kuehn R, et al. | Cochrane Database Syst Rev
Aim: To assess the efficacy and safety of nirmatrelvir/ritonavir (Paxlovid®) plus standard of care compared to standard of care with or without placebo, or any other intervention for treating COVID?19 and for preventing SARS?CoV?2 infection.
CANDIDATE THERAPEUTICS
|
|
|
9/22/22
|
Spadaccio C, Pisani A, Salsano A, et al. | Open Med
Aim: To describe the epidemiological characteristics of MI mechanical complications and compare it with the temporal trends and outcomes of the pre-Covid-19 era.
|
|
|
9/20/22
|
Theetha Kariyanna P, Sabih A, Sutarjono B, et al. | Cureus
Aim: To recognize the clinical features of pericarditis and myopericarditis in COVID-19 patients.
MENTAL HEALTH
|
|
|
9/20/22
|
Kumar R, Misra AK, Dutta S, et al. | J Family Med Prim Care
Aim: To conduct a systematic analysis of the cases involving presence of mucormycosis and to find out its association with COVID-19, diabetes mellitus, and corticosteroids.
DIAGNOSTICS
|
|
|
9/20/22
|
Meira-Silva VST, Freire ACTN, Zinezzi DP, et al. | Rev Bras Med Trab
Aim: To present data from Brazilian and international research into the prevalence of burnout syndrome in healthcare workers during the COVID-19 pandemic and observe its possible association with working on the frontline.
MENTAL HEALTH
|
|
|
9/20/22
|
Pata D, Buonsenso D, Valentini P | Mediterr J Hematol Infect Dis
Aim: To identify clinical and laboratory characteristics that allow healthcare workers to differentiate COVID-19 from influenza.
CLINICAL CHARACTERISTICS
|
|
|
9/20/22
|
Hatami H, Qaderi S, Shah J, et al. | Int J Prev Med
Aim: To summarize the data on different ways of managing COVID-19 outbreaks.
CLINICAL CHARACTERISTICS
|
|
|
9/20/22
|
Alimoradi Z, Lotfi A, Lin CY, et al. | Curr Addict Rep
Aim: To estimate the prevalence of different behavioral addictions (i.e., internet addiction, smartphone addiction, gaming addiction, social media addiction, food addiction, exercise addiction, gambling addiction, and shopping addiction) both overall and separately. UPDATED
MENTAL HEALTH
|
|
|
9/20/22
|
Keikha M, Karbalaei M | Microb Pathog
Aim: To investigate the effect of polymorphisms such as rs4646994 and rs2285666 on susceptibility to coronavirus disease-2019 (COVID-19).
LONG COVID
|
|
|
9/20/22
|
Alimohamadi Y, Yekta EM, Sepandi M, | Multidiscip Respir Med
Aim: To collectively estimate the hospital length of stay (LoS) in COVID-19 hospitalized individuals.
INFECTION CONTROL
|
|
|
9/20/22
|
Westphal A, Kalinowski E, Hoferichter CJ, et al. | Front Psychol
Aim: To summarize the existing empirical findings on K?12 teachers' stress and burnout during the COVID-19 pandemic.
CLINICAL CHARACTERISTICS
|
|
|
9/20/22
|
Fazzini B, Battaglini D, Carenzo L, et al. | Br J Anaesth
Aim: To evaluate health-related quality of life (HRQoL), and physical and psychological impairments in ARDS survivors from 3 months to 5 yr follow-up after ICU discharge.
|
|
|
9/20/22
|
Chien TJ, Liu CY, Chang YI, et al. | Front Pharmacol
Aim: To evaluate the efficacy of HM in the treatment of COVID-19 objectively. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
9/19/22
|
Casman C, Fitriani N, Gunawan D, et al. | Florence Nightingale J Nurs
Aim: To analyze the effectiveness of convalescent plasma therapy in children who are confirmed positive for coronavirus disease-2019.
CANDIDATE THERAPEUTICS
|
|
|
9/19/22
|
Reis S, Popp M, Schieber S, et al. | Thromb Res
Aim: To determine the safety and efficacy of anticoagulation at any dosage with standard low-dose prophylactic anticoagulation or no prophylaxis in COVID-19 patients regardless of disease severity and treatment setting.
CANDIDATE THERAPEUTICS
|
|
|
9/19/22
|
de Melo EGM, Andrade RM, de Abreu de Vasconcellos SJ, et al. | Inflammopharmacology
Aim: To investigate the inflammatory biomarkers levels in patients with COVID-19 presenting chemosensory dysfunctions.
INFECTION CONTROL
|
|
|
9/19/22
|
Cong WH, Saha BK, Tan CK | Prague Med Rep
Aim: To assess the efficacy of routine APP versus standard care in preventing death and invasive mechanical ventilation (IMV) in non-intubated hypoxic COVID-19 patients. UPDATED
|
|
|
9/19/22
|
Alhumaid S, Al Mutair A, Busubaih JS, et al. | Infect Agent Cancer
Aim: To estimate the prevalence of SARS-CoV-2 infection in CRC patients and analyse the demographic parameters, clinical characteristics and treatment outcomes in CRC patients with COVID-19 illness with larger and better-quality data.
MENTAL HEALTH
|
|
|
9/19/22
|
Bronz G, Fare PB, Lava SAG, et al. | J Autoimmun
Aim: To determine whether COVID-19 or vaccination against SARS-CoV-2 may be temporally related to a new-onset, or a flare, of an immunoglobulin A-mediated disorder.
CLINICAL CHARACTERISTICS
|
|
|
9/19/22
|
Belay GM, Alemu TG, Techane MA, et al. | Hum Vaccin Immunother
Aim: To determine the overall pooled estimate of COVID-19 vaccine acceptance and its predictors in Ethiopia.
INFECTION CONTROL
|
|
|
9/19/22
|
Farisogullari B, Pinto AS, Machado PM | RMD Open
Aim: To review all the reported cases of ‘COVID-19-associated arthritis'.
INFECTION CONTROL
|
|
|
9/19/22
|
Xie J, He Y, Zheng Y, et al. | Microbiol Res
Aim: To assess the diagnostic accuracy of the rapid antigen test (RAT) compared with RT-PCR (reference standard) for SARS-CoV-2. UPDATED
DIAGNOSTICS
|
|
|
9/19/22
|
Almeida PRL, Person OC, Puga MEDS, et al. | Sao Paulo Med J
Aim: To evaluate the effectiveness and safety of tocilizumab for treating COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
9/19/22
|
Yulistiani, Neldi V, Suprapti B, et al. | J Pharm Pharm Sci
Aim: To analyze the efficacy and safety of anticoagulants for COVID-19 patients in the intensive care unit.
CANDIDATE THERAPEUTICS
|
|
|
9/19/22
|
Wang Z, Teng H, Wu X, et al. | Front Neurol
Aim: To evaluate the efficacy and safety of recanalization therapy for COVID-19 patients who suffered from AIS.
|
|
|
9/19/22
|
Perez Navarro A, Pilkington V, Pepperrell T, et al. | Open Forum Infect Dis
Aim: To compare the efficacy and safety of existing FDA/EMA-unapproved vaccines to FDA/EMA-approved vaccines.
MENTAL HEALTH
|
|
|
9/19/22
|
Yang CW, Chen RD, Zhu QR, et al. | Front Immunol
Aim: To evaluate the effectiveness of UC-MSCs inpatients with COVID-19. UPDATED
|
|
|
9/19/22
|
Kulper-Schiek W, Piechotta V, Pilic A, et al. | Front Immunol
Aim: To summarize evidence on the effectiveness of the coronavirus disease 2019 (COVID-19) vaccine (vaccine effectiveness, VE) and duration of protection against Omicron.
LONG COVID
|
|
|
9/19/22
|
Liu E, Smyth RL, Li Q, et al. | Eur J Pediatr
Aim: To review the evidence on the diagnosis and management of children with COVID-19.
DIAGNOSTICS
|
|
|
9/19/22
|
Abolmaali M, Rezania F, Behnagh AK, et al. | Immunol Res
Aim: To assess different demographic, clinical, and neurophysiological aspects of patients with GBS following immunization with COVID-19 vaccines.
CANDIDATE THERAPEUTICS
|
|
|
9/19/22
|
Boroumand AB, Forouhi M, Karimi F, et al. | Front Immunol
Aim: To assess the immunogenicity of COVID-19 vaccines and its’ associated factors in patients with DM.
INFECTION CONTROL
|
|
|
9/19/22
|
Marcec R, Dodig VM, Radanovic I, et al. | Rev Med Virol
Aim: To investigate the potential impact of IVIg on mortality and length of hospitalisation in adult COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
9/19/22
|
Kloping YP, Hidayatullah F, Rahman ZA, et al. | World J Mens Health
Aim: To evaluate whether SARS-CoV-2 infection affects the male reproductive system.
CLINICAL CHARACTERISTICS
|
|
|
9/19/22
|
Llana T, Zorzo C, Mendez-Lopez M, et al. | Appl Neuropsychol Adult
Aim: To analyze the existing evidence of objective memory impairments in long-COVID-19, as well as to explore associations between memory performance and their epidemiological, clinical, and pathological features.
CLINICAL CHARACTERISTICS
|
|
|
9/19/22
|
Voleti N, Reddy SP, Ssentongo P | Front Cardiovasc Med
Aim: To compare the incidence of myocarditis in COVID-19 vaccines and in severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) infection groups.
CLINICAL CHARACTERISTICS
|
|
|
9/19/22
|
Liang H, Zhang M, Chen M, et al. | Asia Pac J Public Health
Aim: To summarize the latest literature on the trends and incidence of ocular trauma during the COVID-19 pandemic.
CLINICAL CHARACTERISTICS
|
|
|
9/19/22
|
Balestracci B, La Regina M, Di Sessa D, et al. | Intern Emerg Med
Aim: To investigate physiological impact, safety, and risk of masks in predefined categories of patients.
INFECTION CONTROL
|
|
|
9/19/22
|
Pellegrino R, Chiappini E, Licari A, et al. | Eur J Pediatr
Aim: To summarize the current evidence regarding Long COVID in children, with a focus on prevalence and clinical presentation.
LONG COVID
|
|
|
9/19/22
|
Khidir RJY, Ibrahim BAY, Adam MHM, et al. | Int J Health Sci
Aim: To provide a narrative review of the different presentations and mechanisms involved in hyponatremia reported in patients with COVID-19 infection.
CLINICAL CHARACTERISTICS
|
|
|
9/19/22
|
Delpino FM, da Silva CN, Jeronimo JS, et al. | J Affect Disord
Aim: To update the prevalence of anxiety in the general population during the COVID-19 pandemic up to January 2022.
INFECTION CONTROL
|
|
|
9/19/22
|
Li WT, Zhang Y, Liu M, et al. | Eur J Pediatr
Aim: To summarize the duration of fecal viral shedding in children with COVID-19.
INFECTION CONTROL
|
|
|
9/19/22
|
Kaubisch LT, Reck C, von Tettenborn A, et al. | J Affect Disord
Aim: To investigate trauma-related symptoms in the course of the COVID-19 pandemic and the association of the pandemic and its containment measures with trauma-related disorders or symptoms.
CLINICAL CHARACTERISTICS
|
|
|
9/19/22
|
Rahmani K, Shavaleh R, Forouhi M, et al. | Front Public Health
Aim: To evaluate the effectiveness of COVID-19 vaccines, the incidence of SARS-CoV-2 infection, and the hospitalization and mortality due to COVID-19 after vaccination in observational studies. UPDATED
INFECTION CONTROL
|
|
|
9/19/22
|
Trott M, Driscoll R, Pardhan S | Front Med
Aim: To examine the prevalence of persistent anosmia, hyposmia, ageusia, hypogeusia, as well as eye and ear related symptoms related long-COVID, across all populations, that persisted for longer than 12 weeks.
|
|
|
9/19/22
|
Cong B, Deng S, Wang X, et al. | J Glob Health
Aim: To understand the impact of influenza/RSV co-infection on clinical disease severity among COVID-19 patients. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
9/19/22
|
Onakpoya IJ, Heneghan CJ, Spencer EA, | J Hosp Infect
Aim: To assess whether SARS-CoV-2 can be transmitted through fomites, using evidence from viral culture studies. UPDATED
INFECTION CONTROL
|
|
|
9/12/22
|
Deng J, Ma Y, Liu Q, et al. | Int J Environ Res Public Health
Aim: To review the data available to evaluate and compare the effectiveness and safety of heterologous booster doses with homologous booster doses for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines.
INFECTION CONTROL
|
|
|
9/12/22
|
Hasan F, Chiu HY, Salamanca E, et al. | Eur J Dent
Aim: To examine the effects of chlorhexidine (CHX) and povidone-iodine (PVP-I) on the viral load in patients with COVID-19. UPDATED
|
|
|
9/12/22
|
Lee HJ, Lee JH, Cho Y, et al. | Int J Environ Res Public Health
Aim: To investigate the efficacy and safety of convalescent plasma (CP) transfusion against the coronavirus disease 2019 (COVID-19).
CANDIDATE THERAPEUTICS
|
|
|
9/12/22
|
Brakspear L, Boules D, Nicholls D, et al. | Nutrients
Aim: To systematically review and appraise the current literature on the impact of COVID-19-related living restrictions on the eating behaviours of children and adolescents. UPDATED
MENTAL HEALTH
|
|
|
9/9/22
|
Bert F, Moro GL, Peano A, et al. | Perspect Public Health
Aim: To describe what has been published on COVID-19 outbreaks originating from indoor places of worship.
INFECTION CONTROL
|
|
|
9/9/22
|
Liang W, Duan Y, Li F, et al. | Ann Behav Med
Aim: To systematically review and meta-analyze available evidence on psychosocial determinants of the general population's practice of three precautionary behaviors, based on the Risk, Attitudes, Norms, Abilities, and Self-regulation (RANAS) framework. UPDATED
INFECTION CONTROL
|
|
|
9/8/22
|
Sharma R, Kumar A, Majeed J, et al. | Egypt Heart J
Aim: To find out the role of drugs acting on RAAS, particularly ACEi/ARBs in the deaths of COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
9/8/22
|
Lee JH, Yim J, Park J | Respir Res
Aim: To estimate the pooled prevalence of the pulmonary sequelae of COVID-19, as demonstrated by pulmonary function testing (PFT) and chest computed tomography (CT) performed at least 6 months after initial infection. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
9/7/22
|
Rahmig J, Altarsha E, Siepmann T, et al. | Neuropsychiatr Dis Treat
Aim: To systematically review the literature to summarize the available evidence on the association between SARS-CoV-2 vaccination and acute ischemic stroke.
|
|
|
9/7/22
|
Taha AM, Shaarawy AS, Omar MM, et al. | J Transl Med
Aim: To evaluate the effect of Omega-3 on CRP change and CRP level in patients with COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
9/7/22
|
Martins-Filho PR, do Nascimento-Júnior EM, Barreto-Alves JA, et al. | Eur J Clin Pharmacol
Aim: To review the best evidence on the efficacy and safety of nitazoxanide in COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
9/7/22
|
Arif A, Chavarria Y, Qamar MA, et al. | Neuropsychiatr Dis Treat
Aim: To study the clinical picture of NORSE secondary to COVID-19 infection.
CLINICAL CHARACTERISTICS
|
|
|
9/6/22
|
Toro-Huamanchumo CJ, Hilario-Gomez MM, Pinedo-Castillo L, et al. | New Microbes New Infect
Aim: To evaluate the clinical and epidemiological characteristics in patients with COVID-19 reinfection. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
9/6/22
|
Chen Z, Peng Y, Wu X, et al. | Front Public Health
Aim: To identify and assess in-hospital data on comorbidities and complications of COVID-19 that are associated with various levels of disease severity, progression, and mortality in China during centralized isolation and hospitalization. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
9/6/22
|
Sahile AT, Gizaw GD, Mgutshini T, et al. | Can J Infect Dis Med Microbiol
Aim: To review the evidence on the overall level of COVID-19 vaccine acceptance in Ethiopia.
INFECTION CONTROL
|
|
|
9/6/22
|
Addo IY, Dadzie FA, Okeke SR, et al. | Arch Public Health
Aim: To review the evidence on the duration of immunity following full vaccination against SARS-CoV-2.
INFECTION CONTROL
|
|
|
9/6/22
|
Mourikis I, Kokka I, Koumantarou-Malisiova E, et al. | Front Psychiatry
Aim: To systematically explore the potential impact of COVID-19 pandemic on aspects of sexual wellbeing, quantify the change with respect to sexual function, and identify probable behavioral changes.
MENTAL HEALTH
|
|
|
9/6/22
|
Aljishi RS, Alkuaibi AH, Al Zayer FA, et al. | Cureus
Aim: To find the survival outcomes of patients with and without COVID-19 ARDS who were supported with extracorporeal membrane oxygenation (ECMO).
|
|
|
9/6/22
|
Terry E, Cartledge S, Damery S, et al. | BMC Public Health
Aim: To identify factors associated with public intention to receive COVID-19 vaccines until February 2021 to provide accessible data to policymakers to inform framing and targeting of messages designed to optimise vaccine uptake. UPDATED
INFECTION CONTROL
|
|
|
9/6/22
|
Peng Y, Zhong GC, Zhou X, et al. | BMC Geriatr
Aim: To quantify the associations of frailty status with all-cause and cause-specific mortality.
|
|
|
9/6/22
|
Hossain MM, Nesa F, Das J, et al. | Psychiatry Res
Aim: To summarize the global evidence on the epidemiological burden and correlates of mental health problems among children and adolescents during the COVID-19 pandemic from existing systematic reviews and meta-analyses.
MENTAL HEALTH
|
|
|
9/6/22
|
Notarte KI, Catahay JA, Velasco JV, et al. | EClinicalMedicine
Aim: To review the evidence on the impact of COVID-19 vaccines on the risk of developing long-COVID or on existing long-COVID in COVID-19 survivors.
LONG COVID
|
|
|
9/6/22
|
Webster KE, O'Byrne L, MacKeith S, et al. | Cochrane Database Syst Rev
Aim: To evaluate the benefits and harms of any intervention versus no treatment for people with acute olfactory dysfunction due to COVID-19 infection.
CANDIDATE THERAPEUTICS
|
|
|
9/6/22
|
O'Byrne L, Webster KE, MacKeith S, et al. | Cochrane Database Syst Rev
Aim: To assess the effects (benefits and harms) of interventions that have been used, or proposed, to treat persisting olfactory dysfunction due to COVID-19 infection. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
9/6/22
|
Tariq M, Acharekar MV, Guerrero Saldivia SE, et al. | Cureus
Aim: To focus on the two main long-standing symptoms, fatigue and headaches, resulting in poor work performance and difficulty in performing daily activities of life.
LONG COVID
|
|
|
9/6/22
|
Ghasemi S, Dashti M, Fahimipour A, et al. | Eur J Dent
Aim: To review the evidence on COVID-19 associated mucormycosis (CAM) to investigate what are the contributing factors to the outcome of mucormycosis in COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
9/6/22
|
Choudhuri AH, Duggal S, Singh J, et al. | J Anaesthesiol Clin Pharmacol
Aim: To review the evidence on the safety and efficacy of convalescent plasma use in COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
9/6/22
|
Gallardo VJ, Shapiro RE, Caronna E, et al. | Headache
Aim: To study the relationship between coronavirus disease 2019 (COVID-19) mortality and headache among patients evaluated for COVID-19 in Emergency Departments and hospitals.
CLINICAL CHARACTERISTICS
|
|
|
9/6/22
|
Shrestha AB, Aryal M, Magar JR, et al. | Ann Med Surg
Aim: To observe the current scenario of self-medication regarding the management or prevention of COVID-19. UPDATED
|
|
|
9/2/22
|
Zinellu A, Mangoni AA | Expert Rev Clin Immunol
Aim: To review the evidence on the association between the neutrophil, lymphocyte, and platelet count, neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR), and COVID-19 progression and mortality. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
9/2/22
|
Shahramian I, Parooie F, Salarzaei M | Pol Przegl Chir
Aim: To evaluate the prevalence of acute cholecystitis (AC) and review its possible management options during the COVID-19 pandemic.
CLINICAL CHARACTERISTICS
|
|
|
9/2/22
|
Khairwa A, Jat KR | Forensic Sci Med Pathol
Aim: To evaluate autopsy findings in COVID-19 paediatric cases.
CLINICAL CHARACTERISTICS
|
|
|
9/2/22
|
Zewde MG, Alpert N, Taioli E | JNCI Cancer Spectr
Aim: To determine whether cancer is an independent risk factor for COVID-19 mortality.
CLINICAL CHARACTERISTICS
|
|
|
9/2/22
|
Wu PC, Huang IH, Wang CW, et al. | Am J Clin Dermatol
Aim: To investigate the demographics, clinical variables, and outcomes associated with psoriasis following COVID-19 vaccination. UPDATED
INFECTION CONTROL
|
|
|
9/1/22
|
Hyllestad S, Myrmel M, Lomba JAB, et al. | J Water Health
Aim: To identify and synthesise evidence on the ES of SARS-CoV-2 as an EWS to evaluate the added value for public health.
INFECTION CONTROL
|
|
|
9/1/22
|
Ghasemi H, Darvishi N, Salari N, et al. | Trop Med Health
Aim: To evaluate the prevalence of polypharmacy among the COVID-19 patients, and the side effects, by systematic review and meta-analysis. UPDATED
|
|
|
9/1/22
|
Bayati M, Noroozi R, Ghanbari-Jahromi M, et al. | Int J Equity Health
Aim: To determine inequality in vaccine distribution in the world.
INFECTION CONTROL
|
|
|
8/31/22
|
Sayfollahi S, Momeni Z, Bagherzadeh S, et al. | Research Square
Aim: To determine whether LDRT effectively treats COVID-19-associated pneumonia.
CANDIDATE THERAPEUTICS
|
|
|
8/31/22
|
Silva PG, Branco PTBS, Soares RRG, et al. | Indoor Air
Aim: To present an overview of the current aerosol sampling methods (and equipment) being used to investigate the presence of SARS-CoV-2 in the air, along with the main parameters reported in the studies that are essential to analyze the advantages and disadvantages of each method and perspectives for future research regarding this mode of transmission.
INFECTION CONTROL
|
|
|
8/30/22
|
Woller SC, de Wit K, Robert-Ebadi H, et al. | Res Pract Thromb Haemost
Aim: To report the evidence on the prognostic biomarkers for identifying hospitalized patients with COVID?19 at higher risk of developing VTE.
CLINICAL CHARACTERISTICS
|
|
|
8/30/22
|
Elshenawy RA, Umaru N, Alharbi AB, et al. | Research Square
Aim: To investigate the AMS intervention Pre-pandemic (PP) and During-the-pandemic (DP) from the literature. UPDATED
|
|
|
8/30/22
|
Maleki M, Maarefvand M, Nazeri AR, et al. | Iran J Otorhinolaryngol
Aim: To describe the impact of COVID-19 on the auditory-vestibular system and communication problems in subjects with hearing impairment.
CLINICAL CHARACTERISTICS
|
|
|
8/30/22
|
Li Y, Luo W, Liang B | Front Nutr
Aim: To evaluate the trace element status in COVID-19 disease by conducting a meta-analysis.
CLINICAL CHARACTERISTICS
|
|
|
8/30/22
|
Zhao R, Shi J, Song Y, et al. | Therap Adv Gastroenterol
Aim: To summarize laboratory features in COVID-19 with GI symptoms and non-GI symptoms.
CLINICAL CHARACTERISTICS
|
|
|
8/30/22
|
Dadras O, SeyedAlinaghi S, Karimi A, et al. | Arch Acad Emerg Med
Aim: To systematically review the studies regarding the COVID-19 vaccines’ protection three or more months after getting fully vaccinated and assess if vaccine booster doses are required.
INFECTION CONTROL
|
|
|
8/30/22
|
Nabeel A, Al-Sabah SK, Ashrafian H | Med Princ Pract
Aim: To investigate the effectiveness of contact tracing applications currently available in the context of the COVID-19 pandemic.
INFECTION CONTROL
|
|
|
8/30/22
|
Tang HJ, Weng TS, Chen YH, et al. | J Microbiol Immunol Infect
Aim: To investigate the clinical efficacy and safety of oral Janus kinase inhibitors (JAKis) in the treatment of hospitalized patients with COVID-19. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
8/30/22
|
Joli J, Buck P, Zipfel S, et al. | Front Psychiatry
Aim: To describe all symptoms related to post-COVID-19 fatigue, its possible etiology and risk factors as well as treatment approaches employed so far.
LONG COVID
|
|
|
8/30/22
|
Tsiorou K, Sarantaki A | Maedica
Aim: To investigate the literature so as to estimate the safety of COVID-19 vaccination among pregnant women compared with unvaccinated pregnant women, regardless of the trimester of their pregnancy.
INFECTION CONTROL
|
|
|
8/30/22
|
Dadras O, Mehraeen E, Karimi A, et al. | Arch Acad Emerg Med
Aim: To review the evidence on the adverse events of the existing inactivated vaccines and Novavax to determine their safety.
INFECTION CONTROL
|
|
|
8/30/22
|
AlRasheed MM, Fekih-Romdhane F, Jahrami H, et al. | Sleep Med
Aim: To undertake an individual participant data (IPD) analysis to further investigate past meta-analyses, a method that has been shown to be more robust than standard meta-analyses.
|
|
|
8/30/22
|
Do B, Kirkland C, Besenyi GM, et al. | Prev Med Rep
Aim: To identify, evaluate, and synthesize evidence from available published literature examining the impact of the coronavirus disease 2019 (COVID-19) pandemic on youth physical activity (PA).
|
|
|
8/29/22
|
Sakuraba A, Luna A, Micic D | Viruses
Aim: To evaluate the serologic response to the COVID-19 vaccine in SOT recipients.
INFECTION CONTROL
|
|
|
8/29/22
|
Nagarajan R, Krishnamoorthy Y, Rajaa S, et al. | Prev Chronic Dis
Aim: To determine the association of chronic liver disease (CLD), a comorbid condition, with severity of disease and death among COVID-19 patients. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
8/29/22
|
Wal P, Dwivedi J, Wal A, et al. | Curr Diabetes Rev
Aim: To examine the data on the link between diabetes and COVID-19, the pathogenesis of diabetes, and treatment of COVID-19 infection in diabetic patients.
CLINICAL CHARACTERISTICS
|
|
|
8/29/22
|
Maia R, Carvalho V, Faria B, et al. | Micromachines
Aim: To provide an overview of the COVID-19 diagnosis methods and tests already available, as well as their evolution in recent months.
DIAGNOSTICS
|
|
|
8/29/22
|
Mei F, Rota M, Bonifazi M, et al. | J Clin Med
Aim: To summarize data from the literature on the diagnostic yield of BAL for the detection of SARS-CoV-2 in cases with high clinical suspicion for COVID-19 and at least one negative NPS.
DIAGNOSTICS
|
|
|
8/29/22
|
Kang H, Gu X, Tong Z | J Intensive Care Med
Aim: To assess whether APP can reduce the intubation rate and mortality of COVID-19 adults with acute hypoxemic respiratory failure than standard care.
|
|
|
8/29/22
|
Rezaei Tolzali MM, Noori M, Shokri P, et al. | Rev Med Virol
Aim: To determine the efficacy of tocilizumab in treating COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
8/29/22
|
Islam MA, Cavestro C, Alam SS, et al. | Cells
Aim: To systematically evaluate the characteristics (clinical, neuro-radiological aspects, and laboratory features) and outcomes of encephalitis in COVID-19 patients, as well as the possible causative mechanisms of CNS damage. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
8/29/22
|
Montealegre L, Amador E, Pulido T, et al. | J Hypertens
Aim: To determine through the systematic review the survival rate of patients infected by SARS-CoV-2 and previously diagnosed with arterial hypertension and/or diabetes.
CLINICAL CHARACTERISTICS
|
|
|
8/29/22
|
Pires C | Vaccines
Aim: To identify and analyse the most relevant global predictors of COVID-19 vaccine acceptance and/or hesitancy, which were specifically estimated through multivariate regression models.
INFECTION CONTROL
|
|
|
8/29/22
|
Torge D, Bernardi S, Arcangeli M, et al. | Pathogens
Aim: To conduct a histopathological overview of COVID-19 structural and ultrastructural alterations in different organs and tissues, excluding the respiratory system.
CLINICAL CHARACTERISTICS
|
|
|
8/29/22
|
Ahmed TI, Rishi S, Irshad S, et al. | Front Immunol
Aim: To systematically review the overall efficacy, immunogenicity, and safety of BBV152 Covaxin vaccine.
INFECTION CONTROL
|
|
|
8/29/22
|
Abu Hammour K, Abu Farha R, Manaseer Q, et al. | Arch Rheumatol
Aim: To evaluate clinical features, diagnostic tests, current therapeutic management, and outcomes of MIS-C cases in children and adolescents reported in the literature and to evaluate the common points between the MIS-C and KD.
CLINICAL CHARACTERISTICS
|
|
|
8/29/22
|
Hameed I, Khan MO, Nusrat K, et al. | Am J Infect Control
Aim: To primarily evaluate the safety of the COVID-19 vaccine and to further investigate its efficacy.
INFECTION CONTROL
|
|
|
8/29/22
|
Tsermpini EE, Glamoclija U, Ulucan-Karnak F, et al. | Antioxidants
Aim: To extract the relevant genetic variants within the oxidative stress pathway associated with COVID-19 and the anti-oxidative therapies currently evaluated in the clinical trials for COVID-19 treatment, in particular clinical trials on glutathione and N-acetylcysteine.
CANDIDATE THERAPEUTICS
|
|
|
8/29/22
|
Dorantes-Acosta E, Ávila-Montiel D, Domínguez Rojas J, et al. | Front Pediatr
Aim: To determine COVID-19 mortality rates in LAC pediatric cancer patients.
CLINICAL CHARACTERISTICS
|
|
|
8/29/22
|
Nabizadeh F, Ramezannezhad E, Kazemzadeh K, et al. | J Clin Neurosci
Aim: To perform a systematic review of case reports and case series studies to investigate the MS relapses after COVID-19 vaccination with most details.
|
|
|
8/29/22
|
Li M, Wang X, Feng J, et al. | Vaccines
Aim: To assess the incidence of myocarditis and pericarditis after COVID-19 vaccination in children and adolescents. UPDATED
|
|
|
8/29/22
|
Di Spirito F, Amato A, Di Palo MP, et al. | Int J Environ Res Public Health
Aim: To assess current data on cases diagnosed with oral lesions among adult subjects (?18 years old) who had received at least one dose of the World Health Organization (WHO) Emergency Use Listing approved [10] and European Medicines Agency (EMA) authorized [11] anti-SARS-CoV-2 vaccines, classify oral mucosal manifestations based on primary oral lesions, and describe their macroscopic and microscopic features. UPDATED
|
|
|
8/29/22
|
Huilei Zhao MD, Shanshan Huang MD, Shan Huang MD, et al. | Br J Clin Pharmacol
Aim: To assess the prevalence use of NSAIDs in the general COVID-19 population.
CANDIDATE THERAPEUTICS
|
|
|
8/29/22
|
Xu X, Feng Y, Jia Y, et al. | Thromb Res
Aim: To review the evidence on the relationship between both VWF and its cleaving protease ADAMTS13 (a disintegrin and metalloproteinase with thrombospondin type 1 motif, member 13) with the prognosis of COVID-19. UPDATED
|
|
|
8/29/22
|
Muchtaridi M, Amirah SR, Harmonis JA, et al. | Antioxidants
Aim: To review the evidence on the prospect of utilizing natural antioxidants as long-term treatment for COVID-19 via the Nrf2 signaling pathway.
LONG COVID
|
|
|
8/29/22
|
Alhumaid S, Rabaan AA, Dhama K, et al. | Vaccines
Aim: To delineate the range of organ rejections that were elicited following COVID-19 vaccination or SARS-CoV-2 infection.
|
|
|
8/29/22
|
Scarpelli S, Zagaria A, Ratti PL, et al. | Sleep Med
Aim: To provide an update on sleep quality in different world areas and better characterize subjective sleep alterations during the COVID-19 pandemic. UPDATED
|
|
|
8/29/22
|
Lai CC, Wang YH, Chen KH, et al. | Viruses
Aim: To compare the clinical efficacy and safety of anti-viral agents for the prevention of disease progression among non-hospitalized patients with COVID-19. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
8/29/22
|
Parthasarathi A, Padukudru S, Arunachal S, et al. | Vaccines
Aim: To assess the relationship between on-admission NLR values and COVID-19-related disease severity and mortality outcomes. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
8/26/22
|
Acute Arterial Ischemic Stroke Following COVID-19 Vaccination: A Systematic Review and Meta-analysis
 Stefanou MI, Palaiodimou L, Aguiar de Sousa D, et al. | Neurology
Aim: To provide the prevalence of arterial AIS following exposure to vectorbased and mRNA SARS-CoV-2 vaccines. UPDATED
|
|
|
8/26/22
|
Application of Telerehabilitation for Older Adults During the COVID-19 Pandemic: A Systematic Review
Ahmadi Marzaleh M, Peyravi M, Azhdari N, et al. | Disaster Med Public Health Prep
Aim: To evaluate the investigations that utilized telerehabilitation to assist elderly people during the COVID-19 pandemic. UPDATED
|
|
|
8/26/22
|
Jalili M, Sayehmiri K, Ansari N, et al. | Adv Respir Med
Aim: To examine the association between the risk of atherosclerosis, and influenza virus (IV-A and IV-B) and COVID-19 infections in this study.
CLINICAL CHARACTERISTICS
|
|
|
8/26/22
|
Chilkoti GT, Mohta M, Ahmad Z, et al. | Adv Respir Med
Aim: To evaluate the feasibility and efficacy of awake PP along with NIV in them.
|
|
|
8/26/22
|
Zavalaga-Zegarra HJ, Palomino-Gutierrez JJ, Ulloque-Badaracco JR, et al. | Trop Med Infect Dis
Aim: To investigate the CAR values with respect to the severity and mortality of COVID-19 patients. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
8/26/22
|
Ke Y, Zhu Y, Chen S, et al. | Infect Dis Ther
Aim: To explore circulating pneumoproteins in the diagnosis, severity, and prognosis of COVID-19 by meta-analysis.
CLINICAL CHARACTERISTICS
|
|
|
8/26/22
|
Greer N, Bart B, Billington CJ, et al. | BMJ Open
Aim: To examine major organ damage postdischarge among adults hospitalised for COVID-19 versus non-COVID-19 controls. UPDATED VA ESP
LONG COVID
|
|
|
8/26/22
|
Rinaldi I, Pratama S, Wiyono L, et al. | Front Oncol
Aim: To evaluate the efficacy of mRNA vaccines on hematological malignancies.
INFECTION CONTROL
|
|
|
8/26/22
|
Ulloque-Badaracco JR, Alarcon-Braga EA, Hernandez-Bustamante EA, et al. | Trop Med Infect Dis
Aim: To evaluate the association of fibrinogen-to-albumin ratio and blood urea nitrogen-to-albumin ratio with the severity and mortality of COVID-19 patients. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
8/26/22
|
Choudhury A, Tariq R, Jena A, et al. | Therap Adv Gastroenterol
Aim: To assess the GI manifestation of ‘long COVID’ and the frequency of these manifestations.
LONG COVID
|
|
|
8/26/22
|
Rahmati F, Khalili R | J Educ Health Promot
Aim: To investigate the effect of psychological interventions in response to stress, anxiety, and depression in COVID-19 patients.
MENTAL HEALTH
|
|
|
8/26/22
|
Oueijan RI, Hill OR, Ahiawodzi PD, et al. | Medicines
Aim: To discuss the clinical presentation and patient demographics of severe adverse effects following immunization with the approved mRNA-based COVID-19 vaccines.
INFECTION CONTROL
|
|
|
8/26/22
|
Terlizzi V, Motisi MA, Pellegrino R, et al. | Front Pediatr
Aim: To highlight the main risk factors for severe COVID-19 in patients with CF.
CLINICAL CHARACTERISTICS
|
|
|
8/26/22
|
Paterson C, Davis D, Roche M, et al. | J Med Virol
Aim: To determine the physical, psychological, social, and spiritual impacts of the illness which extend beyond the acute phase of COVID-19 survivors.
MENTAL HEALTH
|
|
|
8/25/22
|
Baral PK, Aziz MA, Islam MS | Health Sci Rep
Aim: To find out the significant risk factors and the extent of similarities in CAM and CAA pathogenesis, tracing points to control and manage these infections.
CLINICAL CHARACTERISTICS
|
|
|
8/25/22
|
Duo H, Li Y, Sun Y, et al. | Thromb J
Aim: To review the evidence on the efficacy and safety of therapeutic anticoagulation (T-AC) versus a lower dose, prophylaxis anticoagulation (P-AC) in COVID-19 patients. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
8/25/22
|
Richter SA, Ferraz-Rodrigues C, Schilling LB, et al. | J Sleep Res
Aim: To review the evidence on the potential influence of the COVID-19 pandemic on sleep quality in children and adolescents. UPDATED
|
|
|
8/25/22
|
Nagraj S, Varrias D, Hernandez Romero G, et al. | Stroke
Aim: To provide an accurate and reliable estimate of stroke incidence among patients with COVID-19 by assessing strokes reported as outcome or adverse events in RCTs in COVID-19 patients. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
8/25/22
|
Lewis HC, Ware H, Whelan M, et al. | BMJ Glob Health
Aim: To estimate SARS-CoV-2 seroprevalence in Africa to inform evidence-based decision making on public health and social measures (PHSM) and vaccine strategy.
INFECTION CONTROL
|
|
|
8/25/22
|
Putra SP, Hidayat T, Zhuhra RT | Forensic Sci Med Pathol
Aim: To understand SARS-CoV-2 persistence and infectivity in COVID-19 corpses.
INFECTION CONTROL
|
|
|
8/25/22
|
Aldhamin RA, Al Saif AZ | J Taibah Univ Med Sci
Aim: To summarize the available evidence on the prevalence of stress, burnout, anxiety, and depression among HCWs in GCC countries during the COVID-19 pandemic.
MENTAL HEALTH
|
|
|
8/25/22
|
Luo W, Cai Q, Zhou Y, et al. | BMC Public Health
Aim: To analyze changes in parental feeding practices during COVID-19 that may help shape future interventions and make parental guidance more targeted.
|
|
|
8/24/22
|
Jia LL, Zhao JX, Pan NN, et al. | Eur J Radiol Open
Aim: To provide an overview of radiomics studies identifying COVID-19 from other pneumonias and evaluate the efficacy of prediction models. UPDATED
DIAGNOSTICS
|
|
|
8/24/22
|
Chaudhary H, Nasir U, Syed K, et al. | Hematol Rep
Aim: To provide a comprehensive summary of the available evidence regarding COVID-19-associated TTP with a brief mention of a case at our healthcare center.
CLINICAL CHARACTERISTICS
|
|
|
8/24/22
|
Ezzatvar Y, Ramírez-Vélez R, Izquierdo M, et al. | Br J Sports Med
Aim: To quantify the association between physical activity and risk of SARS-CoV-2 infection, COVID-19-associated hospitalisation, severe illness and death due to COVID-19 in adults. UPDATED
|
|
|
8/24/22
|
Wynants L, Van Calster B, Bonten MMJ | BMJ
Aim: To review and critically appraise published and preprint reports of models that aim to predict either (i) presence of existing COVID-19 infection, or (ii) future complications in individuals already diagnosed with COVID-19 UPDATED
DIAGNOSTICS
|
|
|
8/24/22
|
Almadhoon HW, Hamdallah A, Elsayed SM, et al. | Sci Rep
Aim: To review the evidence on the link between influenza vaccination and the severity of COVID-19 infection. UPDATED
|
|
|
8/23/22
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the impact of the COVID-19 pandemic on the prevalence of eating disorders.
|
|
|
8/23/22
|
Khalid Ahmed S, Gamal Mohamed M, Abdulrahman Essa R, et al. | Int J Cardiol Vasc Heart
Aim: To provide a comprehensive overview of takotsubo cardiomyopathy (TCM) associated with COVID-19 vaccines. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
8/23/22
|
Zangani C, Ostinelli EG, Smith KA, et al. | JMIR Mental Health
Aim: To systematically review the global research literature on how mental health service provision adapted during the first year of the pandemic. UPDATED
MENTAL HEALTH
|
|
|
8/23/22
|
Wu Y, Kang L, Guo Z, et al. | JAMA Netw Open
Aim: To systematically assess the incubation period of COVID-19 and the incubation periods of COVID-19 caused by different SARS-CoV-2 variants.
INFECTION CONTROL
|
|
|
8/23/22
|
Habibzadeh A, Lankarani KB, Farjam M, et al. | Curr Fungal Infect Rep
Aim: To investigate the prevalence and outcomes of fungal drug-resistant in COVID-19 patients.
LONG COVID
|
|
|
8/23/22
|
Vitória BA, Ribeiro MT, Carvalho VS | Front Psychol
Aim: To synthesize how COVID-19 has impacted the work-family interface. UPDATED
|
|
|
8/22/22
|
Al-Moraissi EA, Kaur A, Günther F, et al. | Front Oral Health
Aim: To identify whether there is scientific evidence supporting that DMOSP is AGPs and whether bioaerosols produced at DMOSP can transmit SARS-CoV-2, thus leading to the transmission of COVID-19.
INFECTION CONTROL
|
|
|
8/22/22
|
Mavraganis G, Dimopoulou MA, Delialis D, et al. | Eur J Clin Invest
Aim: To synthesize current evidence on the frequency and the prognostic value of vascular dysfunction during acute and post-recovery COVID-19.
LONG COVID
|
|
|
8/22/22
|
Bhattacharya O, Siddiquea BN, Shetty A, et al. | BMJ Open
Aim: To estimate the vaccines' acceptance level and to find the factors influencing pregnant women's vaccination decisions. UPDATED
INFECTION CONTROL
|
|
|
8/22/22
|
Bepouka B, Odio O, Mangala D, et al. | Cureus
Aim: To determine the mortality rate of COVID-19 among diabetes patients in SSA.
CLINICAL CHARACTERISTICS
|
|
|
8/22/22
|
Dolatshahi Z, Nargesi S, Sadeghifar J, et al. | Int J Surg
Aim: To compare the economic evaluation of different laboratory diagnostic interventions with each other and also with implementing the conservative CDC & WHO guidelines.
DIAGNOSTICS
|
|
|
8/22/22
|
Justin LYS, Yew YW | Contact Dermatitis
Aim: To evalute the evidence on the association between the use of face masks and various facial dermatoses.
INFECTION CONTROL
|
|
|
8/22/22
|
Luo D, Chen X, Du J, et al. | Liver Int
Aim: To evaluate the immunogenicity of COVID-19 vaccines in CLD patients and LT recipients.
INFECTION CONTROL
|
|
|
8/22/22
|
Esmaeilzadeh A, Maleki AJ, Moradi A, et al. | Expert Rev Vaccines
Aim: To review the recently food and drug administration (FDA)-approved vaccines and identify the organ-based major complications of COVID-19 vaccines based on reliable published studies.
INFECTION CONTROL
|
|
|
8/22/22
|
SeyedAlinaghi S, Karimi A, Mojdeganlou H, et al. | SAGE Open Med
Aim: To investigate the minimum infectious dose of coronavirus disease 2019.
INFECTION CONTROL
|
|
|
8/22/22
|
Davoudi-Monfared E, Ahmadi A, Karimpour-Razkenari E, et al. | Am J Ther
Aim: To collect data about the necessity and safety administration of RDV in the setting of renal impairment.
CANDIDATE THERAPEUTICS
|
|
|
8/22/22
|
Nie Z, Sun T, Zhao F | Infect Drug Resist
Aim: To investigate the efficacy and safety of antiviral drugs in the treatment of coronavirus disease 2019 (COVID-19).
CANDIDATE THERAPEUTICS
|
|
|
8/22/22
|
Gupta K, Kaur G, Pathak T, et al. | Gene
Aim: To explore the current knowledge about the genetic influence on susceptibility to SARS-CoV-2 infection and progression to severe disease conditions.
CLINICAL CHARACTERISTICS
|
|
|
8/22/22
|
Tahsini Tekantapeh S, Ghojazadeh M, Ghamari AA, et al. | Expert Rev Respir Med
Aim: To review the evidence on therapeutic and anti-inflammatory effects of baricitinib on mortality, ICU transfer, clinical improvement, and CRS-related laboratory parameters of hospitalized patients with moderate to severe COVID-19 pneumonia. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
8/22/22
|
Martin C, Cheng N, Chang B, et al. | Pol J Radiol
Aim: To stratify studies investigating the sensitivities of RT-PCR and CT for COVID-19 based on bias, to see how biases affect the sensitivities reported.
DIAGNOSTICS
|
|
|
8/18/22
|
Radivojevic A, Abu Jad AA, Ravanavena A, et al. | Cureus
Aim: To assess the relationship between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-induced hepatic dysfunction and the clinical outcome in patients infected with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
8/18/22
|
Siddiq S, Ahmed S, Akram I | Public Health
Aim: To evaluate the differences in clinical outcomes of COVID-19 infection between ethnic minorities and the White ethnic group in the UK. UPDATED
|
|
|
8/18/22
|
Drzymalla E, Green RF, Knuth M, et al. | Clin Immunol
Aim: To evaluate health outcomes in people with PI and COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
8/18/22
|
Patel C, Parmar K, Patel D, et al. | Rev Med Virol
Aim: To investigate the effect of corticosteroids on mortality in patients with COVID-19. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
8/18/22
|
Favara G, Barchitta M, Maugeri A, et al. | J Glob Health
Aim: To assess the impact of the SARS-CoV-2 infection on the risk of death among PLHIV and HIV- seronegative people.
CLINICAL CHARACTERISTICS
|
|
|
8/18/22
|
Ostovan VR, Tabrizi R, Bazrafshan H, et al. | Curr Fungal Infect Rep
Aim: To identify the risk factors that affect the mortality rate of patients with CAM.
CLINICAL CHARACTERISTICS
|
|
|
8/18/22
|
Ali SS, Mumtaz A, Qamar MA, et al. | Ann Med Surg
Aim: To highlight Parkinsonism as a post-COVID-19 sequela and helps us understand a possible link between the two. UPDATED
LONG COVID
|
|
|
8/18/22
|
Lalor JG, Sheaf G, Mulligan A, et al. | Women Birth
Aim: To explore parental experiences and views with maternity care received from healthcare institutions during the COVID-19 pandemic.
INFECTION CONTROL
|
|
|
8/18/22
|
Ge C, Du K, Luo M, et al. | Exp Hematol Oncol
Aim: To evaluate the serologic response and safety of COVID-19 vaccines in these population. UPDATED
INFECTION CONTROL
|
|
|
8/16/22
|
Iryaningrum MR, Supriyadi R, Lawrensia S, et al. | Indian J Nephrol
Aim: To delineate better the association between diabetes and mortality among patients with CKD and COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
8/16/22
|
Zhiyu Y, Wentian L, Ruizi Z | J Affect Disord
Aim: To understand the commonly used psychosocial interventions during the COVID-19 pandemic and the effectiveness of the interventions. UPDATED
MENTAL HEALTH
|
|
|
8/16/22
|
Desye B | Front Public Health
Aim: To provide a synthesis of evidence on the prevalence of COVID-19 vaccine acceptance and determinate factors among HCWs.
INFECTION CONTROL
|
|
|
8/16/22
|
Wang X, Liu Q | Heliyon
Aim: To determine the prevalence of anxiety among Chinese university students during the COVID-19 epidemic.
MENTAL HEALTH
|
|
|
8/16/22
|
Qian Z, Zhang Z, Ma H, et al. | Front Immunol
Aim: To assess whether convalescent plasma therapy could offer survival advantages for patients with novel coronavirus disease 2019 (COVID-19). UPDATED
CANDIDATE THERAPEUTICS
|
|
|
8/15/22
|
Bryant MC, Spencer LT, Yalcindag A | Pediatr Rheumatol Online J
Aim: To present a case of new-onset AAV following COVID-19 infection in an adolescent patient, and we review the literature of AAV following COVID-19 infection.
LONG COVID
|
|
|
8/15/22
|
Kauhanen L, Wan Mohd Yunus WMA, Lempinen L, et al. | Eur Child Adolesc Psychiatry
Aim: To compare the mental health of children and young people aged 0–24, before and during the COVID-19 pandemic, and identify any changes. UPDATED
MENTAL HEALTH
|
|
|
8/15/22
|
Gempeler A, Griswold DP, Rosseau G, et al. | Front Med
Aim: To identify, appraise, and summarize the available evidence on the diagnostic accuracy of chest CT for rapid diagnosis of COVID-19, and discuss important considerations for its use.
DIAGNOSTICS
|
|
|
8/15/22
|
Matar RH, Mansour R, Nakanishi H, et al. | J Clin Med
Aim: To provide insight into the clinical characteristics of patients diagnosed with myocarditis following COVID-19 mRNA vaccination.
|
|
|
8/15/22
|
COVID-19 vaccine acceptance among healthcare workers in China: A systematic review and meta-analysis
Shui X, Wang F, Li L, et al. | PLoS One
Aim: To identify a reliable estimate of acceptance rate of COVID-19 vaccine among HCWs in China.
INFECTION CONTROL
|
|
|
8/15/22
|
Hu W, Zhu Y, Wu Y, et al. | J Zhejiang Univ Sci B
Aim: To determine whether the COVID-19 pandemic had any adverse effects on female fertility and the pregnancy outcomes of women undergoing ART.
|
|
|
8/15/22
|
Nag AK, Saltagi AK, Saltagi MZ, et al. | Ann Otol Rhinol Laryngol
Aim: To establish whether a consensus exists regarding optimal management of olfactory dysfunction and to provide insight into the treatment of anosmia in the current climate of increased prevalence secondary to COVID-19.
LONG COVID
|
|
|
8/15/22
|
Di Fazio N, Morena D, Delogu G, et al. | Int J Environ Res Public Health
Aim: To evaluate the data belonging to the European framework, analyzing the population by age group.
MENTAL HEALTH
|
|
|
8/15/22
|
Freitas T, Ibrahim A, Lourenço A, et al. | Hip Int
Aim: To determine whether patients with PFF affected by COVID-19 have a higher risk of postoperative mortality.
CLINICAL CHARACTERISTICS
|
|
|
8/15/22
|
Duncan DB, Mackett K, Ali MU, et al. | Clin Biochem
Aim: To assess the diagnostic performance of saliva compared with NPS for COVID-19
DIAGNOSTICS
|
|
|
8/15/22
|
Laher Z, Robertson N, Harrad-Hyde F, et al. | Int J Environ Res Public Health
Aim: To review the evidence on the estimated prevalence of moral injury in nursing and care home staff.
MENTAL HEALTH
|
|
|
8/15/22
|
Montrucchio G, Balzani E, Lombardo D, et al. | J Clin Med
Aim: To clarify the use of MR-proADM in severe COVID-19 disease.
CANDIDATE THERAPEUTICS
|
|
|
8/15/22
|
Yu W, Guo Y, Zhang S, et al. | J Med Virol
Aim: To assess the pooled proportion of non-severe disease and asymptomatic infection among COVID-19 patients infected with Omicron and Delta.
CLINICAL CHARACTERISTICS
|
|
|
8/15/22
|
Leal J, Farkas B, Mastikhina L, et al. | Antimicrob Resist Infect Control
Aim: To assess the risk of VRIs to HCWs in the presence of AGMPs, the role respirators versus medical/surgical masks have on reducing that risk, and if the risk to HCWs during AGMPs differed when caring for adult or pediatric patient populations.
INFECTION CONTROL
|
|
|
8/15/22
|
Dobrijevic Z, Robajac D, Gligorijevic N, et al. | EXCLI J
Aim: To investigate the association of VDR and IFITM3 polymorphisms with COVID-19 severity. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
8/15/22
|
Kabia AU, Li P, Jin Z, et al. | J Hypertens
Aim: To review the evidence on the effects of hypertension on the prognosis of COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
8/12/22
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on factors that influence the transmission of and immunological response to SARSCoV-2.
|
|
|
8/12/22
|
Che BW, Chen P, Yu Y, et al. | Asian J Androl
Aim: To explore whether mild/asymptomatic COVID-19 affects semen quality and sex-related hormone levels.
CLINICAL CHARACTERISTICS
|
|
|
8/12/22
|
Dondi A, Sperti G, Gori D, et al. | Eur J Pediatr
Aim: To determine the type, prevalence, time of onset, and evolution of cutaneous manifestations associated with COVID-19 in newborns, children, and adolescents, after excluding multisystem inflammatory syndrome in children (MIS-C).
CLINICAL CHARACTERISTICS
|
|
|
8/12/22
|
Dobrijevic Z, Robajac D, Gligorijevic N, et al. | EXCLI J
Aim: To investigate the association of VDR and IFITM3 polymorphisms with COVID-19 severity.
CLINICAL CHARACTERISTICS
|
|
|
8/12/22
|
Kabia AU, Li P, Jin Z, et al. | J Hypertens
Aim: To review the evidence on the effects of hypertension and age as well as the use of ACEI/ARB treatment on the outcomes of COVID-19. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
8/11/22
|
Che BW, Chen P, Yu Y, et al. | Asian J Androl
Aim: To explore whether mild/asymptomatic COVID-19 affects semen quality and sex-related hormone levels. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
8/11/22
|
Vishwajeet V, Krishna H, Ghatak S, et al. | Saudi J Kidney Dis Transpl
Aim: To summarize the renal histopathological findings in COVID-19 from the published case report and case series.
CLINICAL CHARACTERISTICS
|
|
|
8/11/22
|
Thakur N, Das S, Kumar S, et al. | J Med Virol
Aim: To trace and understand the origin of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) through various available literatures and accessible databases.
|
|
|
8/11/22
|
Franco-Moreno AI, Bustamante-Fermosel A, Manuel Ruiz-Giardin J, et al. | Rev Clin Esp
Aim: To discover the utility of probability models developed for PE in patients with COVID-19 by reviewing the available literature.
|
|
|
8/10/22
|
Tripathi AK, Pilania RK, Bhatt GC, et al. | Pediatr Nephrol
Aim: To evaluate the incidence of AKI, mortality, and the need for kidney replacement therapy (KRT) in patients with MIS-C.
CLINICAL CHARACTERISTICS
|
|
|
8/10/22
|
Lim YJ, Khan U, Karpha I, et al. | EJHaem
Aim: To quantify the clinical outcomes of HCT recipients with COVID?19, as well as a comprehensive subgroup analysis to determine clinical factors associated with adverse outcomes.
CANDIDATE THERAPEUTICS
|
|
|
8/10/22
|
Donovan MR, Miglani A, Lal D, et al. | Laryngoscope Investig Otolaryngol
Aim: To describe factors associated with IFS in patients with COVID?19.
CLINICAL CHARACTERISTICS
|
|
|
8/10/22
|
Brooks D, Schulman-Rosenbaum R, Griff M, et al. | Endocr Pract
Aim: To describe the management of glucocorticoid-induced hyperglycemia and to summarize available management strategies for dexamethasone-associated hyperglycemia in COVID-19 patients.
CANDIDATE THERAPEUTICS
|
|
|
8/10/22
|
Tossetta G, Fantone S, Delli Muti N, et al. | J Hypertens
Aim: To understand the potential involvement of SARS-CoV-2 in preeclampsia onset.
CLINICAL CHARACTERISTICS
|
|
|
8/10/22
|
Holmes Z, Courtney A, Lincoln M, et al. | Skin Health Dis
Aim: To assess rash morphologies associated with COVID?19 and their relationship with disease severity.
CLINICAL CHARACTERISTICS
|
|
|
8/10/22
|
Kim DK, Park JJ, Yang WJ, et al. | J Korean Med Sci
Aim: To characterize the relationship between ADT and the severity of COVID-19 in patients with prostate cancer. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
8/10/22
|
Sharifi A, Akbari Z, Shafie'ei M, et al. | Ophthalmic Plast Reconstr Surg
Aim: To review the evidence on retrobulbar injection of amphotericin B in patients with COVID-19 associated rhino-orbito-cerebral mucormycosis (CAM).
CANDIDATE THERAPEUTICS
|
|
|
8/10/22
|
Mehrabi Nejad MM, Shobeiri P, Dehghanbanadaki H, et al. | Virol J
Aim: To investigate the efficacy of COVID-19 vaccines based on the vaccine type and etiology as well as the necessity of booster dose in this high-risk population.
INFECTION CONTROL
|
|
|
8/10/22
|
Garcia-Albeniz X, Del Amo J, Polo R, et al. | Eur J Epidemiol
Aim: To study the effectiveness of HCQ to prevent COVID-19.
INFECTION CONTROL
|
|
|
8/10/22
|
Mishra P, Parveen R, Bajpai R, et al. | J Prev Med Public Health
Aim: To investigate the association of lower levels of vitamin D and comorbidities with the risk of COVID-19 infection. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
8/9/22
|
Manoharan S, Ying LY | Can J Infect Dis Med Microbiol
Aim: To further understand the clinical benefits of baricitinib in the management of COVID-19 patients.
CANDIDATE THERAPEUTICS
|
|
|
8/9/22
|
Boro E, Stoll B | Front Public Health
Aim: To analyze the barriers to COVID-19 health products in low-and middle-income countries (LMICs).
INFECTION CONTROL
|
|
|
8/9/22
|
Sarfraz M, Sarfraz A, Sarfraz Z, et al. | Ann Med Surg
Aim: To identify the contributing factors of confirmed pediatric COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
8/9/22
|
Liu J, Dong J, Yu Y, et al. | Front Public Health
Aim: To assess the effectiveness and safety of corticosteroids in hospitalized patients with COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
8/9/22
|
Ding S, Deng S, Zhang Y, et al. | Front Public Health
Aim: To explore front-line nurses' experiences and needs during the COVID-19 pandemic through a qualitative meta-synthesis. UPDATED
|
|
|
8/9/22
|
Namavarian A, Eid A, Ziai H, et al. | Laryngoscope
Aim: To identify FNP clinical characteristics and recovery outcomes among patients acutely infected with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
8/9/22
|
Yang Z, Wang X, Zhang S, et al. | Front Public Health
Aim: To compare myopia progression in children before the COVID-19 pandemic and during COVID-19 pandemic home quarantine and at the same time explore the risk factors of myopia progression. UPDATED
|
|
|
8/9/22
|
Yehualashet DE, Seboka BT, Tesfa GA, et al. | Risk Manag Healthc Policy
Aim: To examine the proportion of COVID-19 vaccine hesitancy and its associated factors among the Ethiopian population.
INFECTION CONTROL
|
|
|
8/9/22
|
Gualano MR, Rossi MF, Borrelli I, et al. | Work
Aim: To evaluate the impact of lasting COVID-19 symptoms or disability on the working population upon their return to employment.
LONG COVID
|
|
|
8/9/22
|
Whear R, Bethel A, Abbott R, et al. | J Clin Epidemiol
Aim: To suggest possible approaches to combatting the impact of the COVID-19 infodemic in-order to prevent research waste in future health emergencies and in everyday research and practice. UPDATED
|
|
|
8/8/22
|
Alves EAS, Salazar TCDN, Silvino VO, et al. | Nutr Clin Pract
Aim: To evaluate the association between phase angle and adverse clinical outcomes in hospitalized patients with coronavirus disease-2019 (COVID-19). UPDATED
CLINICAL CHARACTERISTICS
|
|
|
8/8/22
|
Georgakopoulou VE, Gkoufa A, Garmpis N, et al. | Ann Saudi Med
Aim: To review and analyze all reported cases of COVID-19 associated acute pancreatitis, reporting the demographics, clinical characteristics, laboratory and imaging findings, comorbidities and outcomes. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
8/8/22
|
Wu Y, Zhang Q, Li M, et al. | Front Public Health
Aim: To conduct a systematic review of the global experiences of community responses to the COVID-19 epidemic.
INFECTION CONTROL
|
|
|
8/8/22
|
Martinez-Reviejo R, Tejada S, Adebanjo GAR, et al. | Eur J Intern Med
Aim: To summarize the evidence concerning clinical VZV reactivation following SARS-CoV-2 vaccination.
|
|
|
8/5/22
|
Mollalign H, Chala D, Beyene D | Infect Drug Resist
Aim: To summarize the clinical features and treatment outcomes of coronavirus and tuberculosis co-infected patients.
CLINICAL CHARACTERISTICS
|
|
|
8/5/22
|
Pilia E, Belletti A, Fresilli S, et al. | J Thromb Thrombolysis
Aim: To investigate the efficacy and safety of heparin full-dose anticoagulation in hospitalized non-critically ill COVID-19 patients.
|
|
|
8/5/22
|
Meshram HS, Kute V, Rane H, et al. | Transpl Infect Dis
Aim: To analyze the humoral and cellular response to standard and booster (additional doses) COVID-19 vaccination in solid organ transplantation (SOT) and the risk factors involved for an impaired response. UPDATED
|
|
|
8/4/22
|
Sanaullah AR, Das A, Das A, et al. | Soc Netw Anal Min
Aim: To systematically review, assess, and synthesize state-of-the-art research articles that have used different machine learning and deep learning techniques to detect COVID-19 misinformation.
INFECTION CONTROL
|
|
|
8/4/22
|
Balai MK, Avasthi RD, Va R, et al. | J Caring Sci
Aim: To find out associated psychological impacts among HCP during COVID-19 pandemic.
MENTAL HEALTH
|
|
|
8/3/22
|
Aryana IGPS, Daniella D, Paulus IB, et al. | Ann Geriatr Med Res
Aim: To examine the effect of CP in older adults with COVID-19. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
8/3/22
|
Turki A, Abbas KS, Makram AM, et al. | Acta Neurol Belg
Aim: To systematically review the clinical picture, laboratory/imaging findings, treatment options, and prognostic factors of FNP in COVID-19 patients. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
8/3/22
|
Meyer D, Slone SE, Ogungbe O, et al. | AIDS Behav
Aim: To assess the impacts of the pandemic on service engagement, treatment adherence, and viral suppression. UPDATED
|
|
|
8/3/22
|
Khokher W, Malhas SE, Beran A, et al. | J Intensive Care Med
Aim: To evaluate the role of IPVD in COVID-19 patients.
|
|
|
8/2/22
|
Purja S, Oh S, Kim E | Front Neurol
Aim: To compile studies involving COVID-19 patients with neurological manifestations who have undergone polymerase chain reaction (PCR) testing for SARS-CoV-2 in cerebrospinal fluid (CSF) and reported the patient's anosmia status for identifying neurological aspects of COVID-19 and exploring the COVID-19 infected patients with or without anosmia in relation to their CSF PCR assay results.
CLINICAL CHARACTERISTICS
|
|
|
8/2/22
|
Huang H, Chen J, Fang S, et al. | Front Neurol
Aim: To investigate the association between previous stroke and the risk of severe coronavirus disease 2019 (COVID-19).
CLINICAL CHARACTERISTICS
|
|
|
8/2/22
|
Luo X, Lv M, Zhang X, et al. | J Evid Based Med
Aim: To present a comprehensive picture of the clinical symptoms of COVID-19 using an evidence map. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
8/2/22
|
Hong W, White PL, Backx M, et al. | Clin Imaging
Aim: To conduct a systematic review and an individual patient-level image analysis of CT findings of COVID-19-associated pulmonary aspergillosis (CAPA).
CLINICAL CHARACTERISTICS
|
|
|
8/2/22
|
Siddiqui S, Arifeen M, Hopgood A, et al. | SN Comput Sci
Aim: To demonstrate the analysis and performance of recently proposed methods based on DL to diagnose COVID-19.
DIAGNOSTICS
|
|
|
8/2/22
|
Ahmed I, Mustafaoglu R, Yeldan I, et al. | Arch Phys Med Rehabil
Aim: To qualitatively synthesize and quantitatively evaluate the effect of pulmonary rehabilitation (PR) on dyspnea, lung functions, fatigue, exercise capacity, and quality of life (QoL) in patients with COVID-19.
|
|
|
8/2/22
|
Cevik A, Onat Koroglu C, Karacam Z, et al. | Clin Nurs Res
Aim: To determine the effects of the Covid-19 pandemic on the prevalence of insomnia, anxiety, and depression symptoms during pregnancy. UPDATED
MENTAL HEALTH
|
|
|
8/2/22
|
Alshaikh FS, Godman B, Sindi ON, et al. | PLoS One
Aim: To determine current prevalence of bacterial coinfection and antibiotic prescribing in COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
8/2/22
|
Li M, Zhu H, Liu Y, et al. | Front Pharmacol
Aim: To comprehensively summarize the efficacy and safety of TCM in the treatment of severe/critical COVID-19 patients by systematically collecting available evidence from RCTs and observational studies.
CANDIDATE THERAPEUTICS
|
|
|
8/2/22
|
Nourmohammadi H, Dehkordi AH, Adibi A, et al. |
Aim: To estimate the seroprevalence of COVID-19 in blood donors in the world.
|
|
|
8/1/22
|
COVID-19 vaccination and carditis in children and adolescents: a systematic review and meta-analysis
Chou OHI, Mui J, Chung CT, et al. | Clin Res Cardiol
Aim: To investigate the rates of carditis in children and adolescents receiving COVID-19 vaccines. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
8/1/22
|
Zuin M, Rigatelli G, Bilato C, et al. | J Cardiovasc Med
Aim: To review the evidence on the prevalence and prognostic implications of coronary artery disease (CAD) in patients infected by the novel coronavirus 2019 (COVID-19) disease.
CLINICAL CHARACTERISTICS
|
|
|
8/1/22
|
Du Z, Wang S, Bai Y, et al. | Transbound Emerg Dis
Aim: To conduct a systematic review of viral dynamic parameters used in within-host models by calibrating the model to the viral load data measured from upper respiratory specimens.
CLINICAL CHARACTERISTICS
|
|
|
7/29/22
|
Bhowmik KK, Barek MA, Aziz MA, et al. | Health Sci Rep
Aim: To highlight the correlation of numerous biomarkers, including D?dimers, CRP, serum ferritin, lactate dehydrogenase (LDH), random blood sugar (RBS), absolute neutrophil count (ANC), neutrophil to lymphocyte ratio (NLR), serum creatinine, and hemoglobin with the severity of COVID?19 patients in Bangladesh and how their values change based on the intensity of the illness.
CLINICAL CHARACTERISTICS
|
|
|
7/29/22
|
Sah SK, Shariff A, Pathakamuri N, et al. | PLoS One
Aim: To find the prevalence of fungal secondary infections among COVID-19 patients and patient outcomes in terms of recovery or all-cause mortality following antifungal therapy (AFT) in such patients. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
7/29/22
|
Balaouras G, Eusebi P, Kostoulas P | PLoS One
Aim: To collect and meta-analyze available studies on the relationship between SARS-CoV-2 infection and different blood groups, as well as Rhesus state.
CLINICAL CHARACTERISTICS
|
|
|
7/29/22
|
Bailly M, Pélissier L, Coudeyre E, et al. | Int J Environ Res Public Health
Aim: To systematically review the effects of physical activity programs in the recovery of post-COVID-19 patients. UPDATED
LONG COVID
|
|
|
7/29/22
|
Hayat U, Ashfaq MZ, Johnson L, et al. | Kans J Med
Aim: To determine the clinical outcomes of COVID-19 among MAFLD patients compared to the non-MAFLD group.
CLINICAL CHARACTERISTICS
|
|
|
7/29/22
|
Zewdie A, Mose A, Sahle T, et al. | SAGE Open Med
Aim: To assess predictive ability and identify the most frequently related construct of the model to COVID-19 preventive behavior.
INFECTION CONTROL
|
|
|
7/28/22
|
Anand S, Cao E, Kimura R, et al. | Pathog Glob Health
Aim: To evaluate Asian American COVID-19 healthcare-related behaviors and knowledge.
INFECTION CONTROL
|
|
|
7/28/22
|
Hung KC, Huang YT, Chang YJ, et al. | Diagnostics
Aim: To examine the association of the F/A ratio with prognostic outcomes among patients contracting COVID-19. UPDATED
DIAGNOSTICS
|
|
|
7/28/22
|
Zakariaee SS, Salmanipour H, Naderi N, et al. | Clin Transl Imaging
Aim: To evaluate the association of CT-SS with mortality of COVID-19 patients using systematic review and meta-analysis.
CLINICAL CHARACTERISTICS
|
|
|
7/28/22
|
Hung KC, Ko CC, Wang LK, et al. | Diagnostics
Aim: To evaluate the prognostic value of PNI for predicting the severity and mortality in patients diagnosed with COVID-19. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
7/28/22
|
Santos AP, Gonçalves LC, Oliveira ACC, et al. | Antibiotics
Aim: To assess the prevalence of co-infection in patients admitted to ICUs with SARS-CoV-2 infection.
CLINICAL CHARACTERISTICS
|
|
|
7/28/22
|
Arias M, Oliveros H, Lechtig S, et al. | Pharmaceuticals
Aim: To reevaluate the available evidence of the use of biologics as treatment candidates for the treatment of severe and advanced COVID-19 disease UPDATED
CANDIDATE THERAPEUTICS
|
|
|
7/28/22
|
Kim J, Sung H, Lee H, et al. | Viruses
Aim: To evaluate and compare the available evidence on the real-world diagnostic utility of RATs for detecting variants at the point of care.
DIAGNOSTICS
|
|
|
7/28/22
|
Palomo-Toucedo IC, Lopez-Sanchez MJ, Reina-Bueno M, et al. | Int J Environ Res Public Health
Aim: To determine the most frequent dermatological signs, in the lower limbs, produced by SARS-CoV-2.
CLINICAL CHARACTERISTICS
|
|
|
7/28/22
|
Wangsan K, Sapbamrer R, Sirikul W, et al. | Int J Environ Res Public Health
Aim: To discern the effects of the N95 respirator by assessing the oxygen and carbon dioxide changes in both high- and low-to-moderate-intensity physical activities in a healthy population.
INFECTION CONTROL
|
|
|
7/28/22
|
Komariah M, Amirah S, Faisal EG, et al. | Healthcare
Aim: To evaluate the efficacy of iCBT for depression and anxiety among the global population during the COVID-19 pandemic. UPDATED
MENTAL HEALTH
|
|
|
7/28/22
|
Bücke P, Hellstern V, Cimpoca A, et al. | J Clin Med
Aim: To review the current evidence supporting the use of EVT for SVT on the basis of case presentations, with a focus on patient selection, treatment strategies and the effects of the COVID-19 pandemic.
CANDIDATE THERAPEUTICS
|
|
|
7/28/22
|
Galanis P, Vraka I, Katsiroumpa A, et al. | Vaccines
Aim: To investigate acceptance of the first COVID-19 booster dose and its associated factors among fully vaccinated individuals.
INFECTION CONTROL
|
|
|
7/28/22
|
Lekagul A, Piancharoen P, Chattong A, et al. | BMJ Open
Aim: To assess interventions and their effectiveness in mitigating psychological consequences from pandemic.
MENTAL HEALTH
|
|
|
7/28/22
|
Nazia N, Butt ZA, Bedard ML, et al. | Int J Environ Res Public Health
Aim: To review the methodological approaches used to identify the spatial and spatiotemporal variations of COVID-19 and the socioeconomic, demographic and climatic drivers of such variations.
INFECTION CONTROL
|
|
|
7/28/22
|
Shang W, Kang L, Cao G, et al. | Vaccines
Aim: To assess the percentage of asymptomatic infections among SARS-CoV-2 Omicron variant-positive individuals detected by gene sequencing or specific polymerase chain reaction (PCR).
DIAGNOSTICS
|
|
|
7/28/22
|
Rabaan AA, Bakhrebah MA, Mutair AA, et al. | Vaccines
Aim: To establish the comparison of health complication noted in vaccinated and non-vaccinated individuals (COVID-19 infected patients) to identify the association between vaccination and the multiorgan failure based on the data obtained from case studies, research articles, clinical trials/Cohort based studies and review articles published between 2020-2022.
CLINICAL CHARACTERISTICS
|
|
|
7/28/22
|
Spencer N, Markham W, Johnson S, et al. | Vaccines
Aim: To address the existing gap in the body of evidence and assess the impact of the COVID-19 pandemic on inequities in routine childhood vaccination coverage. UPDATED
INFECTION CONTROL
|
|
|
7/28/22
|
Korres G, Kitsos DK, Kaski D, et al. | Brain Sci
Aim: To review the reported prevalence of dizziness and vertigo symptoms as part of COVID-19 disease and discuss the potential neurotropic mechanisms of SARS-CoV-2.
CLINICAL CHARACTERISTICS
|
|
|
7/28/22
|
Alghamdi NS, Alghamdi SM | Int J Environ Res Public Health
Aim: To summarize the digital technologies used during the COVID-19 pandemic to mitigate the transmission of the COVID-19.
INFECTION CONTROL
|
|
|
7/28/22
|
Migliorini F, Vaishya R, Eschweiler J, et al. | Medicina
Aim: To provide an account of the role played by vitamins C and D on the onset, progression and severity of COVID-19.
|
|
|
7/27/22
|
Pitre T, Van Alstine R, Chick G, et al. | CMAJ
Aim: To compare the effectiveness of antiviral drugs for patients with nonsevere COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
7/27/22
|
Hernandez AV, Piscoya A, Pasupuleti V, et al. | Am J Med
Aim: To assess beneficial and harmful effects of monoclonal antibodies for COVID-19 treatment, and prophylaxis in exposed to SARS-CoV-2.
CANDIDATE THERAPEUTICS
|
|
|
7/27/22
|
Al-Qudimat AR, Al-Zoubi RM, Elaarag M, et al. | Health Sci Rep
Aim: To offer healthcare workers and non?healthcare workers a comprehensive and up?to?date overview of the currently available information on the severity of the BioNTech?Pfizer vaccine in children and adolescents.
|
|
|
7/27/22
|
Gaigher JM, Lacerda IB, Dourado MCN | Front Psychiatry
Aim: To better understand the impacts of the COVID-19 pandemic on people with dementia and on their caregivers' mental health. UPDATED
MENTAL HEALTH
|
|
|
7/27/22
|
Marando M, Tamburello A, Gianella P, et al. | Caspian J Intern Med
Aim: To evaluate the sensitivity of RT-PCR assays specifically on nasopharyngeal specimens in a population of adults with a clinical suspicion of Coronavirus Disease – 2019 (COVID-19).
DIAGNOSTICS
|
|
|
7/27/22
|
Federspiel JM, Ramsthaler F, Kettner M, et al. | Rechtsmedizin
Aim: To summarize of the current knowledge on mRNA vaccination-associated myocarditis as a potentially fatal side effect.
|
|
|
7/27/22
|
Stanford V, Gresh L, Toledo J, et al. | Lancet Reg Health Am
Aim: To characterise the best available evidence (BAE) and assess the extent to which it was used to inform decision-making in 21 Latin American countries.
INFECTION CONTROL
|
|
|
7/27/22
|
Seyedjavadi SS, Bagheri P, Nasiri MJ, et al. | Front Microbiol
Aim: To evaluate the various aspects such as symptoms, diagnosis, and the most frequent etiological agents of patients with fungal co-infecting COVID-19, treatment, and outcome.
CLINICAL CHARACTERISTICS
|
|
|
7/27/22
|
Ghahramani S, Kasraei H, Hayati R, et al. | Int J Psychiatry Clin Pract
Aim: To review the evidence on psychological issues experienced by healthcare providers during the COVID-19 pandemic.
MENTAL HEALTH
|
|
|
7/27/22
|
Nazir M, Asghar S, Rathore MA, et al. | Vacunas
Aim: To give a comprehensive interpretation of menstrual cycle changes after the COVID-19 vaccination.
|
|
|
7/27/22
|
Patrikar S, Sahu R, Basannar D, et al. | Asia Pac J Public Health
Aim: To summarize serological surveys for SARS-CoV-2 infections carried out in India in general population and health care workers separately with the objective to describe the prevalence of SARS-CoV-2 antibodies.
INFECTION CONTROL
|
|
|
7/27/22
|
Kulkarni D, Nundy M, McSwiggan E, et al. | J Glob Health
Aim: To explore the association between alcohol consumption in social gatherings and compliance with COVID-19 public health measures. UPDATED
INFECTION CONTROL
|
|
|
7/27/22
|
Elhiny R, Al-Jumaili AA, Yawuz MJ | Int J Pharm Pract
Aim: To describe the COVID-19 complications after recovery.
LONG COVID
|
|
|
7/25/22
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence for alternative models of care for managing patients with acute medical conditions outside of emergency or inpatient hospital settings.
|
|
|
7/25/22
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the effectiveness of oseltamivir on adults and children in a healthcare setting.
|
|
|
7/25/22
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on post-acute sequelae of COVID-19 infection. UPDATED
|
|
|
7/19/22
|
Noori M, Azizi S, Abbasi Varaki F, et al. | Int Immunopharmacol
Aim: To evaluate the immunogenicity of COVID-19 vaccines in patients with hematological malignancies.
INFECTION CONTROL
|
|
|
7/19/22
|
Silva BM, Assis LCS, Batista Junior MC, et al. | J Bras Nefrol
Aim: To relate the development of COVID-19 associated-AKI with comorbidities, medications, and the impact of mechanical ventilation.
CLINICAL CHARACTERISTICS
|
|
|
7/19/22
|
Biagianti B, Di Liberto A, Nicolo Edoardo A, et al. | Front Aging Neurosci
Aim: To provide a critical narrative of neuropsychological (NPs) deficits commonly observed after SARS-CoV-2 infection and the tests most suited for detecting such cognitive sequelae depending on illness severity. UPDATED
MENTAL HEALTH
|
|
|
7/19/22
|
Kariya A, Krutsri C, Singhatas P, et al. | Int J Surg Open
Aim: To analyze the rate of complicated appendicitis before and during the COVID-19 pandemic. UPDATED
|
|
|
7/19/22
|
Mohammadi S, Gouravani M, Salehi MA, et al. | Neuroradiology
Aim: To aggregate the results of the studies which reported imaging of the olfactory system of patients with COVID-19 versus controls. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
7/19/22
|
Ku YR, Stager C | Front Psychol
Aim: To update previous empirical work and examine the current evidence for the effectiveness of growth mindset interventions in young adults.
MENTAL HEALTH
|
|
|
7/19/22
|
Yao W, Dong H, Qi J, et al. | EClinicalMedicine
Aim: To better understand the efficacy and safety of mesenchymal stromal cells (MSCs) in treating severe/critical patients with COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
7/19/22
|
Hessami K, Sayegh N, Abdolmaleki AS, et al. | J Obstet Gynaecol Res
Aim: To systematically review and summarize the available literature regarding the women's sexual function during COVID-19 pandemic and compare it to pre-pandemic period. UPDATED
|
|
|
7/18/22
|
Lin L, Chen Y, Han D, et al. | Front Cardiovasc Med
Aim: To assess the clinical manifestations and outcomes of cardiorenal syndrome or the presence of both cardiac and renal complications in the 2019 coronavirus disease (COVID-19) patients.
CLINICAL CHARACTERISTICS
|
|
|
7/18/22
|
Lan SH, Hsu CK, Lai CC, et al. | Ann Med
Aim: To assess the usefulness of colchicine in patients with COVID-19. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
7/18/22
|
Hernandez AV, Ingemi J 3rd, Sherman M, et al. | Arch Med Sci
Aim: To review the efficacy of hydroxychloroquine as early treatment for COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
7/18/22
|
Xue C, Liu Z, Xiang H, et al. | Altern Health Ther Med
Aim: To determine the efficacy of interferon (IFN)-based therapy for coronavirus disease 2019 (COVID-19). UPDATED
CANDIDATE THERAPEUTICS
|
|
|
7/18/22
|
Cénat JM, Farahi SMMM, Dalexis RD, et al. | J Affect Disord
Aim: To assess the global evolution of mental health problems during the COVID-19 pandemic. UPDATED
MENTAL HEALTH
|
|
|
7/18/22
|
El-Qushayri AE, Reda A, Dahy A, et al. | Rev Med Virol
Aim: To provide better insight into the efficacy of mechanical thrombectomy (MT) in managing COVID-19 patients suffering from a stroke.
CLINICAL CHARACTERISTICS
|
|
|
7/18/22
|
Fang Y, Ji B, Liu Y, et al. | Sci Rep
Aim: To identify the incidence of psychological stress reactions in student populations following a global outbreak and the associated influencing factors. UPDATED
MENTAL HEALTH
|
|
|
7/18/22
|
Almulla AF, Supasitthumrong T, Tunvirachaisakul C, et al. | BMC Infect Dis
Aim: To systematically review and meta-analyze the status of the TRYCAT pathway, including the levels of TRP and kynurenine (KYN) and the activity of IDO, as measured by the ratio of KYN/TRP.
CLINICAL CHARACTERISTICS
|
|
|
7/15/22
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the effectiveness of exercise in helping individuals with COVID-19 to recover, and if post-exertional symptom exacerbation is a risk in long COVID.
LONG COVID
|
|
|
7/14/22
|
Barberato SH, Bruneto EG, Reis GS, et al. | Arq Bras Cardiol
Aim: To summarize the main echocardiographic findings in patients with Covid-19.
CLINICAL CHARACTERISTICS
|
|
|
7/14/22
|
Siemieniuk RAC, Bartoszko JJ, Ge L, et al. | BMJ
Aim: To compare the effects of treatments for coronavirus disease 2019 (covid-19). UPDATED
CANDIDATE THERAPEUTICS
|
|
|
7/14/22
|
Arayici ME, Kipcak N, Kayacik U, et al. | J Cancer Res Clin Oncol
Aim: To determine both the incidence and ICU (Intensive Care Unit) admission rates and mortality in SARS-CoV-2 infected cancer patients. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
7/14/22
|
Tohmasi S, Kabutey NK, Maithel S, et al. | Ann Vasc Surg Brief Rep Innov
Aim: To assess the incidence, risk factors, interventions, and outcomes of acute aortoiliac arterial thrombosis in patients with active SARS-CoV-2 infections.
CLINICAL CHARACTERISTICS
|
|
|
7/14/22
|
| NSW Health COVID-19 Critical Intelligence Unit
|
|
|
7/14/22
|
| NSW Health COVID-19 Critical Intelligence Unit
|
|
|
7/14/22
|
Baradaran HR, Dehghanbanadaki H, Moradpour F, et al. | Expert Rev Vaccines
Aim: To investigate the pooled effect of COVID-19 mRNA vaccination against SARS-CoV-2 infection and its clinical outcomes. UPDATED
|
|
|
7/14/22
|
Rahmati M, Keshvari M, Mirnasuri S, et al. | J Med Virol
Aim: To estimate the risk of global pediatric new-onset T1D, DKA, and severe DKA before and after the COVID-19 pandemic.
|
|
|
7/13/22
|
Bianchi FP, Stefanizzi P, Di Gioia MC, et al. | Expert Rev Vaccines
Aim: To estimate the proportion of pregnant and breastfeeding women expressing hesitation to the COVID-19 vaccine worldwide.
INFECTION CONTROL
|
|
|
7/13/22
|
Saragih ID, Tarihoran DETAU, Rasool A, et al. | J Nurs Scholarsh
Aim: To update estimates of the prevalence of stigmatization and violence against healthcare workers during the pandemic. UPDATED
|
|
|
7/13/22
|
Tunjungputri RN, Tetrasiwi EN, Mulansari NA, et al. | Acta Med Indones
Aim: To provide the most recent update on available evidence on the clinical benefits and risk of oral and parenteral anticoagulants, as well agents with anticoagulant properties, in hospitalized and post-discharge COVID-19 patients.
|
|
|
7/13/22
|
Dobrijevic Z, Gligorijevic N, Sunderic M, et al. | Rev Med Virol
Aim: To elucidate the potential involvement of genetic variability within HLA loci in the molecular genetics of COVID-19.
|
|
|
7/13/22
|
Bitar AN, Sulaiman SAS | Curr Med Res Opin
Aim: To evaluate the evidence from clinical trials on the effect of colchicine and corticosteroids against COVID-19. UPDATED
|
|
|
7/13/22
|
Tugasworo D, Kurnianto A, Retnaningsih, et al. | Egypt J Neurol Psychiatr Neurosurg
Aim: To assess and conclude the research-based study systematically to analyze the relationship of MG and COVID-19. UPDATED
|
|
|
7/12/22
|
Rangel-Ramírez VV, Macias-Pina KA, Servin-Garrido RR, et al. | Microbiol Res
Aim: To review the scientific literature on antibody IgA immunity to SARS-CoV-2 to determine if IgA could be useful as a diagnostic tool or as a biomarker of severity.
DIAGNOSTICS
|
|
|
7/12/22
|
Girma D, Dejene H, Adugna L, et al. | Infect Drug Resist
Aim: To summarize the CFR of COVID-19 and factors contributing to mortality in Ethiopia.
CLINICAL CHARACTERISTICS
|
|
|
7/12/22
|
Nazari T, Sadeghi F, Izadi A, et al. | PLoS One
Aim: To summarize the studies that have reported CAFIs in Iran. UPDATED
|
|
|
7/12/22
|
Raviraj KG, Shobhana SS | Forensic Sci Med
Aim: To determine the findings obtained and inferences drawn from various studies published globally among patients who died due to COVID19.
CANDIDATE THERAPEUTICS
|
|
|
7/12/22
|
Neville RD, Lakes KD, Hopkins WG, et al. | JAMA Pediatr
Aim: To estimate whether changes in physical activity differed between participant-level, contextual, and methodological moderators during the COVID-19 pandemic. UPDATED
|
|
|
7/12/22
|
Skafle I, Nordahl-Hansen A, Quintana DS, et al. | J Med Internet Res
Aim: To synthesize the existing research on misinformation about COVID-19 vaccines spread on social media platforms and its effect.
INFECTION CONTROL
|
|
|
7/12/22
|
Sawadogo W, Tsegaye M, Gizaw A, et al. | BMJ Nutr Prev Health
Aim: To quantify the association between overweight or obesity and COVID-19-related hospitalisations (including hospital admission, intensive care unit (ICU) admission, invasive mechanical ventilation (IMV)) and death, and to assess the magnitude of the association and the potential dose–response relationships. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
7/12/22
|
Bass JR, Poland GA | Vaccine
Aim: To describe SIRVA in the current pandemic, increase clinician awareness, and offer considerations for prevention.
|
|
|
7/12/22
|
Steeg S, John A, Gunnell DJ, et al. | Br J Psychiatry
Aim: To systematically review evidence on presentations to health services following self-harm during the COVID-19 pandemic.
MENTAL HEALTH
|
|
|
7/12/22
|
Caironi V, Pitoia F, Trimboli P | Front Endocrinol
Aim: To analyze and summarize data about COVID-19 vaccination and thyroid disease.
CLINICAL CHARACTERISTICS
|
|
|
7/11/22
|
Carbone L, Trinchillo MG, Di Girolamo R, et al. | Int J Gynaecol Obstet
Aim: To explore perinatal outcomes in SARS-CoV-2 vaccinated pregnant women comparing with unvaccinated counterparts.
|
|
|
7/11/22
|
Wu HT, Ji CH, Dai RC, et al. | J Integr Med
Aim: To systematically evaluate the methodological quality and quality of evidence in the published systematic reviews and meta-analyses on the use of TCM in the treatment of COVID-19.
|
|
|
7/7/22
|
Wasim A, Truong J, Bakshi S, et al. | J Ment Health
Aim: To examine mental health literature on prior outbreaks to provide recommendations for developing effective strategies to mitigate the short- and long-term psychological impact of the current pandemic.
MENTAL HEALTH
|
|
|
7/7/22
|
Dieter C, Brondani LA, Leitao CB, et al. | PLoS One
Aim: To identify genetic polymorphisms that are likely to contribute to COVID-19 pathogenesis. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
7/7/22
|
Huldani H, Kamal Abdelbasset W, Abdalkareem Jasim S, et al. | Women Health
Aim: To estimate the pooled prevalence of (intimate partner violence) IPV against pregnant women in the COVID-19 pandemic.
MENTAL HEALTH
|
|
|
7/7/22
|
D'Ecclesiis O, Gavioli C, Martinoli C, et al. | PLoS One
Aim: To assess the evidence on SARS-CoV2 infection and Covid-19 in relation to deficiency and supplementation of vitamin D. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
7/6/22
|
Moura-Coelho N, Cunha JP, Papa-Vettorazzi R, et al. | Acta Ophthalmol
Aim: To examine all the documented cases of acute corneal allograft rejection following SARS-CoV-2 vaccination, and to characterize possible risk factors and graft outcomes after rejection.
|
|
|
7/6/22
|
Javed A, Karki S, Sami Z, et al. | Biomed Res Int
Aim: To explore the therapeutic potential and safety of using MSC obtained by isolation from health cord tissues in the treatment of patients with COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
7/6/22
|
Malinga DM, Laher AE, McDowall J, et al. | Curr Urol
Aim: To explore the potential relationship between priapism and COVID-19. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
7/6/22
|
Tolksdorf KH, Tischler U, Heinrichs K | BMC Nurs
Aim: To identify factors associated with nurses' turnover intention during the COVID-19 pandemic.
MENTAL HEALTH
|
|
|
7/6/22
|
Hammoud H, Bendari A, Bendari T, et al. | Cureus
Aim: To provide a comprehensive picture of the SARS-CoV-2 histopathological features of different body organs in postmortem autopsies.
CLINICAL CHARACTERISTICS
|
|
|
7/6/22
|
Araújo ST, Araújo CT, Silva E Castro R, et al. | Curr Med Chem
Aim: To investigate potential neuroimaging markers of early diagnosis and prognosis of neurologic manifestations in COVID-19. UPDATED
DIAGNOSTICS
|
|
|
7/6/22
|
Barmanray RD, Cheuk N, Fourlanos S, et al. | BMJ Open Diabetes Res Care
Aim: To quantify the association between diabetes, hyperglycemia, and outcomes in patients hospitalized for community-acquired pneumonia (CAP) prior to the COVID-19 pandemic.
|
|
|
7/6/22
|
Qi G, Yuan P, Qi M, et al. | Saf Health Work
Aim: To assess the prevalence and important risk factors of PTSD among medical staff during the COVID-19.
MENTAL HEALTH
|
|
|
7/6/22
|
Behers BJ, Patrick GA, Jones JM, et al. | Yale J Biol Med
Aim: To perform an in-depth analysis of documented case reports of individuals who developed myocarditis following administration of either the Pfizer or Moderna vaccine.
|
|
|
7/6/22
|
Pinzon RT, Wijaya VO, Jody AA, et al. | J Infect Public Health
Aim: To conduct a systematic review and meta-analysis on the persistent neurological manifestations in COVID-19 survivors.
LONG COVID
|
|
|
7/6/22
|
Tadesse AW, Aychiluhm SB, Mare KU, et al. | Front Public Health
Aim: To estimate the pooled preventive practice and its determinants among the general population.
INFECTION CONTROL
|
|
|
7/6/22
|
Rayatdoost E, Rahmanian M, Sanie MS, et al. | Yale J Biol Med
Aim: To summarize data regarding the association between sleep and time of vaccination with immunity after vaccination.
INFECTION CONTROL
|
|
|
7/6/22
|
Halabchi F, Selk-Ghaffari M, Tazesh B, et al. | Sport Sci Health
Aim: To investigate the role of exercise rehabilitation programs, either in acute or post-acute phase, on physical and psychological outcomes among COVID-19 patients. UPDATED
|
|
|
7/6/22
|
Chen CH, Wang CY, Wang YH, et al. | Expert Rev Clin Pharmacol
Aim: To review the evidence on the effect of inhaled corticosteroids (ICS) on the clinical outcomes of patients with coronavirus disease 2019 (COVID-19).
CANDIDATE THERAPEUTICS
|
|
|
7/6/22
|
Lai CC, Chen WC, Chen CY, et al. | Expert Rev Anti Infect Ther
Aim: To investigate the effectiveness of IVIG in patients with COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
7/5/22
|
Chao M, Menon C, Elgendi M | Front Med
Aim: To investigate the prevalence of common COVID-19 symptoms in pregnant women and compared the ranked list of symptoms to articles of various sizes.
CLINICAL CHARACTERISTICS
|
|
|
7/5/22
|
Parvu S, Müller K, Dahdal D, et al. | Eur Rev Med Pharmacol Sci
Aim: To elaborate the possible mechanisms influencing cardiovascular damage, myocardial injury and thromboembolic disease process in particular.
CLINICAL CHARACTERISTICS
|
|
|
7/5/22
|
Sun XH, Zhang S, Yang Z, et al. | Chin J Integr Med
Aim: To evaluate the efficacy and safety of LHQW for COVID-19 by conducting a systematic review with meta-analysis. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
7/5/22
|
Li P, Guan Y, Zhou S, et al. | Sci Prog
Aim: To review the clinical features and risk factors in patients undergoing maintenance hemodialysis (MHD) who also acquired coronavirus disease 2019 (COVID-19).
CLINICAL CHARACTERISTICS
|
|
|
7/5/22
|
Zong K, Peng D, Yang H, et al. | Front Immunol
Aim: To determine the factors that contribute to poor antibody response in organ transplant recipients after receiving the 2-dose severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
7/1/22
|
Almeda N, Gomez-Gomez I | Front Psychiatry
Aim: To analyse the changes in smoking consumption during the COVID-19 pandemic through longitudinal studies. UPDATED
|
|
|
6/28/22
|
Kolahchi Z, Khanmirzaei M, Mowla A | J Neurol Sci
Aim: To review the evidence on the incidence of AIS after COVID-19 vaccination.
|
|
|
6/28/22
|
Yang W, Zhang D, Li Z, et al. | Eur J Cancer
Aim: To assess the factors that predict poor seroconversion comprehensively in order to plan better prevention strategies in this frail population.
|
|
|
6/24/22
|
Roshdy A, Elsayed AS, Saleh AS | J Intensive Care Med
Aim: To explore the evidence surrounding the use of Airway Pressure Release Ventilation (APRV) in patients with coronavirus disease 2019 (COVID-19). UPDATED
|
|
|
6/24/22
|
Rozani S, Evangelou K, Schuffert L, et al. | Chirurgie (Heidelb)
Aim: To investigate the reasons for the occurrence of substance dependence and burnout in surgeons and anesthesiologists timelessly and during the COVID-19 pandemic and what improvement measures could help in the clinical practice?
|
|
|
6/24/22
|
Gioia F, Albasata H, Hosseini-Moghaddam SM | J Fungi
Aim: To evaluate studies reporting concomitant COVID-19 and Pneumocystis jirovecii pneumonia (PJP).
|
|
|
6/24/22
|
Morello R, Pepe M, Martino L, et al. | Acta Paediatr
Aim: To summarize the cases of myopericarditis after COVID-19 vaccination in pediatric patients and describe its incidence, clinical features, diagnostic pathways, therapeutic strategies and outcome.
|
|
|
6/24/22
|
Boet S, Etherington C, Ghanmi N, et al. | Diving Hyberb Med
Aim: To review the evidence on hyperbaric oxygen treatment (HBOT) for hypoxaemic COVID-19 patients.
|
|
|
6/24/22
|
Raquib A, Raquib R, Jamil S, et al. | Front Med
Aim: To review the evidence on the KAP for COVID-19 prevention in Bangladesh.
|
|
|
6/24/22
|
Santabárbara J, Olaya B, Bueno-Notivol J, et al. | Rev Med Chil
Aim: To review the prevalence of depression in medical students during the COVID-19 pandemic.
|
|
|
6/24/22
|
Zhang M, Yan X, Shi M, et al. | Glob Health Res Policy
Aim: To reviewe the safety and efficiency of stem cell therapy in COVID-19 cases.
|
|
|
6/23/22
|
Kao YS, Lin KT | Radiol Med
Aim: To investigate the predictive power of a CT-based radiomics model in determining COVID-19 severity.
CLINICAL CHARACTERISTICS
|
|
|
6/23/22
|
Joshi D, Gyanpuri V, Pathak A, et al. | Curr Pain Headache Rep
Aim: To discuss the case-reports having neuropathic pain during and after COVID-19 infection.
CLINICAL CHARACTERISTICS
|
|
|
6/23/22
|
Li L, Xie H, Wang L, et al. | Chin Med
Aim: To systematically review the clinical efficacy and safety of Chinese herbal medicine (CHM) with and without Western medicine (WM) for different severity of COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
6/23/22
|
Ji Z, Hu H, Qiang X, et al. | Am J Chin Med
Aim: To compare the efficacy of different traditional Chinese medicine (TCM) therapies for the treatment of coronavirus disease 2019 (COVID-19). UPDATED
CANDIDATE THERAPEUTICS
|
|
|
6/22/22
|
Wang Q, Guo S, Wei X, et al. | BMJ Open
Aim: To systematically review the evidence on this topic and provide comprehensive information to guide the control and treatment of TB-COVID coinfection. UPDATED
INFECTION CONTROL
|
|
|
6/22/22
|
Yang F, Wen J, Huang N, | Eur Psychiatry
Aim: To estimate the worldwide prevalence of posttraumatic stress disorder (PTSD) in children due to the COVID-19 pandemic, as well as to identify protective or risk factors contributing to child PTSD.
MENTAL HEALTH
|
|
|
6/21/22
|
Susanna D, Pratiwi D, Purnama SG | F1000Res
Aim: To examine the variations in COVID-19 diagnostic testing and clinical characteristics across various studies.
DIAGNOSTICS
|
|
|
6/21/22
|
Singh R, Rathore SS, Khan H, et al. | Front Endocrinol
Aim: To estimate the association of obesity with the severity and mortality in coronavirus disease 2019 (COVID-19) patients.
CLINICAL CHARACTERISTICS
|
|
|
6/21/22
|
Qin J, Wang G, Han D | Int J Infect Dis
Aim: To determine the efficacy of therapeutic plasma exchange (TPE) on mortality in patients with COVID-19. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
6/21/22
|
Khanal R, Raj Bhattarai S, Basnet K, et al. | Interdiscip Perspect Infect Dis
Aim: To review the evidence on the cardiac implications of COVID-19, both in terms of cardiac factors predisposing to the disease and cardiac complications of the disease. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
6/21/22
|
Levy M, Lestrade V, Said C, et al. | Front Pediatr
Aim: To synthesize knowledge describing the impact of social distancing measures (SDM) during the first wave of the COVID-19 pandemic on acute illness in children. UPDATED
INFECTION CONTROL
|
|
|
6/21/22
|
Batu ED, Sener S, Ozen S | Semin Arthritis Rheum
Aim: To present a detailed analysis of COVID-19 associated pediatric vasculitis.
CLINICAL CHARACTERISTICS
|
|
|
6/21/22
|
Alemayehu A, Demissie A, Yusuf M, et al. | Health Serv Res Manag Epidemiol
Aim: To pool the prevalence of COVID-19 vaccine acceptance and identify its determinants in East Africa. UPDATED
INFECTION CONTROL
|
|
|
6/21/22
|
Fattahi H, Seproo FG, Fattahi A | BMC Public Health
Aim: To identify factors affecting the preventive behaviors during the covid-19 pandemic.
INFECTION CONTROL
|
|
|
6/21/22
|
Li Y, Xiao P, Liu N, et al. | Front Pharmacol
Aim: To integrate the existing evidence to evaluate the efficacy and safety of LQ paired with western medicine in the treatment of patients with COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
6/21/22
|
Anakpo G, Mishi S | Hum Vaccin Immunother
Aim: To review the measurement of COVID-19 vaccine hesitancy, key determinants and evidence-based strategies to prevent COVID-19 vaccine hesitancy.
INFECTION CONTROL
|
|
|
6/21/22
|
Tan RSJ, Ng KT, Xin CE, et al. | J Cardiothorac Vasc Anesth
Aim: To evaluate the use of high-dose versus low- dose corticosteroids on the mortality rate of COVID-19 patients. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
6/21/22
|
Sadeghi S, Kalantari Y, Shokri S, et al. | J Clin Virol
Aim: To collect all the data about immunogenicity, efficacy, and safety of available COVID-19 vaccines to guide health care workers and families on vaccinating the younger population (2 – 21 years old). UPDATED
INFECTION CONTROL
|
|
|
6/21/22
|
Li L, Wang F, Shui X, et al. | PLoS One
Aim: To evaluate the pooled estimated level of knowledge, attitudes, and practices (KAP) about COVID-19 among college students in China. UPDATED
|
|
|
6/21/22
|
Idehen JB, Kazi U, Quainoo-Acquah JA, et al. | Cureus
Aim: To determine the patterns of neuropsychiatric manifestations of COVID-19, discussing the frequency and its impact on pre-existing psychiatric disorders.
CLINICAL CHARACTERISTICS
|
|
|
6/21/22
|
Almas T, Malik J, Alsubai AK, et al. | Ann Med Surg
Aim: To estimate the prevalence of persisting COVID-19 signs and symptoms after recovery.
CLINICAL CHARACTERISTICS
|
|
|
6/21/22
|
Ramzi ZS, Fatah PW, Dalvandi A | Front Pyschol
Aim: To estimate the overall prevalence of WPV against HCWs.
|
|
|
6/21/22
|
Molina-Carballo A, Palacios-López R, Jerez-Calero A, et al. | Curr Issues Mol Biol
Aim: To analyze the knowledge and evidence that exists after the use of melatonin in the treatment of SARS-CoV-2 infection.
CANDIDATE THERAPEUTICS
|
|
|
6/21/22
|
Ngangue P, Pilabré AH, Barro A, et al. | J Public Health Afr
Aim: To identify and understand the significance of population attitudes toward COVID-19 vaccines in Africa.
INFECTION CONTROL
|
|
|
6/21/22
|
Schoberer D, Osmancevic S, Reiter L, et al. | Public Health Pract
Aim: To assess the effectiveness of PPE in terms of how well it protected HCWs from COVID-19 infections as well as the side effects experienced by HCWs who used PPE in clinical settings.
INFECTION CONTROL
|
|
|
6/21/22
|
Lee JX, Chieng WK, Abdul Jalal MI, et al. | Front Med
Aim: To determine the role of serum ferritin in predicting outcomes of COVID-19 infection among patients with SCD. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
6/21/22
|
Hirsch C, Park YS, Piechotta V, et al. | Cochrane Database Syst Rev
Aim: To assess the effects of SARS-CoV-2-neutralising mAbs, including mAb fragments, to prevent infection with SARS-CoV-2 causing COVID-19.
INFECTION CONTROL
|
|
|
6/21/22
|
Ishak A, Mehendale M, Mahmoud AlRawashdeh M, et al. | Gene
Aim: To evaluate the correlation between variability in the host genetics and the severity and susceptibility towards COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
6/21/22
|
Antonini M, Hinwood M, Paolucci F, et al. | World J Surg
Aim: To investigate changes in the epidemiology of major trauma presentations during the implementation of movement restriction measures to manage the first wave of the SARS-CoV-2 (COVID-19) pandemic. UPDATED
|
|
|
6/21/22
|
Sanders I, Stather P, Sivagangan P, et al. | Cureus
Aim: To review our understanding of the incidence, management, and outcomes of patients with COVID-19 who develop thrombotic complications, to reduce direct mortality.
CLINICAL CHARACTERISTICS
|
|
|
6/17/22
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the current and emerging patient safety issues arising from the COVID-19 pandemic.
|
|
|
6/17/22
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on seasonal influenza prophylaxis in healthcare and aged care settings.
|
|
|
6/17/22
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence for rapid access models of care for respiratory illnesses, especially during winter seasons, in emergency departments.
|
|
|
6/16/22
|
Pasquini Neto R, Mazzo FAT, Vieira FA, et al. | Rev Paul Pediatr
Aim: To evaluate the coronavirus disease 2019 (COVID-19) cutaneous manifestations described in pediatric patients and discuss their relevance for early diagnosis.
MENTAL HEALTH
|
|
|
6/16/22
|
Seid AA, Woday Tadesse A, Hasen AA | BMJ Open
Aim: To determine the severity and mortality of COVID-19 among people with different types of disabilities. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
6/16/22
|
Chun HR, Cheon E, Hwang JE | BMJ Open
Aim: To examine changed smoking behaviours, cessation intentions and associated psychological states among smokers during the COVID-19 pandemic.
|
|
|
6/15/22
|
Cao B, Jing X, Liu Y, et al. | J Thorac Dis
Aim: To summarize the available data on the association between the severity of (COVID-19) and routine blood indicators, inflammatory, biochemical parameters and coagulation parameter.
CANDIDATE THERAPEUTICS
|
|
|
6/15/22
|
Cremades-Martínez P, Parker LA, Chilet-Rosell E, et al. | Microbiol Spectr
Aim: To review strategies for identifying SARS-CoV-2 infection before the availability of molecular test results, and to assess the reporting quality of the studies identified through the application of the STARD guideline.
CLINICAL CHARACTERISTICS
|
|
|
6/15/22
|
Shafiee A, Teymouri Athar MM, Kohandel Gargari O, et al. | Virol J
Aim: To evaluate the efficacy of ivermectin for COVID-19 patients based on current peer-reviewed RCTs and to address disputes over the existing evidence.
CLINICAL CHARACTERISTICS
|
|
|
6/15/22
|
Tao K, Tzou PL, Kosakovsky Pond SL, et al. | Microbiol Spectr
Aim: To determine the extent to which Omicron variants reduced MAb susceptibility.
INFECTION CONTROL
|
|
|
6/15/22
|
Hatami H, Deravi N, Danaei B, et al. | Int J Methods Psychiatr Res
Aim: To investigate the effectiveness of telephone-delivered services for psychological disorders in the COVID-19 pandemic.
|
|
|
6/14/22
|
Wright T, Mughal F, Babatunde OO, et al. | Bull World Health Organ
Aim: To provide a comprehensive overview and meta-analysis of the prevalence of burnout among primary health-care professionals in low- and middle-income countries.
MENTAL HEALTH
|
|
|
6/14/22
|
Meng X, Zhu K, Wang J, et al. | Am J Otolaryngol
Aim: To outline the current knowledge regarding the effects of maternal SARS-CoV-2 infection during pregnancy on newborn hearing.
CLINICAL CHARACTERISTICS
|
|
|
6/14/22
|
Cao B, Jing X, Liu Y, et al. | J Thorac Dis
Aim: To summarize the available data on the association between the severity of (COVID-19) and routine blood indicators, inflammatory, biochemical parameters and coagulation parameter.
INFECTION CONTROL
|
|
|
6/14/22
|
Messova A, Pivina L, Muzdubayeva Z et al. | J Emerg Nurse
Aim: To review the evidence on the pathophysiology, symptoms, and treatment of COVID-19-mediated immunoglobulin A vasculitis.
|
|
|
6/14/22
|
Shobhana SS, Raviraj KG | Egypt J Forensic Sci
Aim: To note the global trends of suicidal ideation, self-harm, and suicidal thoughts amidst the pandemic.
CLINICAL CHARACTERISTICS
|
|
|
6/14/22
|
Shoar S, Prada-Ruiz ACC, Patarroyo-Aponte G, et al. | Clin Med Insights Circ Respir Pulm Med
Aim: To summarize scarce data in the literature on the development of immune response following vaccination against SARS-CoV-2 and factors associated with a weaker immunity.
MENTAL HEALTH
|
|
|
6/14/22
|
Kramer A, Prinz C, Fichtner F, et al. | Cochrane Database Syst Rev
Aim: To assess the effects of systemic JAK inhibitors plus standard of care compared to standard of care alone (plus/minus placebo) on clinical outcomes in individuals (outpatient or in-hospital) with any severity of COVID-19. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
6/14/22
|
Watanabe A, So M, Iwagami M, et al. | Respirol
Aim: To investigate the characteristics and time-course of pulmonary sequelae after recovery from COVID-19 through 1-year follow-up.
CLINICAL CHARACTERISTICS
|
|
|
6/14/22
|
Motwani R, Deshmukh V, Kumar A, et al. | Infez Med
Aim: To review and summarize histopathological and ultrastructural changes in the placental tissue following SARS-CoV-2 infection.
|
|
|
6/14/22
|
Battaglini D, Premraj L, Huth S, et al. | J Neurosurg Anesthesiol
Aim: To investigate the use of noninvasive multimodal neuromonitoring in critically ill adult patients with COVID-19 infection. UPDATED
|
|
|
6/14/22
|
Drumheller K, Fan CW | Sleep Epidemiol
Aim: To determine if screen time affected sleep during the COVID-19 pandemic.
CLINICAL CHARACTERISTICS
|
|
|
6/13/22
|
Alarcon-Braga EA, Hernandez-Bustamante EA, Salazar-Valdivia FE, et al. | Travel Med Infect Dis
Aim: To estimate the prevalence of the intention to vaccinate against COVID-19 in LAC, and to explore how it varies between different age groups. UPDATED
INFECTION CONTROL
|
|
|
6/13/22
|
Kirby A, Drummond FJ, Lawlor A, et al. | Support Care Cancer
Aim: To examine the social, psychological, and economic impacts of COVID-19 on cancer patients. UPDATED
|
|
|
6/13/22
|
Ma Y, Deng J, Liu Q, et al. | Int J Environ Res Public Health
Aim: To evaluate the long-term consequences of coronavirus disease 2019 (COVID-19) at 6 months and above. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
6/13/22
|
Hernández-Díaz Y, Genis-Mendoza AD, Ramos-Méndez MÁ, et al. | Int J Environ Res Public Health
Aim: To review the evidence on the mental health effects of the COVID-19 pandemic on the general population in Mexico. UPDATED
MENTAL HEALTH
|
|
|
6/13/22
|
D'Onofrio G, Trotta N, Severo M, et al. | J Clin Med
Aim: To review the evidence and effectiveness of psychological interventions applied during Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) pandemic.
CLINICAL CHARACTERISTICS
|
|
|
6/13/22
|
Krumbein H, Kümmel LS, Fragkou PC, et al. | Rev Med Virol
Aim: To critically assess the published literature related to community-acquired viral co-infections and COVID-19 and to evaluate the prevalence, most identified co-pathogens, and relevant risk factors. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
6/13/22
|
Fleming CA, Fullard A, Croghan S, et al. | J Clin Med
Aim: To review reported surgical practice and peer-reviewed published review recommendations and guidelines relating to RAS during the pandemic.
MENTAL HEALTH
|
|
|
6/13/22
|
Li M, Wang Q, Shen J | Int J Environ Res Public Health
Aim: To examine the association between PA and mental health during the COVID-19 pandemic in China.
INFECTION CONTROL
|
|
|
6/13/22
|
Banchelli F, Negro P, Guido M, et al. | J Clin Med
Aim: To investigate the role that ABO blood groups play in susceptibility to SARS-CoV-2 infection. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
6/13/22
|
Unraveling the Mystery of COVID-19 Postvaccination Myocarditis: A Systematic Review of Current Cases
Ghoshouni H, Bagherieh S, Parvizinia M, et al. | Int J Clin Pract
Aim: To better understand whether there is a link between COVID-19 vaccination and cardiac Inflammation.
MENTAL HEALTH
|
|
|
6/10/22
|
Depression prevalence in Vietnam during the Covid-19 pandemic: A systematic review and meta-analysis
Duc TQ, Chi V, Quang PN | Ethics Med Public Health
Aim: To better understand a comprehensive range of the prevalence of depression during the pandemic in Vietnam.
MENTAL HEALTH
|
|
|
6/10/22
|
Ndayishimiye C, Lopes H, Middleton J | Research Square
Aim: To investigate how digital health technologies (DHTs) evolved to support the PHC sector during COVID-19 and lessons for the future improvement of PHC.
|
|
|
6/10/22
|
Bhattarai A, Dhakal G, Shah S, et al. | Interdiscip Perspect Infect Dis
Aim: To review the evidence on the effect of preexisting asthma on the risk of ICU admission, intubation, and death from COVID-19. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
6/10/22
|
Senderovich H, Vinoraj D, Stever M, et al. | Ther Adv Infect Dis
Aim: To assess the current knowledge of the COVID-19 treatment modalities for the geriatric population.
|
|
|
6/10/22
|
Mogharab V, Ostovar M, Ruszkowski J, et al. | Global Health
Aim: To compare the incidence of endpoints marking delayed healthcare seeking in medical emergencies, before and during the pandemic.
|
|
|
6/10/22
|
Aamir Waheed M, Rashid K, Rajab T, et al. | Saudi Med J
Aim: To compare the mortality associated with the intensity of anticoagulation in patients admitted with covid-19. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
6/10/22
|
Loo WK, Hasikin K, Suhaimi A, et al. | Front Public Health
Aim: To understand the current trends and progress in mitigation of hospital readmissions due to COVID-19.
|
|
|
6/9/22
|
Kouhpayeh H, Ansari H | Int Immunopharmacol
Aim: To determine the risk and clinical features of adverse reactions following immunization of the COVID-19.
|
|
|
6/9/22
|
Bezerra GMF, de Lucena Feitosa ES, Vale Catunda JG, et al. | Stud Health Technol Inform
Aim: To review studies on applied telemedicine during the COVID-19 pandemic and had assess its effects on the delivered care.
|
|
|
6/9/22
|
Carle C, Hughes S, Freeman V, et al. | J Cancer Policy
Aim: To review the evidence on the risk for people with cancer to be infected with SARS-CoV-2 compared to people without cancer. UPDATED
INFECTION CONTROL
|
|
|
6/9/22
|
Batista DR, Floriano I, Silvinato A, et al. | J Bras Pneumol
Aim: To answer questions related to the use of anticoagulants in the treatment of COVID-19 patients.
CANDIDATE THERAPEUTICS
|
|
|
6/8/22
|
Zeng N, Zhao YM, Yan W, et al. | Mol Psychiatry
Aim: To review the evidence on COVID-19 survivors’ health consequences and sequelae for COVID-19. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
6/8/22
|
Fei Z, Chen Z, Du X, et al. | Transfus Med Hemother
Aim: To determine the safety and efficacy of IVIG and CP for COVID-19 and the different treatment effects between these two therapeutics to provide references for treating COVID-19. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
6/8/22
|
Ventura CAI, Denton EE, David JA, et al. | Open Access Emerg Med
Aim: To analyze prehospital Emergency Medical Services (EMS) response to the COVID-19 pandemic.
INFECTION CONTROL
|
|
|
6/8/22
|
Benvari S, Mahmoudi S, Mohammadi M | World J Pediatr
Aim: To evaluate the viral shedding pattern in gastrointestinal specimens of children with COVID-19.
INFECTION CONTROL
|
|
|
6/8/22
|
Washrawirul C, Triwatcharikorn J, Phannajit J, et al. | J Eur Acad Dermatol Venereol
Aim: To assess the global prevalence and clinical manifestations of cutaneous adverse reactions following COVID-19 vaccination.
|
|
|
6/8/22
|
Wang K, Wang L, Li M, et al. | Front Med
Aim: To evaluate the overall effectiveness of current vaccines and the differences between the various vaccines and variants.
INFECTION CONTROL
|
|
|
6/7/22
|
Aryana IGPS, Setiati S, Paulus IB, et al. | J Nutr Metab
Aim: To investigate physical training on muscle health and QOL in patients with COVID-19. UPDATED
|
|
|
6/7/22
|
Shaikh CF, Palmer Kelly E, Paro A, et al. | J Surg Educ
Aim: To summarize current research on burnout among surgical trainees and surgeons during the COVID-19 pandemic.
MENTAL HEALTH
|
|
|
6/7/22
|
Shafiee A, Teymouri Athar MM, Nassar M, et al. | Diabetes Metab Syndr
Aim: To evaluate the current evidence available to investigate clinical outcomes between patients with type 1 and type 2 diabetes. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
6/7/22
|
Salari N, Vepa A, Daneshkhah A, et al. | Public Health
Aim: To assess to what extent COVID-19 clinical trials have considered the impact of race and ethnicity on COVID-19 vaccine safety and efficacy. UPDATED
INFECTION CONTROL
|
|
|
6/7/22
|
Ahmed SK, Mohamed MG, Essa RA, et al. | Diabetes Metab Syndr
Aim: To examine the evidence on myocarditis following COVID-19 vaccination, focusing on patient and disease characteristics, as well as investigation and clinical outcome. UPDATED
INFECTION CONTROL
|
|
|
6/7/22
|
Sood A, Tran M, Murthy V, et al. | J Clin Rheumatol
Aim: To examine the immunogenicity and safety of SARS-CoV-2 vaccination in patients with RD.
INFECTION CONTROL
|
|
|
6/7/22
|
Delanerolle G, Zeng Y, Shi JQ, et al. | World J Psychiatry
Aim: To identify and report: (1) MH conditions commonly observed across all 3 pandemics; (2) Impact of MH outcomes across HCPs, patients and the general public associated with all 3 pandemics; and (3) The prevalence of the MH impact and clinical epidemiological significance. UPDATED
MENTAL HEALTH
|
|
|
6/7/22
|
Zhi H, Ji X, Zhao Z, et al. | EClinicalMedicine
Aim: To review the evidence on the potential risk factors for impaired diffusing capacity for carbon monoxide (DLCO) in convalescent COVID-19 patients. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
6/6/22
|
Mose A, Wasie A, Shitu S, et al. | PLoS One
Aim: To estimate the pooled prevalence of COVID-19 vaccine acceptance and its determinants in Ethiopia. UPDATED
INFECTION CONTROL
|
|
|
6/6/22
|
Mirzay-Razaz J, Hassanghomi M, Ajami M, et al. | BMC Nutr
Aim: To review effective food hygiene principles and dietary intakes to reinforce the immune system for prevention of corona virus disease 2019 (COVID-19).
|
|
|
6/6/22
|
Piscoya A, Parra Del Riego A, Cerna-Viacava R, et al. | PLoS One
Aim: To assess benefits and harms of tocilizumab (TCZ), which is an antibody blocking IL-6 receptors, in hospitalized COVID-19 patients.
CANDIDATE THERAPEUTICS
|
|
|
6/6/22
|
Bello UM, Kannan P, Chutiyami M, et al. | Front Public Health
Aim: To review the evidence on the prevalence of anxiety and depression among the general populace in Africa during the COVID-19 pandemic and examine associated risk factors. UPDATED
MENTAL HEALTH
|
|
|
6/6/22
|
Banerjee M, Pal R, Dutta S | Prim Care Diabetes
Aim: To provide a pooled estimate of the risk of developing incident diabetes following hospital discharge or at least 28 days after the COVID-19 diagnosis compared to matched controls or severity matched influenza/ non-COVID-19 acute upper respiratory tract infections (AURI).
CLINICAL CHARACTERISTICS
|
|
|
6/6/22
|
Azami M, Moradi Y, Moradkhani A, et al. | Eur J Med Res
Aim: To estimate the prevalence of global SARS-CoV-2 serology in different populations and geographical areas.
INFECTION CONTROL
|
|
|
6/6/22
|
Subramaniam A, Lim ZJ, Ponnapa Reddy M, et al. | ANZ J Surg
Aim: To investigate the occurrence of SARS-CoV-2 transmission from patients to healthcare workers (HCWs) when tracheostomies are performed. UPDATED
INFECTION CONTROL
|
|
|
6/3/22
|
Perez-Lopez FR, Lopez-Baena MT, Perez-Roncero G, et al. | Gynecol Endocrinol
Aim: To compare the female sexual function before and during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic using the Female Sexual Function Index (FSFI).
|
|
|
6/3/22
|
Park DY, An S, Kaur A, et al. | Clin Cardiol
Aim: To review the evidence on COVID-19 vaccine-associated myocarditis, delineating its demographics and clinical characteristics.
|
|
|
6/2/22
|
Shin JI, Kim SE, Lee MH, et al. | Eur Rev Med Pharmacol Sci
Aim: To assess the susceptibility to and clinical outcomes of COVID-19 in autoimmune inflammatory rheumatic disease (AIRD) and following AIRD drug use. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
6/2/22
|
Okita Y, Morita T, Kumanogoh A | Inflamm Regen
Aim: To review the evidence on the duration of SARS-CoV-2 RNA positivity from several parts of the obdy and clinical characteristics affecting it. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
6/2/22
|
Au WY, Cheung PP | BMJ
Aim: To evaluate the effectiveness of heterologous and homologous covid-19 vaccine regimens with and without boosting in preventing covid-19 related infection, hospital admission, and death.
INFECTION CONTROL
|
|
|
6/2/22
|
Piechotta V, Mellinghoff SC, Hirsch C, et al. | Blood Cancer J
Aim: To assess clinical efficacy parameters, humoral and cellular immunogenicity and adverse events (AE) following two doses of COVID-19 approved vaccines.
INFECTION CONTROL
|
|
|
6/2/22
|
Fragkou PC, Palaiodimou L, Stefanou MI, et al. | Ther Adv Neurol Disord
Aim: To review the effects of different dosing regimens of low molecular weight heparin and/or fondaparinux (LMWH/F) on mortality risk as well as the risk of arterial/venous thrombotic events and hemorrhagic complications in confirmed COVID-19 cases. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
6/2/22
|
Qu W, Wang Z, Engelberg-Cook E, et al. | Stem Cells Transl Med
Aim: To assess the efficacy and adverse events (AE) rates of MSC cell therapy in individuals hospitalized for COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
6/2/22
|
Pourasghari H, Tavolinejad H, Soleimanpour S, et al. | Int J Cardiol Heart Vasc
Aim: To compare the rate of AMI admissions and major complication during the pandemic, in comparison with pre-pandemic periods.
|
|
|
6/2/22
|
Fakhruddin KS, Samaranayake LP, Buranawat B, et al. | PLoS One
Aim: To review the prevalence, the likely aetiopathogenesis, and the management of oro-facial mucocutaneous manifestations of Coronavirus Disease-2019 (COVID-19), caused by the Severe Acute Respiratory Syndrome Coronavirus -2 (SARS-CoV-2). UPDATED
CLINICAL CHARACTERISTICS
|
|
|
6/2/22
|
Leazer S, Collen J, Alcover K, et al. | Mil Med
Aim: To determine critical care and organ support outcomes of intensive care unit (ICU) COVID-19 patients and whether they varied depending on the completeness of study follow-up or admission time period.
CLINICAL CHARACTERISTICS
|
|
|
6/2/22
|
Zhou Y, Ge YT, Yang XX, et al. | Front Public Health
Aim: To determine the prevalence of PE elevation, and the relationship between elevated PE and prognosis in COVID-19 patients. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
6/2/22
|
Huntley CC, Patel K, Bil Bushra SE, et al. | ERJ Open Res
Aim: To describe and compare the longitudinal pulmonary function and computed tomography (CT) features of patients recovering from SARS, MERS and COVID-19 during follow-up. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
6/2/22
|
Hawco S, Rolnik DL, Woolner A, et al. | Eur J Obstet Gynecol Reprod Biol
Aim: To review the evidence on the relationship between SARS-CoV-2 mitigation measures and perinatal outcomes, with extensive subgroup analysis. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
6/1/22
|
Allotey J, Stallings E, Bonet M, et al. | BMJ
Aim: To determine the clinical manifestations, risk factors, and maternal and perinatal outcomes in pregnant and recently pregnant women with suspected or confirmed coronavirus disease 2019 (covid-19). UPDATED
CLINICAL CHARACTERISTICS
|
|
|
6/1/22
|
Zhang L, Ma Y, Shi N, et al. | Phytomedicine
Aim: To systematically assemble the evidence on the efficacy and safety of QFPDD combined with Western medicine treatments (WMT) for COVID-19.
|
|
|
6/1/22
|
Sheerin D, Abhimanyu, Peton N, et al. | iScience
Aim: To identify mechanisms of immunopathogenic interaction between COVID-19 and TB.
CLINICAL CHARACTERISTICS
|
|
|
6/1/22
|
Curtin M, Richards HL, Fortune DG | Clin Psychol Rev
Aim: To appraise and synthesize studies investigating resilience among HCWs during COVID-19, H1N1, MERS, EBOLA and SARS pandemics.
MENTAL HEALTH
|
|
|
5/31/22
|
Brümmer LE, Katzenschlager S, McGrath S, et al. | PLoS Med
Aim: To review the accuracy of commercially available Ag-RDTs, further explore the impact of viral load, the presence of symptoms, and the testing procedure on the accuracy of Ag-RDTs.
DIAGNOSTICS
|
|
|
5/31/22
|
Lemes IR, Smaira FI, Ribeiro WJD, et al. | Br J Sports Med
Aim: To describe acute/postacute COVID-19 presentations in athletes. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
5/31/22
|
Mei Y, Guo X, Chen Z, et al. | Int J Environ Res Public Health
Aim: To quest for the optimal HCW monitoring mechanism and provide practical recommendations for administrators of healthcare facilities, leadership of healthcare systems, as well as policy makers tackling this global issue.
INFECTION CONTROL
|
|
|
5/31/22
|
Levin AT, Owusu-Boaitey N, Pugh S, et al. | BMJ Glob Health
Aim: To review the evidence on age-specific seroprevalence or IFR for developing countries.
CLINICAL CHARACTERISTICS
|
|
|
5/31/22
|
Lee ARYB, Wong SY, Tay SH | Vaccines
Aim: To study seroconversion rates and antibody levels post-vaccination in IMID patients. UPDATED
INFECTION CONTROL
|
|
|
5/31/22
|
Parmar K, Subramanyam S, Del Rio-Pertuz G, et al. | Vaccines
Aim: To investigate the patient characteristics and provide an overview of the management for patients that develop AEs after vaccination.
|
|
|
5/31/22
|
Trott M, Driscoll R, Irlado E, et al. | EClinicalMedicine
Aim: To (a) aggregate changes in screen time in adults and children, and (b) report on variables in relation to screen time during the COVID-19 pandemic.
|
|
|
5/31/22
|
Gopinath S, Ishak A, Dhawan N, et al. | Trop Med Infect Dis
Aim: To assess breakthrough SARS-CoV-2 infections in vaccinated individuals by variant distribution and to identify the common risk associations.
INFECTION CONTROL
|
|
|
5/31/22
|
Achangwa C, Park H, Ryu S, et al. | Viruses
Aim: To investigate the collateral impact of PHSMs used during the coronavirus disease 2019 (COVID-19) pandemic on the epidemiology of other respiratory viruses, including influenza, parainfluenza, respiratory syncytial virus, rhinovirus, and adenovirus infections.
INFECTION CONTROL
|
|
|
5/31/22
|
Fernández-Lázaro D, Ortega CD, Sánchez-Serrano N, et al. | Pharmaceutics
Aim: To systematically analyze the evidence of the effect and safety of treatment with CP therapy using randomized controlled trials (RCTs) to confirm the usefulness of this intervention in hospitalized patients with COVID-19. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
5/31/22
|
Dadras O, SeyedAlinaghi S, Karimi A, et al. | Health Sci Rep
Aim: To systematically review the mortality rates in older patients compared to young patients.
|
|
|
5/31/22
|
Patwary MM, Bardhan M, Haque MZ, et al. | Vaccines
Aim: To assess the acceptance and hesitancy of COVID-19 vaccination rates among HCSs globally and identify the factors predicting vaccine acceptance.
INFECTION CONTROL
|
|
|
5/31/22
|
Hosseini B, El Abd A, Ducharme FM | Nutrients
Aim: To evaluate the impact of vitamin D supplementation on COVID-19 related outcomes. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
5/31/22
|
Toro-Huamanchumo CJ, Castro-Reyes MM, Peralta V, et al. | Int J Environ Res Public Health
Aim: To assess the efficacy and safety of extracorporeal membrane oxygenation (ECMO) in patients under mechanical ventilation with COVID-19 and severe acute respiratory distress syndrome (ARDS).
|
|
|
5/31/22
|
Panneer S, Kantamaneni K, Palaniswamy U, et al. | Healthcare
Aim: To explore health, economic and social development issues in a COVID-19 pandemic context and aftermath.
|
|
|
5/31/22
|
Degarege A, Naveed Z, Kabayundo J, et al. | Pathogens
Aim: To review the evidence on the risk factors of severe illness, admission to the ICU, and death among COVID-19 patients, and we assessed the sources of heterogeneity and publication bias among the studies.
|
|
|
5/31/22
|
Cheng H, Peng Z, Si S, et al. | Vaccines
Aim: To assess the immunogenicity and safety of the different combinations of prime–boost vaccinations.
INFECTION CONTROL
|
|
|
5/31/22
|
Jia Q, Qu Y, Sun H, et al. | Front Psychol
Aim: To assess the pooled prevalence of depression and anxiety among medical students worldwide. UPDATED
MENTAL HEALTH
|
|
|
5/31/22
|
Jamiruddin MR, Meghla BA, Islam DZ, et al. | Life
Aim: To explore the different microfluidic-based diagnostics kits and how their amalgamation with the various detection techniques has spearheaded their availability throughout the world.
DIAGNOSTICS
|
|
|
5/31/22
|
Firouzkouhi M, Abdollahimohammad A, Rezaie-Kheikhaie K, et al. | Health Sci Rev
Aim: To explore nurses' caring experiences in the COVID-19 pandemic.
MENTAL HEALTH
|
|
|
5/31/22
|
Buitrago-Garcia D, Ipekci AM, Heron L, et al. | PLoS Med
Aim: To review the evidence on asymptomatic SARS-CoV-2 transmission. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
5/31/22
|
Anghelescu A, Onose G, Popescu C, et al. | Biomedicines
Aim: To review the evidence on post-SARS-CoV-2 immune-mediated reactions responsible for promoting neurodegeneration.
CLINICAL CHARACTERISTICS
|
|
|
5/31/22
|
Pogorzelska K, Chlabicz S | Int J Environ Res Public Health
Aim: To review the evidence on the effectiveness of this modality and patient satisfaction with telemedicine.
INFECTION CONTROL
|
|
|
5/31/22
|
Loader J, Taylor FC, Lampa E, et al. | J Am Heart Assoc
Aim: To assess the extent of bias in that research and reevaluated RAAS inhibitor-COVID-19 associations in studies without critical risk of bias. UPDATED
|
|
|
5/31/22
|
Dzinamarira T, Murewanhema G, Chitungo I, et al. | J Infect Public Health
Aim: To determine the association of HIV/AIDS comorbidity with COVID-19 mortality. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
5/31/22
|
Marin S, Val AM, Peligero MB, et al. | Pharmaceuticals
Aim: To assess and summarise the available literature on the early toxicity of CQ and HCQ alone or in combination with other drugs that have been used to treat COVID-19 in different clinical situations. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
5/31/22
|
Wang Y, Xie Y, Hu S, et al. | Front Immunol
Aim: To compare the risk of SARS-CoV-2 infection, severe COVID-19 symptoms, and death of PLWH with those without HIV.
CLINICAL CHARACTERISTICS
|
|
|
5/31/22
|
Golawski M, Lewandowski P, Jablonska I, et al. | Viruses
Aim: To identify mutations that have been applied to—or could be applied to—SARS-CoV-2 to attenuate it.
INFECTION CONTROL
|
|
|
5/31/22
|
Sasidharanpillai S, Ravishankar N | Asian Pac J Cancer Prev
Aim: To assess the pooled proportion of women screened for cervical cancer before and during the COVID-19 pandemic.
|
|
|
5/31/22
|
Galanis P, Vraka I, Siskou O, et al. | Vaccines
Aim: To evaluate the evidence in the literature regarding the uptake of COVID-19 vaccinations among pregnant women.
INFECTION CONTROL
|
|
|
5/31/22
|
Kim TH, Kang JW, Jeon SR, et al. | Front Med
Aim: To identify the overall usage prevalence of TCIM interventions for COVID-19. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
5/31/22
|
See KC | Vaccines
Aim: To review the evidence on the effects of vaccination on immunocompromised patients.
INFECTION CONTROL
|
|
|
5/31/22
|
Oliveira da Silva Kist ML, Hanzen Andrades GR, Drumond Costa CA, et al. | Clin Nutr ESPEN
Aim: To systematically review the literature on the relation between weight excess and the severity of COVID-19 in children and adolescents. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
5/26/22
|
Higdon MM, Wahl B, Jones CB, et al. | Open Forum Infect Dis
Aim: To review COVID-19 vaccine efficacy and effectiveness data against multiple clinical outcomes, for both full and partial immunization courses, by circulating SARS-CoV-2 variants of concern.
INFECTION CONTROL
|
|
|
5/26/22
|
Hariyanto TI, Jodhinata C, Halim DA, et al. | Gastroenterol Hepatol Bed Bench
Aim: To provide evidence of the association between viral hepatitis and severe outcomes of COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
5/26/22
|
Samimisedeh P, Jafari Afshar E, Shafiabadi Hassani N, et al. | J Magn Reson Imaging
Aim: To summarize cardiac MRI findings in COVID-19 vaccine-related myocarditis.
CLINICAL CHARACTERISTICS
|
|
|
5/26/22
|
Cui X, Zhai Y, Wang S, et al. | Med Sci Monit
Aim: To systemically evaluate the effect of the COVID-19 pandemic on serum vitamin D levels in people under age 18 years.
|
|
|
5/26/22
|
Hernández-Vásquez A, Barrenechea-Pulache A, Comandé D, et al. | Evid Based Dent
Aim: To review the evidence regarding the effect of different mouthrinses on the viral load of SARS-CoV-2 in the saliva of infected patients.
INFECTION CONTROL
|
|
|
5/26/22
|
de Sire A, Andrenelli E, Negrini F, et al. | Eur J Phys Rehabil Med
Aim: To investigate the literature on rehabilitation services for COVID-19 patients. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
5/26/22
|
Cascini F, Pantovic A, Al-Ajlouni YA, et al. | EClinicalMedicine
Aim: To synthesize the current evidence regarding the potential role of social media in shaping COVID-19 vaccination attitudes, and to explore its potential for shaping public health interventions to address the issue of vaccine hesitancy. UPDATED
INFECTION CONTROL
|
|
|
5/25/22
|
Zeng B, Gao L, Zhou Q, et al. | BMC Med
Aim: To provide a comprehensive overview of the effectiveness profile of COVID-19 vaccines against VOC. UPDATED
INFECTION CONTROL
|
|
|
5/25/22
|
Ling RR, Ramanathan K, Sim JJL, et al. | Crit Care
Aim: To characterise changes in mortality over time and elucidate risk factors for poor outcomes in COVID-19 patients receiving ECMO. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
5/25/22
|
ElSawi HA, Elborollosy A | Egypt J Intern Med
Aim: To assess post-COVID vaccination immune-mediated adverse events and evaluate its association to specific type of vaccine global wide.
INFECTION CONTROL
|
|
|
5/25/22
|
Epton T, Ghio D, Ballard LM, et al. | Soc Sci Med
Aim: To determine which interventions and behavior change techniques (BCTs) are effective in promoting adherence to distancing and through which potential mechanisms of action (MOAs). UPDATED
INFECTION CONTROL
|
|
|
5/25/22
|
Ulloque-Badaracco JR, Mosquera-Rojas MD, Hernandez-Bustamante EA, et al. | Heliyon
Aim: To evaluate the prognostic value of the AGR in COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
5/25/22
|
Dadashi M, Dadashi A, Sameni F, et al. | Gene Rep
Aim: To assess the status of patients co-infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and HIV.
CLINICAL CHARACTERISTICS
|
|
|
5/25/22
|
Zhai K, Xu X, Zhang P, et al. | Perfusion
Aim: To evaluate the effect of VV-ECMO in the treatment of patients with COVID-19.
|
|
|
5/24/22
|
Liana P, Liberty IA, Murti K, et al. | Immunol Res
Aim: To summarize studies on the role of NETs in determining the prognosis of COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
5/24/22
|
Panagouli ED, Thirios AC, Psaltopoulou T, et al. | EMBnet
Aim: To evaluate special features and probable correlations between symptoms, laboratory findings, treatment, and outcomes of COVID-19 in children and adolescents.
CLINICAL CHARACTERISTICS
|
|
|
5/24/22
|
Chen J, Zhang SX, Yin A, et al. | J Glob Health
Aim: To summarize the prevalence of anxiety, depression, distress, insomnia, and PTSD in the adult population during the first year of the COVID pandemic in developing countries.
MENTAL HEALTH
|
|
|
5/24/22
|
Pacheco JA, Molena KF, Martins CROG, et al. | Bull Natl Res Cent
Aim: To critically assess the clinical evidence on the use of photobiomodulation (PBMT) and antimicrobial photodynamic therapy (aPDT) for the treatment of oral lesions in patients infected with Sars-Cov-2.
CANDIDATE THERAPEUTICS
|
|
|
5/24/22
|
Ulloque-Badaracco JR, Mosquera-Rojas MD, Hernandez-Bustamante EA, et al. | Heliyon
Aim: To evaluate the prognostic value of the AGR in COVID-19 patients. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
5/24/22
|
Lee TC, Murthy S, Del Corpo O, et al. | Clin Microbiol Infect
Aim: To evaluate the role of remdesivir for hospitalized inpatients as a function of oxygen requirements.
CANDIDATE THERAPEUTICS
|
|
|
5/24/22
|
Barberis N, Cannavò M, Cuzzocrea F, et al. | Clin Neuropsychiatry
Aim: To carry out a comprehensive investigation of suicide risk factors during the current COVID-19 pandemic.
MENTAL HEALTH
|
|
|
5/24/22
|
Huang JA, Hartanti IR, Colin MN, et al. | Digit Health
Aim: To review various artificial intelligence-based telemedicine research during the COVID-19 outbreak and proposes a framework for developing telemedicine powered by artificial intelligence to monitor progression in COVID-19 patients during isolation at home.
INFECTION CONTROL
|
|
|
5/24/22
|
Michailidou D, Stavridou A, Panagouli ED, et al. | EMBnet
Aim: To summarize current evidence on vertical transmission rates, maternal, perinatal and neonatal outcomes and mode of delivery in pregnancies affected by COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
5/24/22
|
O'Mahoney LL, Highton PJ, Kudlek L, et al. | Diabetes Obes Metab
Aim: To identify, appraise and synthesise available evidence on the impact of the pandemic on glycaemic control in people with diabetes. UPDATED
|
|
|
5/24/22
|
Tabatabaeizadeh SA | Eur J Med Res
Aim: To evaluate the effect of zinc supplementation on COVID-19 mortality.
CANDIDATE THERAPEUTICS
|
|
|
5/23/22
|
Talukder A, Razu SR, Alif SM, et al. | J Multidiscip Healthc
Aim: To evaluate the association between symptoms and severity of disease in adult patients with confirmed COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
5/23/22
|
Lee CJ, Woo W, Kim AY, et al. | J Med Virol
Aim: To provide a comparative meta-analysis and systematic review of the risk and clinical outcomes of COVID-19 infection between fully vaccinated and unvaccinated groups.
CLINICAL CHARACTERISTICS
|
|
|
5/23/22
|
Kesheh MM, Shavandi S, Haeri Moghaddam N, et al. | Virol J
Aim: To review the evidence on the effectiveness of herbal compounds against coronavirus family, which may have the potential in treating COVID19 infection.
CANDIDATE THERAPEUTICS
|
|
|
5/23/22
|
Castanares-Zapatero D, Chalon P, Kohn L, et al. | Ann Med
Aim: To conduct a comprehensive review to address the putative pathophysiology underlying the persisting symptoms of long COVID.
LONG COVID
|
|
|
5/23/22
|
Zuin M, Rigatelli G, Bilato MJ, et al. | Vascular
Aim: To assess prevalence and prognostic implications of pre-existing peripheral artery disease (PAD) in patients infected by the SARS-CoV-2.
CLINICAL CHARACTERISTICS
|
|
|
5/23/22
|
Kudhail K, Thompson J, Mathews V, et al. | Int J Infect Dis
Aim: To describe the prevalence of risks of bias in randomised trials of therapeutic interventions for COVID-19.
|
|
|
5/23/22
|
Kim H, Hughes E, Cavanagh A, et al. | PLoS One
Aim: To conduct a mixed methods systematic review on the impacts of the COVID-19 pandemic on the health of people who experience imprisonment. UPDATED
|
|
|
5/20/22
|
Keskin AU, Ciragil P, Topkaya AE | Int J Microbiol
Aim: To collect and analyse current evidence on real-world performance based on clinical accuracy of instrument-read rapid antigen diagnostic tests (Ag-IRRDTs) for SARS-CoV-2 identification. UPDATED
DIAGNOSTICS
|
|
|
5/20/22
|
Lee KH, Li H, Lee MH, et al. | Eur Rev Med Pharmacol Sci
Aim: To describe the clinical and laboratory characteristics of MIS-C.
CLINICAL CHARACTERISTICS
|
|
|
5/20/22
|
Clinical prognosis of coronavirus disease 2019 in children and vitamin D levels: a systematic review
Alvares MA, Ribas BHB, Miranda GB, et al. | Rev Assoc Med Bras
Aim: To correlate 25(OH)D levels with the clinical prognosis of pediatric patients diagnosed with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
5/20/22
|
Javadinia SA, Alizadeh K, Mojadadi MS, et al. | Front Endocrinol
Aim: To assesse the literature involving the use of COVID-19 vaccines in cancer patients and reported the seroconversion rates as the main outcome, with severity of COVID-19 infection and side effects following COVID-19 vaccination as the secondary outcomes.
INFECTION CONTROL
|
|
|
5/20/22
|
Alahyari S, Moradi M, Rajaeinejad M, et al. | Expert Rev Hematol
Aim: To comprehensively assess the post-COVID hematologic complications in patients.
CLINICAL CHARACTERISTICS
|
|
|
5/19/22
|
Ackah M, Ameyaw L, Gazali Salifu M, et al. | PLoS One
Aim: To review the acceptance rate and possible reasons for COVID-19 vaccine non-acceptance/hesitancy amongst HCWs in Africa. UPDATED
INFECTION CONTROL
|
|
|
5/19/22
|
Pandey R, Rai D, Tahir MW, et al. | Arch Med Sci Atheroscler Dis
Aim: To review the evidence on the comorbidities and symptoms of adult patients with coronavirus disease 2019 (COVID-19) to evaluate comorbidities, symptoms, and severity.
CLINICAL CHARACTERISTICS
|
|
|
5/18/22
|
Lan SH, Lai CC, Chang SP, et al. | Expert Rev Clin Pharmacol
Aim: To investigate the clinical efficacy and safety of favipiravir for patients with mild-to-critical COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
5/17/22
|
Sofizan NMFBN, Rahman AFBA, Soon LP, et al. | Egypt J Forensic Sci
Aim: To summarize the autopsy findings related to COVID-19 death.
CLINICAL CHARACTERISTICS
|
|
|
5/17/22
|
Péterfi A, Mészáros Á, Szarvas Z, et al. | Physiol Int
Aim: To review the evidence on the relationship of comorbidities and mortality due to Coronavirus Disease 2019 (COVID-19) among the elderly population.
CLINICAL CHARACTERISTICS
|
|
|
5/17/22
|
Mayra ST, Kandiah J, McIntosh CE | Psychol Sch
Aim: To synthesize the existing literature on how COVID?19 impacted K?12 students' eating patterns, physical activity, and sleep in the United States.
MENTAL HEALTH
|
|
|
5/17/22
|
Meng X, Wang J, Sun J, et al. | Front Neurol
Aim: To examine whether COVID-19 causes an increased incidence of SSNHL and the clinical characteristics of patients with COVID-19-related SSNHL.
CLINICAL CHARACTERISTICS
|
|
|
5/17/22
|
Zareei M, Tabanejad Z, Oskouie F, et al. | J Educ Health Promot
Aim: To review the studies on burnout among nurses during the COVID-19 epidemic.
MENTAL HEALTH
|
|
|
5/17/22
|
Alshammary AF, Alsughayyir JM, Alharbi KK, et al. | Front Med
Aim: To analyze T-cell subsets (CD4/CD8) and IL-10 in severe and fatal cases of COVID-19. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
5/16/22
|
Riccò M, Ranzieri S, Peruzzi S, et al. | Acta Biomed
Aim: To assess available evidence and to explore the reliability of antigenic tests in the management of the SARS-CoV-2 pandemic.
DIAGNOSTICS
|
|
|
5/16/22
|
Afzal S, Nasir M | J Coll Physicians Surg Pak
Aim: To assess risk factors and case fatality in COVID-19 cases with aspergillosis or mucormycosis.
CLINICAL CHARACTERISTICS
|
|
|
5/16/22
|
Lee B, Ashcroft T, Agyei-Manu E, et al. | J Glob Health
Aim: To assess whether the common clinical features of COVID-19 have changed to the point that the criteria used to identify both COVID-19 and influenza in surveillance programs needs to be altered.
CLINICAL CHARACTERISTICS
|
|
|
5/16/22
|
Mastan S, Hodhody G, Sajid M, et al. | Geriatr Orthop Surg Rehabil
Aim: To assess the early mortality rate of hip fracture patients in the UK, with and without COVID-19 infection.
CLINICAL CHARACTERISTICS
|
|
|
5/16/22
|
Toro-Huamanchumo CJ, Benites-Meza JK, Mamani-García CS, et al. | J Clin Med
Aim: To assess the efficacy of colchicine in COVID-19 patients. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
5/16/22
|
Vaseghi N, Sharifisooraki J, Khodadadi H, et al. | Mycoses
Aim: To evaluate and estimate the global prevalence of coronavirus-associated C. auris infection (CACa). UPDATED
CLINICAL CHARACTERISTICS
|
|
|
5/16/22
|
Lv J, Wu H, Xu J, et al. | Infect Dis Poverty
Aim: To pool the evidence on the immunogenicity and safety of heterologous versus homologous prime-boost vaccination schedule.
INFECTION CONTROL
|
|
|
5/16/22
|
Cho K, Park S, Kim EY, et al. | J Med Virol
Aim: To compare the efficacy of COVID-19 vaccination in patients with solid tumor, hematologic malignancy, autoimmune disease, inflammatory bowel disease, and patients who received transplantation or dialysis.
INFECTION CONTROL
|
|
|
5/16/22
|
Altobelli E, Angeletti PM, Marzi F, et al. | J Clin Med
Aim: To robustly quantify admission trends of patients with ST-segment elevation MI (STEMI) and non-ST-segment elevation MI (NSTEMI) during the first wave of the pandemic and to characterize on a large basis the risk profile and early prognosis.
CLINICAL CHARACTERISTICS
|
|
|
5/16/22
|
Landoni G, Belloni O, Russo G, et al. | J Clin Med
Aim: To identify all the literature published and all the currently ongoing trials on volatile anesthetics in COVID-19 patients to enlighten the pros/cons of their role in this setting.
|
|
|
5/16/22
|
Nappi F, Bellomo F, Avtaar Singh SS | J Clin Med
Aim: To investigate the role of inflammatory pathways, highlighting several culprits including neutrophil extracellular traps (NETs) which have since been extensively investigated.
CLINICAL CHARACTERISTICS
|
|
|
5/16/22
|
Juneau CE, Pueyo T, Bell M, et al. | Syst Rev
Aim: To provide a comprehensive summary of the evidence on past pandemic controls, with a focus on cost-effectiveness.
|
|
|
5/16/22
|
Teschke R, Méndez-Sánchez N, Eickhoff A | Int J Mol Sci
Aim: To analyze published reports on conventional drugs and their role in causing liver injury among COVID-19 patients.
|
|
|
5/16/22
|
Ruvinsky S, Voto C, Roel M, et al. | Front Pediatr
Aim: To describe the clinical course, laboratory findings, epidemiology, treatment, and use of resources of MIS-C in children from LAC. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
5/16/22
|
Santana LADM, Vieira WA, Gonçalo RIC, et al. | J Stomatol Oral Maxillofac Surg
Aim: To better understand the relationship between COVID-19 infection and oral lesions. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
5/16/22
|
Carmassi C, Pacciardi B, Gravina D, et al. | Int J Environ Res Public Health
Aim: To evaluate and gather the scientific evidence on pharmacologic handling during delirium in COVID-19 patients to provide practical recommendations on the optimal management of psychotropic medication in these kinds of patients.
CLINICAL CHARACTERISTICS
|
|
|
5/16/22
|
Fugazzaro S, Contri A, Esseroukh O, et al. | Int J Environ Res Public Health
Aim: To explore the effectiveness of rehabilitation interventions for adult patients with PACS by reporting the main changes in outcomes after the experimental interventions. UPDATED
|
|
|
5/16/22
|
Caini S, Martinoli C, La Vecchia C, et al. | Int J Environ Res Public Health
Aim: To estimate SARS-CoV-2 infections detected in schools comparing positive rates found from screening and contact tracing methods, to compare infectivity and susceptibility of students compared to school staff, and to investigate reasons of between-study heterogeneity.
INFECTION CONTROL
|
|
|
5/16/22
|
Carvalho S, Coelho CG, Kluwe-Schiavon B, et al. | Int J Environ Res Public Health
Aim: To systematically review the impact of the early stages COVID-19 pandemic on people with pre-existing psychiatric disorders.
MENTAL HEALTH
|
|
|
5/16/22
|
Dellafiore F, Arrigoni C, Nania T, et al. | Acta Biomed
Aim: To synthesize the current evidence on the impact of the COVID-19 pandemic on caregivers' mental health. UPDATED
MENTAL HEALTH
|
|
|
5/16/22
|
Chen F, Tian Y, Zhang L, et al. | Int J Infect Dis
Aim: To (1) assess the prevalence of pediatric COVID-19 in family clusters; (2) estimate the household secondary attack rate of children in different periods and variants; (3) compare the transmissibility of SARS-CoV-2 in different age groups and explore its potential determinants. UPDATED
INFECTION CONTROL
|
|
|
5/16/22
|
Mani A, Ojha V | Ann Vasc Surg
Aim: To systematically review thromboembolic events reported after Covid-19 vaccination.
|
|
|
5/13/22
|
| NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on emerging SARS-CoV-2 variants.
|
|
|
5/12/22
|
Moneer O, Daly G, Skydel JJ, et al. | BMJ
Aim: To systematically identify, match, and compare treatment effects and study demographics from individual or meta-analysed observational studies and randomized controlled trials (RCTs) evaluating the same covid-19 treatments, comparators, and outcomes.
CANDIDATE THERAPEUTICS
|
|
|
5/12/22
|
Tavares-Júnior JWL, de Souza ACC, Borges JWP, et al. | Cortex
Aim: To determine any relationship between COVID-19 and cognitive complaints, such as dementia, mild cognitive impairment (MCI), or subjective cognitive decline (SCD). UPDATED
CLINICAL CHARACTERISTICS
|
|
|
5/12/22
|
Prasad S, Kalafat E, Blakeway H, et al. | Nat Commun
Aim: To review the effects of COVID-19 vaccination in pregnancy, and on vaccine effectiveness in pregnancy. UPDATED
INFECTION CONTROL
|
|
|
5/11/22
|
Chang Y, Bai M, You Q | Biomed Res Int
Aim: To investigate the association between interleukins (IL-1beta, IL-2, IL-4, IL-6, IL-8, and IL-10) and the disease severity of coronavirus disease 2019 (COVID-19).
CLINICAL CHARACTERISTICS
|
|
|
5/11/22
|
Jiang L, Tang K, Irfan O, et al. | Curr Pediatr Rep
Aim: To investigate and synthesize evolving evidence on its clinical characteristics, management, and outcomes in pediatric patients.
CLINICAL CHARACTERISTICS
|
|
|
5/11/22
|
Kolahdouzan K, Chavoshi M, Bayani R, et al. | Int J Radiat Oncol Biol Phys
Aim: To review studies incorporating WLI for the treatment of COVID-19 pneumonia. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
5/11/22
|
Verleye A, Wijtvliet V, Abrams S, et al. | Nephrol Dial Transplant
Aim: To compare the antibody response after two-dose mRNA-1273 versus BNT162b2 vaccination in solid organ transplant (SOT) recipients. UPDATED
INFECTION CONTROL
|
|
|
5/10/22
|
Weng Y, Yi GY | J Med Virol
Aim: To provide sensible estimates of the mean incubation time of COVID-19 by capitalizing on available estimates reported in the literature and exploring different ways to accommodate heterogeneity involved in the reported studies.
CLINICAL CHARACTERISTICS
|
|
|
5/4/22
|
| NSW Health COVID-19 Critical Intelligence Unit
LONG COVID
|
|
|
5/4/22
|
| NSW Health COVID-19 Critical Intelligence Unit
|
|
|
5/4/22
|
| NSW Health COVID-19 Critical Intelligence Unit
|
|
|
5/2/22
|
Chow KW, Pham NV, Ibrahim BM, et al. | Dig Dis Sci
Aim: To analyze every published case of AIH and reviewed their characteristic findings, treatment, and outcomes.
INFECTION CONTROL
|
|
|
5/2/22
|
Rahmani A, Dini G, Leso V, et al. | Med Lav
Aim: To review the evidence on the duration of SARS-CoV-2 shedding and infectivity in the working age population.
INFECTION CONTROL
|
|
|
5/2/22
|
Umesh A, Pranay K, Pandey RC, et al. | Infection
Aim: To perform a rapid review and evidence mapping of systemic complications and symptoms of long-COVID and underlying pathophysiological mechanisms.
|
|
|
5/2/22
|
Madewell ZJ, Yang Y, Longini IM Jr, | JAMA Netw Open
Aim: To evaluate how reported household SARs changed over time and whether SARs varied by viral variant and index case and contact vaccination status.
INFECTION CONTROL
|
|
|
5/2/22
|
Doceda MV, Gavriiloglou M, Petit C, et al. | Oral Health Prev Dent
Aim: To evaluate the potential association of COVID-19 infection with oral health.
CLINICAL CHARACTERISTICS
|
|
|
5/2/22
|
Shahsavarinia K, Rahvar G, Soleimanpour H, et al. | Pak J Med Sci
Aim: To investigate the underlying factors causing pneumothorax, pneumomediastinum, and subcutaneous emphysema in COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
5/2/22
|
McCosker LK, El-Heneidy A, Seale H, et al. | Vaccine
Aim: To identify, analyse the characteristics of, and evaluate the outcomes of, strategies to improve vaccination rates in people who are homeless.
INFECTION CONTROL
|
|
|
5/2/22
|
Gupta S, Jawanda MK | Eur J Neurol
Aim: To evaluate the number of published cases of Bell's palsy as the only major neurological manifestation in patients with COVID-19 from March 2020 to December 2021 and to investigate the association of SARS-CoV2 and Bell's palsy.
CLINICAL CHARACTERISTICS
|
|
|
5/2/22
|
Kow CS, Ramachandram DS, Hasan SS | J Cardiovasc Pharmacol
Aim: To perform a systematic review and meta-analysis to determine the effect of preadmission/prediagnosis use of CCBs on the clinical outcomes in patients with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
4/26/22
|
Geng H, Cao K, Zhang J, et al. | Hum Vaccin Immunother
Aim: To synthesize the attitudes and determinants in vaccination hesitancy of college students.
INFECTION CONTROL
|
|
|
4/26/22
|
Alosaimi B, AlFayyad I, Alshuaibi S, et al. | BMC Sports Sci Med Rehabil
Aim: To measure the prevalence of CV complications suffered by COVID-19 athletic patients, explore the outcomes, optimal approaches to diagnoses, and safe return-to-play considerations.
CLINICAL CHARACTERISTICS
|
|
|
4/26/22
|
Fabrizi F, Alfieri CM, Cerutti R, et al. | Pathogens
Aim: To evaluate the frequency of AKI and dialysis requirement in patients who underwent hospitalization due to COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
4/26/22
|
Deng J, Heybati K, Ramaraju HB, et al. | Infection
Aim: To assess and compare the relative efficacy and safety of anti-SARS-CoV-2 antibody regimens for COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
4/26/22
|
Conti V, Sellitto C, Torsiello M, et al. | JAMA Netw Open
Aim: To identify DDIs that led to adverse clinical outcomes and/or adverse drug reactions in patients with COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
4/26/22
|
Zhang SX, Batra K, Xu W, et al. | Epidemiol Psychiatr Sci
Aim: To provide meta-analytical evidence on mental health symptoms during COVID-19 among frontline healthcare workers, general healthcare workers, the general population and university students in Latin America.
MENTAL HEALTH
|
|
|
4/26/22
|
Sakur FJ, Ward K, Khatri NN, et al. | JMIR Hum Factors
Aim: To review how self-care behaviours have changed for people with chronic conditions during the COVID-19 pandemic, and what technology they have adopted to manage their conditions during that period. UPDATED
MENTAL HEALTH
|
|
|
4/26/22
|
Romeo FJ, Barbagelata L, Chiabrando JG, et al. | Am J Ther
Aim: To conduct an updated systematic review and meta-analysis of randomized clinical trials to assess a potential benefit of colchicine in hospitalized patients with COVID-19 infection. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
4/22/22
|
Luo S, Liang Y, Wong THT, et al. | Int J Epidemiol
Aim: To summarize modifiable factors for coronavirus disease 2019 (COVID-19) suggested by Mendelian randomization studies. UPDATED
|
|
|
4/22/22
|
Giannos P, Katsikas Triantafyllidis K, et al. | Front Neurol
Aim: To screen the current literature and provide a summary of the reported cases of SARS-CoV-2 infected patients presenting with persistent hiccups.
CLINICAL CHARACTERISTICS
|
|
|
4/21/22
|
Sankova MV, Nikolenko VN, Oganesyan MV, et al. | Curr Drug Targets
Aim: To evaluate the pathogenetic relationship between gut microbiota, immunological reactivity disruption and microbiota pathologies with the new coronavirus infection's course in order to substantiate the use of current drugs correcting gut microbiota during the SARS-CoV-2 pandemic.
|
|
|
4/21/22
|
Kastora S, Patel M, Carter B, et al. | Endocrinol Diabetes Metab
Aim: To analyse the collective and geographically stratified mortality, ICU admission, ventilation requirement, illness severity and discharge rate amongst patients with diabetes. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
4/21/22
|
Vinayagamoorthy K, Pentapati KC, Prakash H | Mycoses
Aim: To address the prevalence, underlying diseases, iatrogenic risk factors, treatment and outcome of C. auris infections in COVID-19 patients.
|
|
|
4/19/22
|
Crawshaw AF, Farah Y, Deal A, et al. | Lancet Infect Dis
Aim: Exploring barriers and facilitators of vaccine uptake (categorised using the 5As taxonomy: access, awareness, affordability, acceptance, activation) and sociodemographic determinants of undervaccination among migrants in the EU and European Economic Area, the UK, and Switzerland.
INFECTION CONTROL
|
|
|
4/19/22
|
Chen C, Haupert SR, Zimmermann L, et al. | J Infect Dis
Aim: To examine the worldwide prevalence of post COVID-19 condition.
LONG COVID
|
|
|
4/19/22
|
Alahyari S, Rajaeinejad M, Jalaeikhoo H, et al. | Arch Iran Med
Aim: To evaluate the role of regulatory T cells (Tregs) as one of the main cells that maintain immune homeostasis.
CLINICAL CHARACTERISTICS
|
|
|
4/18/22
|
Haghshomar M, Shobeiri P, Brand S, et al. | J Eat Disord
Aim: To provide a comprehensive overview of symptoms of ED and metabolic changes during the COVID-19 confinement.
MENTAL HEALTH
|
|
|
4/18/22
|
Sabaghian T, Rommasi F, Omidi F, et al. | Bratisl Lek Listy
Aim: To collate the condition and risk factors of AKI and non-AKI COVID-19 patients and to investigate AKI incidence in high-risk patients.
CLINICAL CHARACTERISTICS
|
|
|
4/18/22
|
Sulakshana S, Nayak SS, Perumal S, et al. | Anesth Essays Res
Aim: To review the evidence on the occurance of heparin-induced thrombocytopenia in COVID-19
CANDIDATE THERAPEUTICS
|
|
|
4/18/22
|
Tasoudis PT, Arvaniti CK, Adamou AT, et al. | Eur J Intern Med
Aim: To assess the efficacy of IL-6 inhibitors compared to standard of care (SOC) in COVID-19 patients.
CANDIDATE THERAPEUTICS
|
|
|
4/18/22
|
Ling RR, Ramanathan K, Tan FL, et al. | Lancet Respir Med
Aim: To characterise the incidence of myopericarditis following COVID-19 vaccination, and compare this with non-COVID-19 vaccination.
INFECTION CONTROL
|
|
|
4/18/22
|
Lotan I, Lydston M, Levy M | J Neuroophthalmol
Aim: To summarize the available postmarketing data regarding the occurrence of neuro-ophthalmological and other ocular complications of the COVID-19 vaccines.
INFECTION CONTROL
|
|
|
4/14/22
|
Daniels NF, Burrin C, Chan T, et al. | Curr Dev Nutr
Aim: To explore the indirect effects of the first year of COVID-19 on obesity and its risk factors. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
4/14/22
|
Rahmati M, Shamsi MM, Khoramipour K, et al. | Rev Med Virol
Aim: To explore the hospitalisation, intensive care unit (ICU) admissions, and mortality rates of COVID-19 patients with a history of PA participation before the onset of the pandemic, and to evaluate the reliability of the evidence.
CLINICAL CHARACTERISTICS
|
|
|
4/14/22
|
Panda SK, Mishra A, Pathak M | Cureus
Aim: To analyze the clinical outcomes and SARS-CoV-2 infectivity of neonates born to SARS-CoV-2 positive mothers in India from published literature.
|
|
|
4/14/22
|
Minkove SJ, Sun J, Li Y, et al. | Rev Med Virol
Aim: To analyse studies presenting the adjusted effects specifically of ICI therapy on either survival, a severe event, or need for hospitalisation in cancer patients presenting with COVID-19. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
4/14/22
|
Yang H, Rigsby M, Zhu X, et al. | HERD
Aim: To identify factors associated with LTCF residents' COVID-19 infections and the impacts of the pandemic and the corresponding preventive measures on residents' mental health and behavioral problems.
CLINICAL CHARACTERISTICS
|
|
|
4/14/22
|
Ludhiadch A, Paul SR, Khan R, et al. | Int J Neurosci
Aim: To summarize the available literature on SCV-2 induced ischemic Stroke and its subtypes.
MENTAL HEALTH
|
|
|
4/14/22
|
| NSW Health COVID-19 Critical Intelligence Unit
|
|
|
4/14/22
|
Ortenzi M, Balla A, Botteri E, et al. | Minerva Surg
Aim: To offer a comprehensive overview of the most important recommendations by the International Guidelines about general surgery.
INFECTION CONTROL
|
|
|
4/14/22
|
Ghasemi S, Harmooshi NN, Rahim F | Diagn Pathol
Aim: To investigate the eligible studies for the sensitivity and specificity of rapid tests and explore the factors that influence the result to help better diagnose COVID-19 infection.
DIAGNOSTICS
|
|
|
4/14/22
|
Manothummetha K, Chuleerarux N, Sanguankeo A, et al. | JAMA Netw Open
Aim: To summarize current evidence on vaccine responses and identify risk factors for diminished humoral immune response in recipients of SOT.
|
|
|
4/14/22
|
Umbrello M, Venco R, Antonucci E, et al. | Minerva Anestesiol
Aim: To investigate the incidence, risk factors and clinical outcomes of barotrauma among critically ill COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
4/14/22
|
Modica G, Bianco M, Sollazzo F, et al. | Int J Environ Res Public Health
Aim: To assess the event rates of myocarditis detected by Cardiac Magnetic Resonance (CMR) in athletes who recovered from COVID-19. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
4/14/22
|
Ulbrichtova R, Svihrova V, Svihra J | Int J Environ Res Public Health
Aim: To evaluate the prevalence of COVID-19 vaccination among medical students worldwide. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
4/14/22
|
Vieira AGDS, Pinto ACPN, Garcia BMSP, et al. | J Physiother
Aim: To review the evidence on the effectiveness and safety of telerehabilitation for people with COVID-19 and post-COVID-19 conditions. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
4/14/22
|
Wang H, Li N, Sun C, et al. | Am J Emerg Med
Aim: To explore whether pregnancy increases the risk of adverse outcomes of COVID-19.
MENTAL HEALTH
|
|
|
4/14/22
|
Su W, Wang H, Sun C, et al. | Am J Prev Med
Aim: To assess the association between previous influenza vaccination and COVID-19 on the basis of the available evidence. UPDATED
|
|
|
4/14/22
|
Jia L, Carter MV, Cusano A, et al. | Am J Sports Med
Aim: To investigate the effect of the COVID-19 pandemic on the mental and emotional health of athletes and to identify risk factors associated with poor mental health outcomes.
INFECTION CONTROL
|
|
|
4/11/22
|
Litwinowicz K, Choroszy M, Ornat M, et al. | Sci Rep
Aim: To provide a comprehensive evaluation of the face masks and disposable FFRs effects on human physiology during low, moderate, and high-intensity activities. UPDATED
INFECTION CONTROL
|
|
|
4/11/22
|
Palaiodimou L, Stefanou MI, de Sousa DA, et al. | J Neurol
Aim: To better characterize TTS-associated CVST, along with the therapeutic and prognostic implications, compared to non-TTS–CVST cases.
INFECTION CONTROL
|
|
|
4/11/22
|
Koupaei M, Mohamadi MH, Yashmi I, et al. | J Clin Lab Anal
Aim: To evaluate the features of COVID-19 relapse patients.
CLINICAL CHARACTERISTICS
|
|
|
4/11/22
|
Huang D, Zunong J, Li M, et al. | Curr HIV/AIDS Rep
Aim: To review the evidence on the epidemiological characteristics and clinical presentation of coinfected patients in China, as well as laboratory indicators, antiretroviral therapy status, and disease outcomes in PLHIV coinfected with CoV.
CLINICAL CHARACTERISTICS
|
|
|
4/11/22
|
Perry J, Osman S, Wright J, et al. | PLoS One
Aim: To assess the evidence for a humoral CoP for SARS-CoV-2.
INFECTION CONTROL
|
|
|
4/11/22
|
Boden I, Bernabeu MO, Dhillon B, et al. | Diabetes Res Clin Pract
Aim: To test the hypothesis that pre-existing diabetic retinopathy (DR), a microvascular disease, is a prognostic indicator for poor COVID-19 outcome in this heterogeneous population.
CLINICAL CHARACTERISTICS
|
|
|
4/11/22
|
Chaudhry ZS, Nellessen N, Reis C, et al. | Fam Pract
Aim: To identify and summarize clinical reports of acute inflammatory arthritis associated with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
4/11/22
|
Edilgireeva LA, Sadulaeva TA, Zakharov VV, et al. | Zh Nevrol Psikhiatr Im S S Korsakova
Aim: To assess the effect of antiplatelet therapy on the risk of thrombotic complications and disease course in SARS-COV-2 infected patients.
CANDIDATE THERAPEUTICS
|
|
|
4/11/22
|
Thornton GM, Fleck BA, Fleck N, et al. | PLoS One
Aim: To examine the effectiveness of HVAC design features in reducing virus transmission. UPDATED
INFECTION CONTROL
|
|
|
4/8/22
|
Nawabi NLA, Duey AH, Kilgallon JL, et al. | J Neurointerv Surg
Aim: To review the evidence on how COVID-19 affected stroke response times.
INFECTION CONTROL
|
|
|
4/8/22
|
Wake AD | Glob Pediatr Health
Aim: To evaluate the potential intrauterine vertical transmission of a novel SARS-CoV-2 among confirmed cases of pregnant women.
MENTAL HEALTH
|
|
|
4/8/22
|
Han P, Duan X, Zhao S, et al. | Front Public Health
Aim: To summarize and evaluate the actual psychological experience of nurses caring for patients with severe pneumonia in the ICUs during the COVID-19 pandemic.
|
|
|
4/8/22
|
Marmitt DJ | Inflammopharmacology
Aim: To select clinical trials with anti-inflammatory plants and relate the activity of these plants to inflammatory markers of SARS-CoV-2 infection.
|
|
|
4/8/22
|
Fallah-Aliabadi S, Fatemi F, Heydari A, et al. | Public Health Nurs
Aim: To identify and categorize social vulnerability indicators in the COVID-19 pandemic.
CANDIDATE THERAPEUTICS
|
|
|
4/7/22
|
Hopefl R, Ben-Eltriki M, Deb S | J Pharm Pharm Sci
Aim: To analyze the association of vitamin D levels with the inflammatory markers in COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
4/7/22
|
Rahmani AM, Azhir E, Naserbakht M, et al. | Multimed Tools Appl
Aim: To review the evidence on the application of Machine Learning (ML) methods for the detection of COVID-19.
DIAGNOSTICS
|
|
|
4/7/22
|
Naimi A, Yashmi I, Jebeleh R, et al. | J Clin Lab Anal
Aim: To review the literature reporting the COVID-19 outcomes in patients with hematological malignancies.
CLINICAL CHARACTERISTICS
|
|
|
4/7/22
|
Fu XL, Qian Y, Jin XH, et al. | Lupus
Aim: To evaluate the epidemiology of SLE and COVID-19, to identify the clinical characteristics of SLE patients with COVID-19, to clarify the treatment of COVID-19 in SLE patients and to assess the impact of COVID-19 pandemic on SLE patients.
CLINICAL CHARACTERISTICS
|
|
|
4/7/22
|
Yazdani A, Mirmosayyeb O, Ghaffary EM, et al. | Neurol Sci
Aim: To determine the pooled prevalence of vaccination willingness, unwillingness, and hesitancy among patients with multiple sclerosis.
INFECTION CONTROL
|
|
|
4/7/22
|
Alimoradi Z, Abdi F, Gozal D, et al. | BMJ Open
Aim: To estimate the sleep problems among pregnant women during the COVID-19 pandemic.
MENTAL HEALTH
|
|
|
4/7/22
|
Lee TC, Vigod S, Bortolussi-Courval É, et al. | JAMA Netw Open
Aim: To perform a meta-analysis of the available randomized clinical trial evidence for fluvoxamine in the outpatient management of COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
4/7/22
|
Bhuta S, Khokher W, Kesireddy N, et al. | Am J Ther
Aim: To investigate the efficacy of fluvoxamine in nonhospitalized patients with acute COVID-19 infection.
CANDIDATE THERAPEUTICS
|
|
|
4/7/22
|
Fadlalla M, Ahmed M, Ali M, et al. | Curr Pharmacol Rep
Aim: To review and summarize research of FDA-approved drugs repurposed against SARS-CoV-2 virus.
CANDIDATE THERAPEUTICS
|
|
|
4/7/22
|
Mahdizade Ari M, Mohamadi MH, Shadab Mehr N, et al. | J Clin Lab Anal
Aim: To evaluate the prevalence of neurological complications arises from SARS-CoV-2 and assess the mortality rate from neurological complications.
CLINICAL CHARACTERISTICS
|
|
|
4/7/22
|
Yasmin F, Najeeb H, Moeed A, et al. | PLoS One
Aim: To evaluate the safety profile of colchicine in COVID-19 patients using the gold-standard randomised-control trials.
CANDIDATE THERAPEUTICS
|
|
|
4/7/22
|
James D, Jena A, Bharath PN, et al. | Dig Liver Dis
Aim: To review the evidence on the various adverse events following COVID-19 vaccination in patients with IBD in order to inform the clinicians and patients regarding the (lack of) risks) of COVID vaccination.
INFECTION CONTROL
|
|
|
4/7/22
|
J Devoe D, Han A, Anderson A, et al. | Int J Eat Disord
Aim: To synthesize the impact of the COVID-19 pandemic on individuals with EDs. UPDATED
MENTAL HEALTH
|
|
|
4/6/22
|
Gupta AK, Leslie A, Hewitt JN, et al. | ANZ J Surg
Aim: To characterize outcomes of COVID-19 positive patients undergoing cardiac surgery. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
4/6/22
|
Bailey CJ, Gwilt M | Front Pharmacol
Aim: To review the clinical literature on clinical outcomes in metformin-treated subjects presenting with Covid-19.
CANDIDATE THERAPEUTICS
|
|
|
4/6/22
|
Theberath M, Bauer D, Chen W, et al. | SAGE Open Med
Aim: To summarize existing survey studies addressing the effects of the current COVID-19 pandemic on the mental health of children and adolescents.
MENTAL HEALTH
|
|
|
4/6/22
|
Gao Y, Bagheri N, Furuya-Kanamori L | Z Gesundh Wiss
Aim: To investigate the impact of the coronavirus lockdowns on ED symptoms severity and summarize factors associated with lockdowns that led to changes in eating disorders.
MENTAL HEALTH
|
|
|
4/6/22
|
Iheanacho CO, Eze UIH | Futur J Pharm Sci
Aim: To evaluate the clinical and laboratory features associated with BNT162b2 messenger RNA COVID-19 vaccine, Ad26.COV2.S and ChAdOx1 adenoviral vector COVID-19 vaccines, to determine their immunogenicity.
INFECTION CONTROL
|
|
|
4/6/22
|
Rauniyar R, Mishra A, Kharel S, et al. | Can J Infect Dis Med Microbiol
Aim: To evaluate the optimal treatment using IVIG alone versus IVIG plus glucocorticoids.
CANDIDATE THERAPEUTICS
|
|
|
4/6/22
|
Liu M, Mei K, Tan Z, et al. | Can J Gastroenterol Hepatol
Aim: To evaluate the relationship between liver fibrosis scores and adverse outcomes in patients with COVID-19, as well as potential dose-response association. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
4/6/22
|
Calvert C, John J, Nzvere FP, et al. | Glob Health Action
Aim: To report the findings of a rapid systematic review of studies on levels of maternal mortality before and during the COVID-19 pandemic. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
4/6/22
|
Moya-Salazar J, Nuñez E, Jaime-Quispe A, et al. | Subst Abuse
Aim: To determine the frequency of substance use among Latin American HCWs.
MENTAL HEALTH
|
|
|
4/5/22
|
Ao G, Li A, Wang Y, et al. | Am J Emerg Med
Aim: To investigate the association between opioid usage and COVID-19 prognosis. UPDATED
|
|
|
4/4/22
|
Patanavanich R, Siripoon T, Amponnavarat S, et al. | Nicotine Tob Res
Aim: To explore the association between current smoking and the risk for mortality due to COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
4/4/22
|
Fomenko A, Weibel S, Moezi H, et al. | Rev Med Virol
Aim: To review the evidence on RT-PCR performance in detecting infectious SARS-CoV-2. UPDATED
DIAGNOSTICS
|
|
|
4/4/22
|
Silverberg SL, Zhang BY, Li SNJ, et al. | BMC Pediatr
Aim: To identify the role of children in SARS-CoV-2 transmission to other children and adults.
INFECTION CONTROL
|
|
|
4/4/22
|
Wang Y, Kang L, Chien CW, et al. | Front Cardiovasc Med
Aim: To compare the characteristics, management, and clinical outcomes between the COVID-19 and non-COVID-19 patients concomitant STEMI. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
4/4/22
|
Mondal R, Mishra S, Pillai JSK, et al. | J Family Prim Med Care
Aim: To identify the impacts of the pandemic on biomedical waste management.
|
|
|
4/4/22
|
Mohanty RR, Biswa Mohan Padhy, Meher BR | J Pharm Pharm Sci
Aim: To determine the efficacy and safety of the pulse dose methyl prednisolone in management of COVID-19. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
4/4/22
|
Len P, Iskakova G, Sautbayeva Z, et al. | Front Cardiovasc Med
Aim: To assess the association between early hemostatic parameters and infection severity.
CLINICAL CHARACTERISTICS
|
|
|
4/4/22
|
Yang F, Xu Y, Dong Y, et al. | Pancreatology
Aim: To determine the pooled prevalence and prognostic significance of increased pancreatic enzymes in adult patients with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
4/4/22
|
Mazidimoradi A, Alemzadeh E, Alemzadeh E, et al. | Life Sci
Aim: To evaluate the effect of polyunsaturated fatty acids on the prognosis of Covid-19 disease.
CANDIDATE THERAPEUTICS
|
|
|
4/4/22
|
Mirhashemi A, Khami MR, Kharazifard M, et al. | Front Public Health
Aim: To systematically review the relationship between oral habits (bruxism- temporomandibular disorders) and COVID-19 pandemic in adults and adolescents.
MENTAL HEALTH
|
|
|
4/1/22
|
van Mulukom V, Pummerer LJ, Alper S, et al. | Soc Sci Med
Aim: To provide a comprehensive overview of the available research on COVID-19 conspiracy beliefs and to synthesise this research to make it widely accessible.
INFECTION CONTROL
|
|
|
4/1/22
|
Khedr A, Al Hennawi H, Rauf I, et al. | Infez Med
Aim: To assess and compare mortality outcomes between LMICs and high-income countries (HICs).
CLINICAL CHARACTERISTICS
|
|
|
4/1/22
|
El-Qushayri AE, Mahmoud MA, Salman S, et al. | Dermatol Ther
Aim: To evaluate the safety of dupilumab use in the management of atopic dermatitis (AD) during the current pandemic regarding the risk and the hazards of COVID-19 infection.
CLINICAL CHARACTERISTICS
|
|
|
4/1/22
|
Bhurwal A, Mutneja H, Bansal V, et al. | Aliment Pharmacol Ther
Aim: To summarize the available literature regarding the safety and effectiveness of SARS-CoV-2 vaccine in IBD.
INFECTION CONTROL
|
|
|
4/1/22
|
Yasuda H, Mayumi T, Okano H | Infection
Aim: To examine the effects of anticoagulant doses administered to patients with COVID-19. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
4/1/22
|
Kim DH, Kim SW, Kang M, et al. | Clin Otolaryngol
Aim: To assess the effect of topical steroids on acute-onset olfactory dysfunction in patients infected with COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
4/1/22
|
Ma BM, Tam AR, Chan KW, et al. | Front Med
Aim: To review the evidence on the efficacy and safety of COVID-19 vaccine in patients on RRT. UPDATED
INFECTION CONTROL
|
|
|
4/1/22
|
Patterson PD, Mcilvaine QS, Nong L, et al. | J Am Coll Emerg Physicians Open
Aim: To assess the evidence regarding masking in the workplace during the initial months of the COVID?19 pandemic.
INFECTION CONTROL
|
|
|
4/1/22
|
Wang F, Ma Y, Xu S, et al. | Clin Rheumatol
Aim: To assess the risk of COVID-19 in patients with rheumatic diseases.
CLINICAL CHARACTERISTICS
|
|
|
4/1/22
|
Su Y, Rao W, Li M, et al. | Int Psychogeriatr
Aim: To provide up-to-date pooled estimates of the prevalence of social isolation and loneliness among older adults during the COVID-19 pandemic and other pandemics in the last two decades. UPDATED
MENTAL HEALTH
|
|
|
4/1/22
|
Figueiredo EAB, Silva WT, Tsopanoglou SP, et al. | Rev Soc Bras Med Trop
Aim: To discuss the main findings regarding HRQoL in post-COVID-19 patients who required hospitalization.
CLINICAL CHARACTERISTICS
|
|
|
3/31/22
|
Liu G, Chen Y, Runa A, et al. | Eur Radiol
Aim: To provide an updated overview of the diagnostic performance of CO-RADS in COVID-19, with a focus on the possible practical application of CO-RADS.
DIAGNOSTICS
|
|
|
3/31/22
|
Diallo A, Carlos-Bolumbu M, Diallo MH, et al. | Z Gesundh Wiss
Aim: To optimize vaccination strategy, evidence on vaccine efficacy against COVID-19 is needed. UPDATED
INFECTION CONTROL
|
|
|
3/31/22
|
Abdel-Gawad M, Zaghloul MS, Abd-Elsalam S, et al. | Antiinflamm Antiallergy Agents Med Chem
Aim: To assess the prevalence of post-COVID-19 manifestations.
LONG COVID
|
|
|
3/31/22
|
de Oliveira YLM, de Sa Resende A, Martins-Filho PR, et al. | Inflammopharmacology
Aim: To evaluate the expression of TREM-1 in patients with COVID-19 and other viral pneumonias compared to healthy individuals.
CLINICAL CHARACTERISTICS
|
|
|
3/31/22
|
Hong S, Wang H, Zhang Z, et al. | Steroids
Aim: To evaluate the efficacy and safety of methylprednisolone in the treatment of patients with COVID-19 compared with no corticosteroids therapy.
CANDIDATE THERAPEUTICS
|
|
|
3/30/22
|
Zheng W, Sun HL, Cai H, et al. | J Affect Disord
Aim: To evaluate the efficacy and safety of adjunctive antidepressants for COVID-19 patients.
CANDIDATE THERAPEUTICS
|
|
|
3/30/22
|
Yu SY, Koh DH, Choi M, et al. | Emerg Microbes Infect
Aim: To investigate the efficacy and safety of interleukin-6 (IL-6) receptor antagonists with standard care treatment in patients with coronavirus disease 2019 (COVID-19). UPDATED
CANDIDATE THERAPEUTICS
|
|
|
3/30/22
|
Almamlouk R, Kashour T, Obeidat S, et al. | Clin Microbiol Infect
Aim: To better understand the pathologic cardiac findings in COVID-19 patients at the time of postmortem evaluation.
CLINICAL CHARACTERISTICS
|
|
|
3/30/22
|
Zuin M, Bilato C, Quadretti L, et al. | G Ital Cardiol
Aim: To determine the in-hospital incidence of acute PE, based on Italian studies published on this issue.
CLINICAL CHARACTERISTICS
|
|
|
3/30/22
|
Kim AY, Woo W, Yon DK, et al. | Int J Infect Dis
Aim: To meta-analyze the clinical manifestations, diagnosis, treatment, and mortality of vaccine-induced immune thrombotic thrombocytopaenia (VITT) after adenoviral vector vaccination.
INFECTION CONTROL
|
|
|
3/28/22
|
Whited N, Cervantes J | Breastfeed Med
Aim: To investigate the presence of antibodies to SARS-CoV-2 in human breast milk after vaccination.
INFECTION CONTROL
|
|
|
3/28/22
|
Asiimwe IG, Pushpakom SP, Turner RM, et al. | Br J Clin Pharmacol
Aim: To review the evidence on cardiovascular drug exposure and COVID-19 clinical outcomes.
CLINICAL CHARACTERISTICS
|
|
|
3/28/22
|
Beran A, Mhanna M, Srour O, et al. | Clin Nutr ESPEN
Aim: To provide a quantitative assessment of the clinical significance of micronutrient supplements in patients with COVID-19.
CANDIDATE THERAPEUTICS
|
|
|
3/28/22
|
García H, Allende-López A, Morales-Ruíz P, et al. | Arch Med Res
Aim: To conduct a systematic review of the literature on published studies of COVID-19 in newborns with a positive RT–PCR test.
CLINICAL CHARACTERISTICS
|
|
|
3/28/22
|
Sriwastava S, Sharma K, Khalid SH, et al. | Brain Sci
Aim: To discern CNS and PNS manifestations following the COVID-19 vaccine to help produce methods to mitigate them.
INFECTION CONTROL
|
|
|
3/28/22
|
Patwary MM, Alam MA, Bardhan M, et al. | Vaccines
Aim: To estimate COVID-19 vaccine acceptance and hesitance rates among the people of LMICs.
INFECTION CONTROL
|
|
|
3/28/22
|
Co M, Wong PCP, Kwong A | Cancer Treat Res Commun
Aim: To evaluate the best available evidence of axillary lymphadenopathy after COVID-19 vaccination.
INFECTION CONTROL
|
|
|
3/28/22
|
Alboksmaty A, Beaney T, Elkin S, et al. | Lancet Digit Health
Aim: To assess the effectiveness and safety of the use of pulse oximetry in the remote monitoring of patients at home with COVID-19. UPDATED
|
|
|
3/28/22
|
Gao P, Cai S, Liu Q, et al. | Vaccines
Aim: To evaluate the effectiveness and safety of SARS-CoV-2 vaccines in children and adolescents.
INFECTION CONTROL
|
|
|
3/28/22
|
Ghazy RM, Ashmawy R, Hamdy NA, et al. | Vaccines
Aim: To assess the efficacy and effectiveness of COVID-19 vaccines to prevent mortality and reduce the risk of developing severe disease after the 1st and 2nd doses.
INFECTION CONTROL
|
|
|
3/28/22
|
Garcia-Sanchez A, Peña-Cardelles JF, Ruiz S, et al. | J Clin Med
Aim: To evaluate the efficacy of different mouthwashes on the reduction of salivary viral load of SARS-CoV-2 in COVID-19 positive patients confirmed with RT-PCR tests as pre-procedural rinses.
INFECTION CONTROL
|
|
|
3/28/22
|
Fabbri L, Moss S, Khan FA, et al. | Thorax
Aim: To assess the proportion of chest CT scans and pulmonary function tests consistent with parenchymal lung disease in the follow-up of people hospitalised with COVID-19 and viral pneumonitis.
CLINICAL CHARACTERISTICS
|
|
|
3/28/22
|
Maglietta G, Diodati F, Puntoni M, et al. | J Clin Med
Aim: To identify, in patients who had been hospitalized for COVID-19, which factors already present or emerging during hospitalization, were associated with an increased risk of exhibiting new or persisting symptoms. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
3/28/22
|
Gentile F, Bocci T, Coppola S, et al. | Biomedicines
Aim: To discuss current clinical and pre-clinical data on the relationship between the lung and brain during COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
3/28/22
|
De Rose DU, Salvatori G, Dotta A, et al. | Viruses
Aim: To summarize current knowledge about maternal and neonatal outcomes following COVID-19 vaccination during pregnancy and breastfeeding.
INFECTION CONTROL
|
|
|
3/28/22
|
Riccò M, Ferraro P, Peruzzi S, et al. | Microorganisms
Aim: To summarize the available data about the risk of co-infections SARS-CoV-2–Legionella, specifically focusing on their prevalence, risk factors, and two main outcomes—ICU admission and case fatality ratio (CFR).
CLINICAL CHARACTERISTICS
|
|
|
3/28/22
|
Li S, Ren J, Hou H, et al. | Neurol Sci
Aim: To investigate the association between stroke and the risk for mortality among coronavirus disease 2019 (COVID-19) patients.
CLINICAL CHARACTERISTICS
|
|
|
3/28/22
|
Batteux E, Mills F, Jones LF, et al. | Vaccines
Aim: To identify and evaluate the effectiveness of interventions which can increase COVID-19 vaccine uptake. UPDATED
INFECTION CONTROL
|
|
|
3/28/22
|
Furnica C, Chistol RO, Chiran DA, et al. | Diagnostics
Aim: To evaluate the impact of the early COVID-19 pandemic on the presentation, management, and prognosis of STEMI patients. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
3/28/22
|
Fatima K, Almas T, Lakhani S, et al. | Trop Med Infect Dis
Aim: To address the relationship between the use of PPI and the severity of COVID-19 infection.
INFECTION CONTROL
|
|
|
3/28/22
|
Bania A, Pitsikakis K, Mavrovounis G, et al. | J Pers Med
Aim: To summarize the most recent evidence regarding the therapeutic role of vitamin D on severe COVID-19 outcomes (length of hospital stay, mechanical ventilation, mortality) in adult populations. UPDATED
CANDIDATE THERAPEUTICS
|
|
|
3/28/22
|
Decyk A, Kobylinska M, Antosik K, et al. | Rocz Panstw Zakl Hig
Aim: To review the current literature on the influence and importance of vitamin D levels on the course of SARS-CoV-2 infection.
CLINICAL CHARACTERISTICS
|
|
|
3/25/22
|
Seirafianpour F, Pourriyahi H, Mesgarha MG, et al. | Dermatol Ther
Aim: To review the evidence on the dermatologic side effects of COVID-19 vaccinations.
INFECTION CONTROL
|
|
|
3/25/22
|
Muthuka JK, Kiptoo M, Oluoch K, et al. | JMIR Pediatr Parent
Aim: To examine the relationship between pregnancy status and the clinical COVID -19 severity characterized by cytokine storm. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
3/25/22
|
Jefferson L, Golder S, Heathcote C, et al. | Br J Gen Pract
Aim: To synthesise international evidence exploring the impact of COVID-19 on primary care doctors' mental health and wellbeing, and identify risk factors associated with their psychological wellbeing during this time.
MENTAL HEALTH
|
|
|
3/25/22
|
Beran A, Srour O, Malhas SE, et al. | Respir Care
Aim: To evaluate the effect of HFNC vs. NIV in COVID-19-related AHRF.
CANDIDATE THERAPEUTICS
|
|
|
3/25/22
|
He Y, Liu N, Zhuang X, et al. | Ther Adv Respir Dis
Aim: To compare the effectiveness and value of high-flow nasal cannula (HFNC) with noninvasive ventilation (NIV) for COVID-19 patients.
CANDIDATE THERAPEUTICS
|
|
|
3/25/22
|
Tan CJ, Tan BKJ, Tan XY, et al. | Laryngoscope
Aim: To review the evidence on the pathogenesis of COVID-19 olfactory dysfunction.
CLINICAL CHARACTERISTICS
|
|
|
3/25/22
|
Mutua V, Henry BM, Csefalvay CV, et al. | Acta Biomed
Aim: To explore the clinical benefits and safety of tocilizumab in addition to standard of care (SOC) in treating patients with coronavirus disease 2019 (COVID-19). UPDATED
CANDIDATE THERAPEUTICS
|
|
|
3/25/22
|
Helman SN, Adler J, Jafari A, et al. | Allergy Asthma Proc
Aim: To review the evidence on the medical and procedural treatment options for PVOD.
CANDIDATE THERAPEUTICS
|
|
|
3/24/22
|
Bhakta S, Erben Y, Sanghavi D, et al. | J Vasc Surg Venous Lymphat Disord
Aim: To assess the association between race and VTE in hospitalized COVID-19 patients.
CLINICAL CHARACTERISTICS
|
|
|
3/24/22
|
Bitterman A, Martins CP, Cices A, et al. | JAMA Netw Open
Aim: To evaluate the association between regional prevalence of strongyloidiasis and ivermectin trial results for the outcome of mortality by testing the hypothesis that strongyloidiasis prevalence interacts with the RR of mortality.
CANDIDATE THERAPEUTICS
|
|
|
3/24/22
|
Jeon SR, Kang JW, Ang L, et al. | Integr Med Res
Aim: To create an evidence map which includes information for the CAM interventions according to what those interventions have strong evidence and those that need further testing.
CANDIDATE THERAPEUTICS
|
|
|
3/24/22
|
Farsi Y, Tahvildari A, Arbabi M, et al. | Front Cell Infect Microbiol
Aim: To evaluate the composition of gut microbiota in COVID-19 patients compared with healthy individuals.
CLINICAL CHARACTERISTICS
|
|
|
3/24/22
|
Alimoradi Z, Ohayon MM, Griffiths MD, et al. | BJPsych Open
Aim: To synthesize empirical evidence to understand fear of COVID-19 and its associations with mental health-related problems during this pandemic period. UPDATED
|
|
|
3/24/22
|
Seyferth AV, Wood SM, Kane RL, et al. | Plast Reconstr Surg
Aim: To quantify the prevalence of ethical discussions and representation of the four ethical principles in COVID-19 research, and to identify which principles and topics are underrepresented across scientific disciplines.
|
|
|
3/24/22
|
Tutal E, Ozaras R, Leblebicioglu H | Travel Med Infect Dis
Aim: To assess the prevalence, clinical features and outcome of autoimmune thyroid disorders triggered by COVID-19. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
3/21/22
|
Crivelli L, Palmer K, Calandri I, et al. | Alzheimers Dement
Aim: To review the evidence on the cognitive effects of coronavirus disease 2019 (COVID-19) in adults with no prior history of cognitive impairment. UPDATED
MENTAL HEALTH
|
|
|
3/21/22
|
Wang F, Zhang L, Ding L, et al. | Front Public Health
Aim: To review the evidence on the fear among college students during the COVID-19 pandemic. UPDATED
MENTAL HEALTH
|
|
|
3/21/22
|
Lee KW, Ang CS, Lim SH, et al. | HIV Med
Aim: To assess the prevalence of depression, anxiety, psychological stress, insomnia and loneliness among PLHIV during the COVID-19 pandemic. UPDATED
MENTAL HEALTH
|
|
|
3/21/22
|
Allotey J, Chatterjee S, Kew T, et al. | BMJ
Aim: To assess the rates of SARS-CoV-2 positivity in babies born to mothers with SARS-CoV-2 infection, the timing of mother-to-child transmission and perinatal outcomes, and factors associated with SARS-CoV-2 status in offspring.
CLINICAL CHARACTERISTICS
|
|
|
3/21/22
|
Huang YZ, Kuan CC | Eur Rev Med Pharmacol Sci
Aim: To examine the efficacy of different types of vaccines in reducing hospitalization rates, disease severity, and mortality.
INFECTION CONTROL
|
|
|
3/18/22
|
Kumar R, Rai AK, Phukan MM, et al. | Curr Genomics
Aim: To assess the cumulative risk assessment of multiple co-morbid conditions associated with severe COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
3/18/22
|
Ashktorab H, Russo T, Oskrochi G, et al. | Gastro Hep Adv
Aim: To analyze data from studies reporting Gastrointestinal bleeding (GIB) and/or endoscopic findings in COVID-19 patients in Western countries.
CLINICAL CHARACTERISTICS
|
|
|
3/18/22
|
Gatti M, Rinaldi M, Bussini L, et al. | Clin Microbiol Infect
Aim: To assess the clinical outcome in SOT recipients with COVID-19 compared to general population.
CLINICAL CHARACTERISTICS
|
|
|
3/18/22
|
Glenardi G, Chriestya F, Oetoro BJ, et al. | Acute Crit Care
Aim: To investigate the efficacy of HFNC compared to NIV in COVID-19 patients.
CANDIDATE THERAPEUTICS
|
|
|
3/18/22
|
Rawal S, Tackett RL, Stone RH, et al. | Am J Obstet Gynecol MFM
Aim: To identify and synthesize what is known about COVID-19 vaccination amongst pregnant people in the U.S., including safety, effectiveness, acceptance, hesitancy, and uptake of COVID-19 vaccinations. UPDATED
INFECTION CONTROL
|
|
|
3/18/22
|
Mekonnen BD, Mengistu BA | Clin Epidemiol Glob Health
Aim: To estimate the pooled proportion of COVID-19 vaccine acceptance and its determinants in Ethiopia. UPDATED
INFECTION CONTROL
|
|
|
3/18/22
|
Fatima M, Ahmad Cheema H, Ahmed Khan MH, et al. | Ann Med Surg
Aim: To provide a detailed account of the development of myocarditis and pericarditis following the COVID-19 vaccination UPDATED
CLINICAL CHARACTERISTICS
|
|
|
3/18/22
|
Nikpour M, Sepidarkish M, Omidvar S, et al. | Expert Rev Vaccines
Aim: To evaluate the acceptance of a coronavirus disease 2019 (COVID-19) vaccine among pregnant women and its determinants.
INFECTION CONTROL
|
|
|
3/18/22
|
Hartwell M, Lin V, Gatewood A, et al. | J Matern Fetal Neonatal Med
Aim: To examine the inclusion of the equity reporting in SRMAs focused on pregnancy outcomes and COVID-19 using PROGRESS-Plus equity framework.
CLINICAL CHARACTERISTICS
|
|
|
3/18/22
|
Gong X, Yuan B, Yuan Y | PLoS One
Aim: To assess the pooled incidence of pulmonary embolic events and the prognostic value of such events in intensive care unit (ICU) admissions of patients with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
3/18/22
|
Obstetric and perinatal outcomes of pregnancies with COVID 19: a systematic review and meta-analysis
Perez-Lopez FR, Saviron-Cornudella R, Chedraui P, et al. | J Matern Fetal Neonatal Med
Aim: To compare obstetric and perinatal outcomes in laboratory-tested pregnant women for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection before delivering.
CLINICAL CHARACTERISTICS
|
|
|
3/18/22
|
Qi X, Northridge ME, et al. | Aging Health Res
Aim: To determine the prevalence of oral health conditions in participants with COVID-19 infection and identify the associations of oral health conditions with COVID-19 related outcomes. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
3/18/22
|
Zou Y, Han M, Wang J, et al. | Ann Transl Med
Aim: To compare the mortality risk of frail vs. non-frail hospitalized patients with COVID-19.
CLINICAL CHARACTERISTICS
|
|
|
3/18/22
|
Jaiswal V, Almas T, Peng Ang S, et al. | Ann Med Surg
Aim: To find the symptoms, risk factors, clinical findings, and outcomes in patient of COVID-19 having STEMI. UPDATED
CLINICAL CHARACTERISTICS
|
|
|
3/18/22
|
Ripp T, Roer JP, et al. | BMC Psychol
Aim: To review the evidence on the association between COVID-19-related conspiracy belief and infection-preventive behavior and vaccination willingness.
INFECTION CONTROL
|
|
|
3/18/22
|
Silva A, Azevedo M, Sampaio-Maia B, et al. | J Am Dent Assoc
Aim: To assess the effectiveness of mouthrinses in reducing SARS-CoV-2 viral load. UPDATED
INFECTION CONTROL
|
|
|
3/18/22
|
Aem L, Morath LP, Burstrom B, et al. | BMC Health Serv Res
Aim: To examine the impact of facility and staff characteristics on the risk of infectious disease outbreaks in care homes.
INFECTION CONTROL
|
|
|
3/18/22
|
Kamal L, Ramadan A, Farraj S, et al. | Saudi Pharm J
Aim: To review the evidence on molnupiravir safety and anti-viral activity.
CANDIDATE THERAPEUTICS
|
|
|
3/18/22
|
Mbunge E, Batani J, Gaobotse G, et al. | Glob Health J
Aim: To identify virtual healthcare services and digital health technologies deployed in South Africa during coronavirus disease 2019 (COVID-19) and the challenges associated with their use.
INFECTION CONTROL
|
|
|
3/14/22
|
Argano C, Mallaci Bocchio R, Lo Monaco M, et al. | Int J Mol Sci
Aim: To assess the association between vitamin D supplementation and inflammatory markers in patients with diabetes; furthermore, vitamin D’s possible role in COVID-19 patients was assessed as well.
CANDIDATE THERAPEUTICS
|
|
|
3/14/22
|